AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISE..

The Liver Meeting 2024

 

November 15-19, 2024 San Diego
Close
N. Poster
Poster title
Applicant name
Status
  1002-FRI Mechanosensitive regulation of LXR by YAP/TAZ determines hepatic cholesterol accumulation Na Young Lee Received Received
  1003-FRI Liver single-cell RNA transcriptome evolution in response to diet-induced MASH/fibrosis Simeng Wang Received Received
  1005-FRI Soluble Siglec-9 improves intestinal barrier function in a mouse model of metabolic-dysfunction associated steatohepatitis (MASH) Hisanori Muto Received Received
  1006-FRI A new therapeutic approach for MASLD/MASH treatment Takashi Tsuchiya Received Received
  1007-FRI 11β-HSD1 inhibition on non-alcoholic fatty liver disease: Investigating immune cell dynamics via single-cell mass cytometry Dae Won Jun Received Received
  1008-FRI DGAT2 Inhibition Blocks Activation of SREBP-1 and Improves Hepatic Steatosis by Increasing ER Phosphatidylethanolamine Shunxing Rong Received Received
  1009-FRI Cytoplasmic export of circPOLD1 promotes metabolic dysfunction-associated steatohepatitis liver disease through interaction with HuR Qingmin Zeng Received Received
  1012-FRI Hepatic chenodeoxycholic acid promotes MASH with HCC in high-fat/high-sucrose diet-fed mice with human-like bile acid composition Hajime Ueda Received Received
  1015-FRI The role of BH3-only protein Noxa in metabolic dysfunction-associated steatotic liver disease. SHINNOSUKE KUDO Received Received
  1016-FRI The increased IL-1β secretion of macrophages accompanying autophagy dysfunction enhances the inflammatory chemokine expression of LSECs, contributing to the progression of MASH pathology Kenji Fukumoto Received Received
  1019-FRI Extracellular vesicles derived from the iPS-derived mesenchymal stem cells ameliorated liver fibrosis and fatty deposition in MASLD-related cirrhotic mice. Tsuyoshi Fujioka Received Received
  1021-FRI Generating hepatic cells expressing the various PNPLA3-I148M variants by prime editing. Takuro Uchida Received Received
  1024-FRI Murine MASH livers display bias towards a hypertrophic mechanism of regeneration following partial hepatectomy Maylene Yu Received Received
  1025-FRI Endothelial-stellate cell crosstalk underlies fibrosis resolution in liver Kenneth Li Received Received
  1027-FRI Impact of adult-onset, hepatocyte-specific, loss of the growth hormone receptor on MASH progression Mercedes del Rio-Moreno Received Received
  1028-FRI Oxidized LDL´s Role in MASLD: Insights from Liver Spheroid Transcriptomics Ana Maretti-Mira Received Received
  1030-FRI WFDC2 promotes MASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia Peiyu Wu Received Received
  1034-FRI ROLE OF STARD1 IN HEPATIC MITOCHONDRIAL-DERIVED OXYSTEROLS IN THE DEVELOPMENT OF CARDIOVASCULAR DYSFUNCTION IN MASH Sandra Torres Received Received
  1035-FRI Hepatocyte arginase-2 protects from metabolic dysfunction-associated steatohepatitis by regulating mitochondrial fatty acid oxidation. Hui Han Received Received
  1037-FRI The pan-PPAR agonist lanifibranor improves liver inflammation, ballooning, and fibrosis in a diet-induced obese MASH hamster model of binge drinking Francois Briand Received Received
  1038-FRI Neutrophil Depletion attenuated NLRP3-Induced Liver Inflammation and Fibrosis in NASH Lin Kui Received Received
  1039-FRI A novel steatohepatitis model in the FAH-deficient swine Silvana Wilken Received Received
  1040-FRI The exercise-induced metabokine beta-aminoisobutyric acid regulates hepatic lipid metabolism and reduces hepatic metabolic dysfunction and fatty liver in a dietary obese mouse model Shaimaa Gad Received Received
  1042-FRI Hepatocyte-Specific Deletion of the Novel Hexokinase, HKDC1, Protects Against MASH-induced Fibrosis in Female Mice. Irene Corona-Avila Received Received
  1043-FRI Adipocyte activating transcription factor 3 is a gatekeeper in preventing non-alcoholic steatohepatitis Shuwei Hu Received Received
  1044-FRI C/EBPβ-VCAM1 axis in Kupffer cells promotes hepatic inflammation in metabolic dysfunction-associated steatohepatitis Shuangzhe Lin Received Received
  1045-FRI Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves cardiac dysfunction of NASH mice Ying-Ying Yang Received Received
  1046-FRI The Gene Expression Characteristic in MASLD-HCC Progression with Diet-Induced Metabolic Shifts yuyun song Received Received
  1048-FRI Carriage of multiple genetic risk factors for MASH stimulates an altered inflammatory secretome in a human stem cell-based in vitro model Alexandra Gatzios Received Received
  1049-FRI Fam172a Gene Knockdown aggravates Hepatocyte Lipotoxic Injury through Activating the ERK Pathway Mengqi Li Received Received
  1051-FRI The effects of CSE deficiency on high-fat diet-induced nonalcoholic fatty liver Se Young Jang Received Received
  1052-FRI Hepatic mitochondrial quality control regulates skeletal muscle adaptation to exercise through selenoprotein P in MASH-related hepatocarcinogenic mice Keisuke Hino Received Received
  1058-FRI An Oral inhibitor of CBP/β-catenin signaling, C-82, improves liver steatosis, function, inflammation and fibrosis in the GAN diet-induced obese mouse model of MASH Kenzaburo Yamaji Received Received
  1059-FRI Therapeutic Implications of DNA Methylation in MASLD Progression Hyunahm Sohn Received Received
  1062-FRI PUM1 knockdown aggravates lipid deposition in metabolic dysfunction-associated steatotic liver disease Zhiping Wan Received Received
  1063-FRI Intestine-Specific Faf2 Depletion Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Impairing Lipid Absorption Jingjing ZHANG Received Received
  1066-FRI The influence and mechanism of vitamin C on PM2.5 exposure metabolic dysfunction associated fatty liver disease Lili Zhao Received Received
  1067-FRI Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocytes pyroptosis Fangyuan Chen Received Received
  1071-FRI Novel Hepatic Lipid-Induced Enhancer activation modulates Steatohepatitis via S100A11 P. Vineeth Daniel Received Received
  1074-FRI A PNPLA3-deficient iPSC-derived hepatocyte screen identifies pathways to potentially reduce steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease Caren Doueiry Received Received
  1075-FRI Potential of Novel Regulatory Bile Acid, 3β-Sulfate-5-Cholestenoic Acid (3SCA) in MASLD Therapy Yaping Wang Received Received
  1076-FRI A Fructose-enriched diet consumption promotes a specific transcriptomic signature defining an aggressive phenotype. Lisette Chávez Rodríguez Received Received
  1078-FRI In vitro cellular studies implicate HSD17B13 in lipid and immune associated pathways in cultured primary human hepatocytes Wensheng Xie Received Received
  1080-FRI Liver-derived extracellular matrix hydrogels augment the survival and function of primary rat liver sinusoidal endothelial cells Junyu Wang Received Received
  1084-FRI Glucagon engagement is essential for the direct anti-inflammation and anti-fibrosis effect of efocipegtrutide in TAA-induced mouse model of liver injury and fibrosis yohan kim Received Received
  1085-FRI Sulfonated albumin activates hepatic stellate cells to accelerate NASH liver fibrosis Tiantian Liu Received Received
  1086-FRI Phocaeicola coprocola alleviates metabolic dysfunction-associated steatotic liver disease by modulating lipogenesis JeongHa Park Received Received
  1089-FRI Reproducible therapeutic effects of semaglutide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH Malte Nielsen Received Received
  1090-FRI Reproducible therapeutic effects of resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH Malte Nielsen Received Received
  1092-FRI NSrp70 deficiency worsens metabolic dysfunction-associated steatohepatitis by regulating lipogenesis Daram Yang Received Received
  1093-FRI Unravelling MASLD heterogeneity at single cell level in the switching towards progressive disease Paola Dongiovanni Received Received
  1094-FRI High frequency ultrasound shear wave elastography for preclinical liver investigation: a pilot study on an OGT mouse model jean-luc gennisson Received Received
  1095-FRI New steps forward in learning about the use of DGAT1 and DGAT2 inhibitors for metabolic dysfunction-associated steatotic liver disease (MASLD) management: benefits for their single or combined application Miriam Longo Received Received
  1096-FRI AKT Isoform Specific Regulation of Hepatic Steatosis Induced by Bioactive Lipids Mario Alba Received Received
  1097-FRI Treatment with the CCR2/CCR5 antagonist Cenicriviroc does not affect MASH and fibrosis development in Ldlr-/-.Leiden mice, translational to clinical phase 3 trial results Martine Morrison Received Received
  1098-FRI Liver fibrosis induced by CDAHFD and surfactant Polysorbate 80 Masaki Yamamoto Received Received
  1100-FRI Highly sensitive metabolic flux analysis using 14C-microtracers combined with accelerator mass spectrometry - A proof of concept study on de novo lipogenesis Martine Morrison Received Received
  1101-FRI Hepatoprotective effects of longer-term treatment intervention with Semaglutide and Tirzepatide in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH Jacob Nøhr-Meldgaard Received Received
  1102-FRI Synergistic hepatoprotective effects of semaglutide and resmetirom combination therapy in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH Jacob Nøhr-Meldgaard Received Received
  1103-FRI Treatment with retinoic acid improves diet-induced MASLD in male mice Katharina Burger Received Received
  1105-FRI Understanding how HMGCS2-derived ketone body metabolites impact MASLD progression Jessica Shay Received Received
  1106-FRI Toll-like receptor ligands pattern in alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease patients Raphaela Staltner Received Received
  1108-FRI Neutralizing the OX40L-OX40 axis attenuates fibrosis and recruitment of monocyte-derived macrophages in murine metabolic dysfunction-associated steatohepatitis. Lucia Valenzuela Perez Received Received
  1111-FRI Glycogen Synthase Kinase 3β Hepatocyte Deletion Ameliorates Murine Metabolic Dysfunction-Associated Steatohepatitis Khaled Warasnhe Received Received
  1113-FRI JiGuCao capsule alleviates metabolic dysfunction-associated fatty liver disease by regulating the gut microbiota and lipid metabolism Wenying Qi Received Received
  1114-FRI The effects of hydroxynonenal on hepatocytes and its association with the pathogenesis of NAFLD Masahiro Yanagi Received Received
  1116-FRI Blockade of CXCR3 attenuates CD4 T cell-mediated liver injury in murine metabolic dysfunction-associated steatohepatitis Hyun Se Kim Lee Received Received
  1120-FRI Expression of hepatic drug metabolizing enzymes is altered by concomitant obesogenic lipids and ethanol in mice and adult human hepatic organoids Joseph Dempsey Received Received
  1121-FRI Modulation of Gut Microbiota and Metabolic and Histological Improvements through Methyl Group Donor Supplementation in a MetALD model Carolina Diaz Canul Received Received
  1122-FRI The Role of MicroRNA-122 in Metabolic Dysfunction-Associated Steatotic Liver Disease Khang Tran Received Received
  1123-FRI Retatrutide improves steatohepatitis in a new accelerated mouse model of diet-induced steatohepatitis with a fructose binge Greta Viebahn Received Received
  1129-FRI ENTPD1/CD39 regulates inflammatory process in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Vanessa Garcia-Fernandez Received Received
  1134-FRI In vivo experiments and network pharmacology to investigate mechanisms of JiGuCao capsule for metabolic-associated fatty liver disease Wenying Qi Received Received
  1135-FRI Reduced HNF4α Expression in MASLD iPSC-Derived Hepatocytes and Associated Epigenetic Modifications Dounia Le Guillou Received Received
  1136-FRI Frataxin deficiency induces hepatocyte ferroptosis and liver injury in metabolic dysfunction-associated steatotic liver disease Somesh Banerjee Received Received
  1138-FRI Manipulating bile acid pool size to target dietary fat absorption in MASLD Alvin Chan Received Received
  1139-FRI Unlocking S-Pindolol´s Potential for MASLD: Beneficial effects on muscle mass and function and liver histology in western-diet fed mice Daniel Cabrera Received Received
  1141-FRI Enhanced muscle mass mitigates MASLD in myostatin knockout mice without impacting exercise performance. Daniel Cabrera Received Received
  1142-FRI Nuclear sequestration of Y box-binding protein 1 reprograms hepatocytes for adipogenicity James Jordan Received Received
  1143-FRI Syphilitic Hepatitis: A Rare Case of Hepatic Injury from a Commonly Transmitted Venereal Disease Karthic Drishna Perumal Received Received
  1144-FRI Clinical Utility of Two-Step Hepatitis E Virus IgM Antibody Testing in a Low-Prevalence Setting: A 10-year Retrospective Multicenter Study Chia-Yu Chiu Received Received
  1145-FRI Successful development of a loop-mediated isothermal amplification assay (LAMP-PCR) for detection HDV-RNA Saruul Enkhjargal Received Received
  1149-FRI The prevalence and clinical characteristics of concurrent hepatitis D infection in chronic hepatitis B patients in Xinjiang region: A multicenter, retrospective, cross-sectional study. WEI SUN Received Received
  1151-FRI Summary of clinical features of 1800 cases of bacterial liver abscesses diandian Hao Received Received
  1155-FRI Real world outcomes of Hepatitis Delta patients with mild or moderate fibrosis Sabela Lens Received Received
  1156-FRI Utility of the fungal biomarker beta-D-glucan (BDG) for diagnosis of invasive fungal infections, antifungal prescription and correlation with mortality for critically ill patients in a liver intensive care unit Anita Verma Received Received
  1157-FRI Recent seroprevalence and epidemiological characteristics of HDV infection among HBsAg-positive inpatients in China Shiyang Pan Received Received
  1158-FRI Establishment and application of a new method for dual detection of HDV RNA and HBV DNA based on CRISPR technology Feng Ren Received Received
  1160-FRI Effect of Sex Steroid Hormones on HEV replication - Clinical Implication Premashis Kar Received Received
  1161-FRI DELTA DESCRIBE, the French collaborative project: Profile and management of hepatits delta patients in metropolitan France Veronique Loustaud-Ratti Received Received
  1163-FRI Sero-prevalence and genotype distribution of HDV among 67 HBsAg-positive pregnant women in Siem Reap, Cambodia, using in-house direct ELISA test method. Golda Akuffo Received Received
  1164-FRI Establishment of BALB/cAJcl-nu/nu Mice Xenograft Model and Drug Screening Platform for Acute Hepatitis A Reina Sasaki-Tanaka Received Received
  1165-FRI Clinical characteristics and prognosis of HEV hepatitis: a retrospective study of 628 Chinese patients Wen An Received Received
  1166-FRI Bulevirtide monotherapy may reduce liver decompensation in patients with HDV-related compensated cirrhosis: a case control study with propensity score weighted analysis Elisabetta Degasperi Received Received
  1167-FRI Epidemiologic and Clinical Characteristics of Acute Viral Hepatitis in South Korea: A Prospective, Nationwide Multicenter Study In Hee Kim Received Received
  1169-FRI Effect of Bulevirtide treatment on the HDV induced antiviral state and cell damage in infected humanized mice and patients with chronic hepatitis D Maura Dandri Received Received
  1170-FRI Association of Socioeconomic Status on the Prevalence of Hepatitis D Co-infection in patients with Chronic Hepatitis B in San Diego County. Karine Moussa Received Received
  1171-FRI Hepatitis D virus (HDV) screening program in a single tertiary liver center in the United States Rohullah Rasikh Received Received
  1173-FRI Day 3 MELD Score as a reliable guide for early liver transplant in Autoimmune hepatitis - A prospective study Shubham Jain Received Received
  1174-FRI Review of evidence to Support the Use of Surrogate Endpoints and Fibroscan in Hepatitis D Infection Prajakta Bhounsule Received Received
  1175-FRI Associations Between Liver Biomarkers and Clinical Events in Patients with Hepatitis D Virus infection: A Retrospective Real-world Study Yunhao Liu Received Received
  1176-FRI PREVALENCE AND CLINICAL CHARACTERISTICS OF HEPATITIS DELTA VIRUS (HDV) INFECTED INDIVIDUALS IN BRITISH COLUMBIA AND ONTARIO: A MULTI-CENTRE UPDATE. Valeriya Zaborska Received Received
  1178-FRI Defining the data requirement to improve hepatitis D co-infection detection in the United Kingdom: the Somerset Liver Improvement Project Emma Saunsbury Received Received
  1179-FRI Seroprevalence and genotype distribution of hepatitis A and E viruses among general residents in Binh Thuan Province, Southern Vietnam Chanroth Chhoung Received Received
  1180-FRI A Systematic Review and Meta-analysis Assessing the Safety and Efficacy of Hepatitis E Virus Vaccine. Islam Mohamed Received Received
  1181-FRI Zinc acetate inhibits hepatitis A virus replication in vitro Tatsuo Kanda Received Received
  1183-FRI Development and implementation of an hepatitis D detection and linkage to care program in Catalonia. Preliminary results. Adriana Palom Received Received
  1184-FRI Differential placental estrogen receptor expression is responsible for the adverse clinical outcomes in Hepatitis E virus and COVID-19 infected pregnant women Maryam Javed Received Received
  1185-FRI Bulevirtide for patients with chronic Hepatitis D (CHD) in Italy: a multicenter prospective nationwide real-life study (D-SHIELD) Maria Paola Anolli Received Received
  1186-FRI HBcrAg mirrors HDV RNA decline and ALT normalisation during bulevirtide therapy in patients with chronic hepatitis delta Ivana Carey Received Received
  1188-FRI Quantification of plasma HDV RNA in untreated and Bulevirtide-treated patients with CHD: a comparison between Robogene 2.0, Eurobioplex and Altostar Maria Paola Anolli Received Received
  1191-FRI Evaluation of COVID-19-related Decompensation and long-term assessment of Post COVID Condition in Patients with Cirrhosis (Eva-Long COVID study) Madhumita Premkumar Received Received
  1192-FRI The asymmetry of the liver and spleen stiffness measures between patients with chronic hepatitis B and D reflects important clinic-pathologic differences Francesco Damone Received Received
  1195-FRI Hepatitis A infection decreases amino acid and SCFA metabolism by gut bacteria, compromising gut barrier integrity and contributing to acute liver failure Anoushka Saxena Received Received
  1196-FRI Hepatitis E virus induced metabolomic and immune shift in acute liver failure is associated with obstetric complications during pregnancy Anoushka Saxena Received Received
  1199-FRI Spectrum of Hepatitis A viral infection and related mortality from a tertiary care centre in South East Asia region : Time for a new era Manasa Alla Received Received
  1200-FRI Management and Care of Patients with HDV Differs Across Specialties Faisal Abaalkhail Received Received
  1201-FRI Duration of nucleos(t)ide analogue (NA) treatments in patients with chronic hepatitis B (CHB) virus infection in the United States (US) Jennifer Bevan Received Received
  1202-FRI Stimulating STING pathway leads to inhibition of HBV replication: insights into kupffer cell Mingyuan Zhang Received Received
  1204-FRI Non-Linear Association Between Liver Fibrosis Scores and Viral Load in Patients with Chronic Hepatitis B Gi-Ae Kim Received Received
  1205-FRI Post-transplant HBV vaccine compliance and seroprotection in thoracic organ transplant recipients Chia-Yu Chiu Received Received
  1206-FRI Optimizing Hepatitis B Virus Seroprotection in Thoracic Organ Transplantation: The Role of Heplisav-B Vaccination Schedule Chia-Yu Chiu Received Received
  1208-FRI The proportion of serum HBsAg-negative patients in hepatitis B virus-associated glomerulonephritis was as high as 70%--A retrospective cohort study from China Tongtong Ji Received Received
  1209-FRI Serum total cholesterol is a predictor of end-stage renal disease in patients with hepatitis B virus-associated glomerulonephritis: a retrospective cohort study from China Tongtong Ji Received Received
  1210-FRI Safety of Tenofovir Alafenamide in the Context of Hyperlipidemia and Cardiovascular Diseases: A Nationwide Analysis Jeong-Ju Yoo Received Received
  1211-FRI Gender-Specific Disparities in Receiving Antiviral Therapy Among Treatment-Eligible Adults with Chronic Hepatitis B Infection Across Three Safety-Net Health Systems in the United States Robert Wong Received Received
  1212-FRI Gaps in Hepatitis B Laboratory Monitoring Among an Ethnically Diverse Cohort of Adults with Treatment-Naïve Chronic Hepatitis B Infection in the United States Robert Wong Received Received
  1214-FRI The efficacy and safety analysis of TDF for preventing mother-to-child transmission of hepatitis B virus in different gestational weeks Xiaohong Gao Received Received
  1215-FRI Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: Liver-related Clinical Outcomes and Subgroup Analysis by Liver Cirrhosis Status Soon Sun Kim Received Received
  1216-FRI Hepatitis B virus subviral particle biogenesis relies on functional ubiquitin and proteasome pathways Sisi Yang Received Received
  1217-FRI HBeAg-positive pregnant mothers with higher HBV DNA decline rate from mid-pregnancy to delivery are more likely to achieve HBeAg seroconversion after delivery without postpartum cessation of nucleos(t)ide analogs therapy Wenting Zhong Received Received
  1218-FRI High functional cure rate induced by Peg IFN alpha-2b in HBV postpartum women with HBeAg negative: an explorational study Wenting Zhong Received Received
  1219-FRI DISMANTLING BARRIERS TO HEPATITIS B AND DELTA SCREENING, PREVENTION, AND LINKAGE TO CARE AMONG THE PWUD COMMUNITY IN PHILADELPHIA Beatrice Zovich Received Received
  1220-FRI Serum HBsAg Rather Than HBV DNA Reflects Liver HBV Transcript Levels of Hepatitis B Patients Treated by Nucleoside Analogues Wenhua Zhang Received Received
  1222-FRI Anti-HBs immune complex levels: A novel biomarker of hepatitis flare in patients with HBeAg-negative chronic hepatitis B who stop nucleos(t)ide analogue therapy Simon Hume Received Received
  1223-FRI The impact of Tenofovir Amibufenamide (TMF) on blood lipids during the process of anti-hepatitis B virus treatment - A real world prospective study Yang Ling Received Received
  1225-FRI Role of healthcare providers in recruitment of minority populations living with hepatitis B in clinical trials Chari Cohen Received Received
  1227-FRI HBV induces liver fibrosis through the generation of ROS in a pyruvate-PPARα-dependent pathway Xiaoqiong Duan Received Received
  1228-FRI Outcomes of nucleos(t)ide analogue discontinuation in chronic hepatitis B participants treated with xalnesiran with and without an immunomodulator: 48 weeks of follow-up results from the phase 2, randomized, controlled, adaptive, open-label platform study HBV Program Roche Received Received
  1229-FRI Stratification of HBeAg-negative chronic hepatitis B patients through longitudinal monitoring of HBV DNA levels Hae Lim Lee Received Received
  1230-FRI High-throughput screening for Antiviral Compounds using a Recombinant Hepatitis B Virus revealed the potent entry inhibitor, Skimmianine Masaya Funaki Received Received
  1232-FRI Therapeutic evaluation of Tenofovir Alafenamide in the treatment of chronic hepatitis B patients with normal alanine transaminase and positive hepatitis B virus DNA: a 48-week multicenter retrospective study from China Yida Yang Received Received
  1233-FRI Risk factors associated with hepatocellular carcinoma occurrence in chronic hepatitis B patients on long-term nucleos(t)ide analogues Kazuhiro Murai Received Received
  1234-FRI Prevalence of hepatitis delta virus infection among hepatitis B positive individuals in Georgia: findings from the national seroprevalence survey, 2021 Nazibrola Chitadze Received Received
  1237-FRI A Comparative Analysis of Adverse Event Incidence Rates between Intermittent and Continuous Regimen of Peginterferon alpha-2b Based on Exposure-Response Analysis Weizhe Jian Received Received
  1238-FRI HBV promotes hepatocyte binucleated polyploid formation through down-regulation of HDAC6 to maintain the stability of the cccDNA pool and promote viral replication Lili Wu Received Received
  1239-FRI Safety and Efficacy Assessment of Tenofovir Alafenamide (TAF) Antiviral Therapy Commenced Preconception or During Early/Mid-Trimester of Pregnancy in Hepatitis B Virus (HBV) Infection Keshu Shen Received Received
  1240-FRI Short-term efficacy and safety after switching from entecavir to tenofovir alaferamide for chronic hepatitis B patients with suboptimal response or intolerant to entecavir Fei Kong Received Received
  1241-FRI Factors associated with MASLD and liver fibrosis in foreign-born Asian-Americans with chronic hepatitis B seen in two non-academic hepatology clinics in Southern California: impact of metabolic features, MASLD and time spent living in the US Michelle Gunawan Received Received
  1242-FRI Imatinib promotes HBV reactivation through oxidative stress-induced blockage of autophagic flux Weixiu Li Received Received
  1243-FRI Nucleotide analogs reduced 3-year recurrence rate after curative radiofrequency ablation therapy in HBV-related HCC patients Jing Liang Received Received
  1244-FRI The efficacy and safety of prophylactic tenofovir alafenamide to prevent HBsAg-positive cancer patients undergoing chemotherapy from HBV reactivation- An interim report of a prospective trial Po-Yueh Chen Received Received
  1245-FRI Immunological correlates of rapid HBsAg decline in chronic HBV hepatitis patients undergoing Tenofovir Amibufenamide treatment Shue Xiong Received Received
  1246-FRI Comparative Analysis of Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated with Tenofovir Alafenamide (TAF), Tenofovir Disoproxil Fumarate (TDF), and Entecavir (ETV): A Systematic Review and Meta-Analysis with GRADE Assessment Natchaya Polpichai Received Received
  1247-FRI Longitudinal profile of serum HBV RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues Lung Yi Mak Received Received
  1248-FRI Longitudinal profile of HBsAg isoforms and HBsAg-antibody immune complex in natural history of chronic hepatitis B infection Lung Yi Mak Received Received
  1249-FRI Customized screening strategy for Hepatocellular Carcinoma demonstrates good cost-effectiveness in patients with HBsAg-positive in China. Xin Hao Received Received
  1250-FRI Current management and treatment indications of baseline grey-zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-) in Greece George Papatheodoridis Received Received
  1251-FRI Long-term outcomes of baseline grey-zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-) in Greece George Papatheodoridis Received Received
  1252-FRI Effectiveness and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Suboptimal Response to Antiviral Therapy Wen Xie Received Received
  1253-FRI The Impact of Superimposed Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD) on Clinical and Patient-Reported Outcomes (PROs) Profile of Patients with Chronic Hepatitis B (CHB) and C (CHC) Zobair Younossi Received Received
  1255-FRI HIV coinfection accelerates HBV-induced liver fibrogenesis through an exosome and miR-103a-3p dependent pathway Min Xu Received Received
  1256-FRI Efficacy and safety of tenofovir amibufenamide in chronic hepatitis B virus infection patients with normal alanine aminotransferase: a multicenter, open-label, randomized controlled trial Qing Xie Received Received
  1258-FRI Metabolic dysfunction-associated fatty liver disease improves response to peginterferon alpha-2b therapy in patients with chronic hepatitis B Ying Zhu Received Received
  1259-FRI Effectiveness of adoptive cell transfer of antigen-specific T cells in mouse models of HBV infection Toshikatsu Tamai Received Received
  1261-FRI Effects of different antiviral treatments on liver inflammation and fibrosis in patients with chronic hepatitis B Huiqing Liang Received Received
  1262-FRI All-cause and cause-specific mortality in non-steatotic chronic hepatitis B patients with cardiometabolic risk factors Shang-Chin Huang Received Received
  1263-FRI ´BeNEG-DO´: A Study of Clinical Outcomes, Immunologic Correlates and Genetic Predictors after NUC Treatment Withdrawal in e-Antigen Negative Chronic Hepatitis B Jiajing Li Received Received
  1264-FRI Efficacy and Safety of PD-L1 Antibody ASC22 (Envafolimab) in Patients with Low Baseline HBsAg Levels: a randomized Phase IIb Expansion Cohort Jinzi Jason Wu Received Received
  1265-FRI Efficacy of Prophylactic Antiviral Therapy in Preventing Hepatitis B Reactivation in Patients with Anti-HBc Antibody Undergoing Daratumumab Treatment Jaejun Lee Received Received
  1266-FRI Capsid Assembly Modulators Such as ALG-001075 Induce Profound HBV DNA Knockdown and Directly Target HBeAg In Vitro Cheng Liu Received Received
  1267-FRI FDA approved drug library screening to identify compounds that reduce HBs antigen Akiyoshi Shimoda Received Received
  1269-FRI A simple model for predicting HBsAg loss using baseline HBsAg in chronic hepatitis B patients who received PEG-IFNα-2b therapy fei yan Received Received
  1270-FRI Pharmacokinetics, Safety, and Tolerability of the siRNA TQA3038 in Healthy Chinese Volunteers Dong Liu Received Received
  1271-FRI The relationship between reproductive history and clinical characteristics in HBeAg-negative chronic HBV-infected women of childbearing age Shimin Yin Received Received
  1272-FRI Management and outcome of baseline grey-zone (GZ) patients among the French HEPATHER cohort: is it different from HBeAg negative chronic hepatitis B infection (CHBVe-) or HBeAg negative chronic hepatitis (CHBVHe-)? Lucia Parlati Received Received
  1274-FRI First-In-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of an oral Toll-like Receptor 8 Agonist in Healthy Subjects Bei Cao Received Received
  1275-FRI The role of steatosis and fibrosis parameters in predicting hepatocellular carcinoma recurrence in chronic hepatitis B patients Ke Yin Received Received
  1276-FRI The Impact of hepatitis b virus infection on assisted reproductive technology outcomes a systematic review and meta-analysis. Wei Xue Received Received
  1277-FRI Long-term follow up identifies a higher incidence of functional cure following nucleos(t)ide analogue discontinuation in HBeAg-negative Chronic Hepatitis B Simon Hume Received Received
  1279-FRI Performance of hepatocellular carcinoma predictive scores in an Australian cohort with chronic hepatitis B infection Thisuri Jayawardena Received Received
  1281-FRI Peginterferon alpha-2b based antiviral therapy as an effective treatment option for functional cure in inactive hepatitis B surface antigen carriers: A prospective, multicenter, randomized controlled trial Shan Ren Received Received
  1282-FRI Higher Circulating CCR7loPD-1hi Follicular Helper T Cells and Lower HBcrAg Indicate durable clinical cure after PegIFNα-2b-based therapy in patients with CHB Shan Ren Received Received
  1284-FRI Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update Chong Zhang Received Received
  1285-FRI Assessment of clinical outcomes in HBsAg positive individuals compared to patients who achieved HBsAg loss as determined by conventional or ultrasensitive testing for HBsAg Golasa Samadi Kochaksaraei Received Received
  1286-FRI Early off-treatment HBcrAg and anti-HBc levels identify patients at high risk of severe ALT flares after nucleos(t)ide analogue withdrawal - A pooled analysis of two prospective studies Edo Dongelmans Received Received
  1287-FRI Plasma Hepcidin and Haptoglobin concentration predicts pegylated interferon a-2b treatment response in HBeAg-negative chronic hepatitis B patients Jing Liang Received Received
  1288-FRI Pharmacokinetic/pharmacodynamic modelling of RG6084 effects on hepatitis B surface antigen and alanine transaminase to inform Phase 2 dosing regimen selection Sijie Lu Received Received
  1289-FRI Core biomarkers for early detection of primary liver cancer Hien Thi Thu Nguyen Received Received
  1290-FRI Combination therapy with TLR7 agonist TQ-A3334 and anti-PD-L1 TQ-B2450 enhance HBsAg decline in virally-suppressed patients with chronic hepatitis B: OCEANcure05 study Ting Wu Received Received
  1291-FRI Relationship between the clinical efficacy and lymphocyte subsets in the clinical cure advanage population of chronic hepatitis B with pegylated interferon alpha Dan Duan Received Received
  1293-FRI Impact and cost-effectiveness of a hospital-based hepatitis B screening and management program in China: a mathematical modelling prediction Jia Chen Received Received
  1294-FRI HBV antigen-guided switching strategy from nucleos(t)ide analogue to interferon: avoid virologic breakthrough and improve functional cure Da Huang Received Received
  1295-FRI Semi-mechanistic PK/PD modeling and simulation of sequential siRNA and bepirovirsen treatment predicts added benefit in HBsAg response in support of Phase 2b dose selection Nadia Noormohamed Received Received
  1296-FRI NK cells function dvdftrecreases, What is the cause of LLV occurrence? Guo Liying Received Received
  1299-FRI Tenofovir alafenamide to prevent hepatitis B virus reactivation in patients with ´resolved´ infection receiving rituximab-based chemotherapy: A randomized controlled trial Grishma Hirode Received Received
  1300-FRI Residual hepatitis B viremia detected by a high-sensitivity droplet digital-PCR assay predicts hepatocellular carcinoma risk and prognosis in patients on antiviral therapy Rex Wan-Hin Hui Received Received
  1302-FRI ALTERNATIVE HBV VACCINATION STRATEGIES FOR BOTH COMPENSATED AND DECOMPENSATED CIRRHOTICS Brian Pearlman Received Received
  1303-FRI Patients with chronic HBV infection exhibiting significant inflammation and fibrosis should pay particular attention to the status of MASLD during antiviral therapy. Qi Wang Received Received
  1305-FRI CLB-405 and CLB-505 combined with a saponin based adjuvant TQL-1055 exhibits a strong antiviral and enhanced immune responses in a mouse model of persistent Hepatitis B infection Aditi Deshpande Received Received
  1307-FRI Sequential administration of siRNA with CLB-405 and CLB-505 HBsAg variants encoding clearance profile epitopes, combined with a novel adjuvant TQL-1055 exhibits significant anti-viral and T cell activity in an AAV/HBV mouse model Aditi Deshpande Received Received
  1308-FRI Tolerability and immunogenicity of HBsAg variants, CLB-405 and CLB-505, combined with a novel semi-synthetic saponin adjuvant TQL-1055, in New Zealand white rabbits Aditi Deshpande Received Received
  1309-FRI Lower Alanine Aminotransferase Normalization During Antiviral Treatment Is Associated with lower risk of Hepatocellular Carcinoma in Chronic Hepatitis B Hyunjun Park Received Received
  1310-FRI Comparison of denosumab and bisphosphonates for tenofovir-induced osteoporosis in patients with chronic hepatitis B Yunmi Ko Received Received
  1313-FRI Virologic outcome of peginterferon for HBeAg-positive chronic hepatitis B - a 20-year follow-up, entecavir-matched study Che To Jimmy Lai Received Received
  1314-FRI HLA genotype regulates hepatitis B virus mutations associated with hepatocellular carcinoma. Masaya Sugiyama Received Received
  1315-FRI Renal function comparison between entecavir and tenofovir alafenamide in treatment-naïve chronic hepatitis B Wang Liang Received Received
  1316-FRI New Transient Elastography (TE) Device Hepatus? Shows Superior Efficiency and Strong Comparable to a Conventional TE Device in Liver Stiffness Measurement for CHB and NAFLD Patients Shuyan Chen Received Received
  1317-FRI Long-Term Efficacy of the Hepatitis B Vaccine: A 24-Year Follow-Up Study of 6,645 Vaccinated Individuals Saad Alghamdi Received Received
  1318-FRI Kinetics and Prediction of HBsAg Seroclearance during Long-Term Treatment with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B Yim Sun Young Received Received
  1319-FRI Significant increase in risk of hepatic further decompensation from excessive alcohol use in patients with chronic hepatitis B-related decompensated cirrhosis Vicki Wing-Ki Hui Received Received
  1322-FRI Effect of age and development of liver and other organ cancers on HBs antigen loss in hepatitis B patients Takashi Honda Received Received
  1324-FRI Final results of GATE study: a program to narrow Gap between in Accordance with guidelines and consent to Treat CHB population in East of China Shaoqiu Zhang Received Received
  1326-FRI Complete determination of hepatitis B virus genotype in all participants with chronic HBV infection receiving nucleos(t)ide analog therapy using multi-method analysis to better understand clinical outcomes: Phase 2b B-Clear study Jerome Bouquet Received Received
  1327-FRI Impact of hepatitis B surface antigen levels on regulatory T lymphocyte frequency: pooled analysis from single cell RNA sequencing datasets Fengge Zhu Received Received
  1329-FRI Accurate HBsAg Testing is Associated with HBsAg Seroreversion Outcomes Na Gao Received Received
  1331-FRI Evaluation of PAGE-B Score and Machine Learning Enhanced Prediction of Hepatocellular Carcinoma Development in Chronic Hepatitis B patients using Conditional Survival Forest: a multicenter study Athanasios Angelakis Received Received
  1333-FRI Detection and Monitoring of Infant Drug Exposure: A Study on TFV Concentration in TDF and TAF Chengjing Tao Received Received
  1335-FRI FACTORS ASSOCIATED WITH HIGH TITER RESPONSE to HBV VACCINE IN PRIOR VACCINE NON-RESPONDERS WITH HIV: The BEeHIVe TRIAL Kenneth Sherman Received Received
  1336-FRI Role of air pollution in the development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues Chia-Yen Dai Received Received
  1338-FRI Presence of metabolic comorbidities increases the risk of hepatocellular carcinoma in sub-Saharan African individuals living with chronic hepatitis B Lesley Patmore Received Received
  1340-FRI Pharmacokinetics and Safety of a Single Dose of Elebsiran (VIR-2218, siRNA) Subcutaneously Administered in Adult Participants with Moderate Renal Impairment Li Wang Received Received
  1341-FRI Imaging follow-up for HBV patients with advanced fibrosis and/or Page -B score >10 for HCC screening in the HEPATHER French Cohort; is the job well done? Lucia Parlati Received Received
  1342-FRI Implementation of the Hepatitis B ´Triple Panel´ in the Obstetric Care Setting: Prevalence and Predictors of Testing, Exposure, and Vaccine Immunity Natalia Schmidt Received Received
  1343-FRI Hepatitis B virus reactivation in cancer patients receiving Janus kinase inhibitors Khalis Mustafayev Received Received
  1345-FRI Hepatitis B treatment outcomes and factors associated with HBV treatment success: a population-based study in Rwanda. Jean Damascene Makuza Received Received
  1347-FRI Tenofovir Alafenamide Fumarate in Treatment-naïve Chronic Hepatitis B Patients with Liver Fibrosis: a preliminary non-invasive results of 96 weeks Jialing Zhou Received Received
  1348-FRI Late diagnosis of chronic hepatitis B is associated with increased liver-related complications - A population-based, retrospective cohort study Michael Le Received Received
  1350-FRI Outcomes of Nucleos(t)ide Analog Discontinuation in HBeAg-Positive Chronic Hepatitis B Patients Without Achieving HBeAg Loss CHIEN-WEI PENG Received Received
  1351-FRI Male sex, high γ-GTP, high AFP, high GDF15 and high FIB-4 index were high risk factors for the occurrence of primary HCC in CHB patients under NUC treatment. Kazuhiro Murai Received Received
  1352-FRI Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawalWithdrawal of prolonged nucleos(t)ide analogue (NA) treatment can result in HBsAg loss in some subjects with chronic hepatitis B (CHB), potentially reveal Sabela Lens Received Received
  1353-FRI Circular RNA circSMAD2 inhibits autophagy via targeting miR-629/PDCD4 axis in Hepatitis B virus infection Md Ismail Received Received
  1354-FRI Impact of Concurrent Fatty Liver (FL) and Chronic Hepatitis B (CHB) on Virologic (VR), Biochemical (BR), and Complete Response (CR) Among Patients Treated with Nucleos(t)ide Analogs (NA): A REAL-B Study Angela Chau Received Received
  1355-FRI Development of a low-cost diagnostics platform for the identification of HBV DNA using CRISPR/Cas13a system Teja Naveen Sata Received Received
  1356-FRI A twenty years tailored treatment history of an italian cohort patients with HBV/HDV chronic hepatitis: from multiple pegylated interferon-alpha (Peg-IFN) cycles through entecavir/tenofovir to bulevirtide treatment. Aldo Marrone Received Received
  1357-FRI The impact of HIV infection on all-cause mortality among individuals treated for HBV in Rwanda: A population-based cohort study. Jean Damascene Makuza Received Received
  1358-FRI Eliminating viral hepatitis one island at a time - the Hainan experience Min Liao Received Received
  1359-FRI 32.2% of Inactive HBsAg Carriers Achieved Clinical Cure at 48 Weeks with Pegylated Interferon Alpha-2b Therapy: A Multicenter Real-World Study (STARHB Project in China) - 2-Year Data Update Jing ZHAO Received Received
  1360-FRI The effect of tenofovir alafenamide on the risk of hepatocellular carcinoma in different risk groups defined by mPAGE-B score Lilian Yan Liang Received Received
  1362-FRI Factors and prediction model of HBsAg relapse after achieving clinical cure in CHB patients with PEG IFNα-2b Jing Chen Received Received
  1363-FRI Revelation of unknown confounding factors in functional HBV cure: a systemic review and meta-analysis George Lau Received Received
  1364-FRI Single cell RNA sequencing reveals exhausted adaptive immunity in utero to HBV exposed neonates born to mothers with high HBsAg titres persisting despite vaccination Prabhjyoti Pahwa Received Received
  1365-FRI Comparable Outcomes Between Besifovir and Other Antiviral Therapies in Hepatocellular Carcinoma Development Among Patients with Chronic Hepatitis B Jae Seung Lee Received Received
  1366-FRI Functional Analysis of Fumarylacetoacetate Hydrolase as a Hepatocyte Host Factor Gene Regulating Hepatitis B Virus Replication and Hepatocarcinogenesis Shouichi Namikawa Received Received
  1367-FRI Apply HBV RNA and HBcrAg to Follow-up of Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs Xiaoyin Wang Received Received
  1368-FRI Treatment eligibility of patients with chronic hepatitis B in the indeterminate phase Jian Wang Received Received
  1372-FRI Novel therapeutic hepatitis B virus vaccine using plasmid-launched live attenuated flavivirus vector immunization generates robust CD8 T cell responses that correlate with efficacy in a chronic hepatitis B model Frederik Pauwels Received Received
  1373-FRI Serum ESPL1 Protein as an Early Warning Biomarker for the Initial Occurrence and Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma Bobin Hu Received Received
  1377-FRI The rapid reduction rate was significantly lower in grey zone HBeAg-negative patients who started antiviral therapy compared to those with active hepatitis Yen-Chun Liu Received Received
  1378-FRI CCR2 of CD4+CD8+CXCR5+ T cell regulated IL-21 and TNF-α secretion in CHB patients Qi Gu Received Received
  1379-FRI Superior Diagnostic Efficacy of PRO-C3 and GP73 Compared with FIB-4, FAST, Agile 3+, and LSM for Detection of Fibrosis in Chronic Hepatitis B Qianqian Chen Received Received
  1381-FRI Leveraging in silico clinical trials of the Everest study to obtain mechanistic insights into determinants of functional cure with standard-of-care therapies in chronically infected hepatitis B patients Rajat Desikan Received Received
  1382-FRI Risks of discontinuation and benefits of continuation of TDF after interruption of mother-to-child transmission in immunotolerant pregnant women Huan Liang Received Received
  1384-FRI The Impact of Concurrent Chronic Hepatitis B Infection on the Diagnostic Accuracy of FIB-4 in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD) Fajuan Rui Received Received
  1385-FRI Characterization of HDV RNA and HBsAg during pegylated interferon-alpha and ritonavir-boosted lonafarnib combination therapy: The D-LIVR study Leeor Hershkovich Received Received
  1386-FRI Higher Sustained Response rate and Partial cure in NUC Experienced Pegylated Interferon-Treated Patients Compared to NUC Naïve Pegylated Interferon Monotherapy Patients Rachel Wen-Juei Jeng Received Received
  1387-FRI Evaluation of Hepatitis B Vaccination Uptake and Awareness of Liver Cancer Risk Factors Among State Fair-goers in Minnesota: A Cross-Sectional Study Amir Sultan Seid Received Received
  1388-FRI Effectiveness and Safety of 48-Week Tenofovir Amibufenamide vs Tenofovir Alafenamide Fumarate for Patients with Chronic Hepatitis B: A Retrospective Real-World Study Qing-Lei Zeng Received Received
  1389-FRI Innate immunity plays an important role in the inactive chronic HBV carriers with positive HBeAg and high HBV DNA during TAF treatment Qiumin Luo Received Received
  1390-FRI Second line treatment with bulevirtide in HDV patients from the ANRS-MIE French multicentre real-life cohort ANRS HD EP01 BULEDELTA Miroslava Subic Levrero Received Received
  1392-FRI Impact of metabolic disease on treatment response in chronic hepatitis B patients with nucleos(t)ide analogues therapy: a multicenter REAL-B study Rui Huang Received Received
  1394-FRI Temporal changes in demographics and complications/comorbidities of patient with chronic hepatitis B: Results of a real-world U.S. cohort Mindie Nguyen Received Received
  1395-FRI Prevalence of delta hepatitis identified with hepatitis B infection through emergency department blood-borne virus screening Shivaali Karelia Received Received
  1396-FRI Hepatocellular Carcinoma in Western Kenya: Risk Factors, Diagnosis & Surgical Management Mercy Karoney Received Received
  1397-FRI Immune Checkpoint Inhibitor (ICI) Treatment and Immune-related Adverse Events (IrAEs): Lessons Learned from Oncology for its Potential Use for Chronic Hepatitis B (CHB) Patients Mitchell Leus Received Received
  1398-FRI The current burden of hepatitis B in the United States: a state, territorial, and county analysis -the impact of immigration, 2021 Devin Razavi-Shearer Received Received
  1399-FRI Investigation of the reference value of ALT for the initiation of nucleic acid analogs for chronic hepatitis B. Taisei Keitoku Received Received
  1400-FRI Immuno-metabolic driven hepatitis B surface antigen seroconversion in mild and severe hepatitis B reactivation Jayesh Kumar Sevak Received Received
  1404-FRI Single cell sequencing reveals rise in intrahepatic CXCL8, CCL4, and SELL expression with increased fibrosis in naive chronic hepatitis B patients with low HBsAg levels Ravinder Singh Received Received
  1405-FRI Characterization of intrahepatic immune microenvironment in liver biopsies across different phases of untreated HBeAg-negative patients Maria Stella Franzè Received Received
  1406-FRI Uptake and T Cell Stimulation by BJT-778-HBsAg Immune Complexes: Insights into Anti-HBs Monoclonal Antibody Function. Loghman Salimzadeh Received Received
  1407-FRI Preclinical Pharmacokinetics of EDP-514, an Oral, Once-Daily Antiviral Treatment for Hepatitis B Virus Meng Huang Received Received
  1408-FRI Increasing Risk of Metabolic Comorbidities in Patients with HBV Monoinfection, HBV/HCV Coinfection, and HBV/HIV Coinfection: A Nationwide Population-based Study Jae Yoon Jeong Received Received
  1409-FRI Dose-Dependent Effects of Neutralizing Anti-HBs Monoclonal Antibody VIR-3434 on Hepatitis B Surface Antigen Composition Maria Pfefferkorn Received Received
  1410-FRI Global prevalence and outcome of CHB patients with indeterminate phase: A Systematic Review and Meta-analysis of 35 studies and 27,529 patients Jie Li Received Received
  1411-FRI Predictors of HBsAg loss in HIV-HBV coinfected patients receiving antiretroviral therapy: a systematic review Mansoor Rahman Received Received
  1412-FRI Distribution of circulating T follicular helper 17 cell subsets altered in CHB patients Shengxia Yin Received Received
  1413-FRI Differential HBV replicative markers and covalently closed circular DNA transcription in immune-active chronic hepatitis B with and without HBeAg Hye Seon Kim Received Received
  1414-FRI Pre-clinical Characterization of Cavrotolimod, a TLR9 Agonist for the Treatment of Chronic Hepatitis B Hilario Ramos Received Received
  1416-FRI Treatment Response of IFN and Nuc in CHB Patients with Severe Liver Fibrosis or Cirrhosis (OASIS Subgroup Analysis) Ruirui You Received Received
  1417-FRI Antiviral efficacy of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A Multicenter Longitudinal Study Mindie Nguyen Received Received
  1418-FRI Risk of Cirrhosis and HCC in CHB Patients during IFN or Nuc Treatment (OASIS Subgroup Analysis) Ruirui You Received Received
  1419-FRI Surveillance of Hepatocellular Carcinoma is Cost-Effective in Chronic Viral Hepatitis Patients in Korea Young Youn Cho Received Received
  1420-FRI Association of Proton Pump Inhibitors and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B patients: A Korean Nationwide Cohort Study Young Youn Cho Received Received
  1421-FRI Behaviour, Aspirations and Treatment needs of people living with hepatitis B (BEAT-B): a mixed methods study in hepatitis B patients from five countries in South Asia Manya Prasad Received Received
  1422-FRI Long-term clinical outcomes after HCV elimination by direct-acting antivirals in patients with chronic hepatitis C: A large-scale, multicenter cohort study Eiichi Ogawa Received Received
  1423-FRI High GGT levels is a risk factor for HCC development having potential to reflect mitochondrial dysfunction after HCV eradication Mina Nakagawa Received Received
  1424-FRI Scanvir: an ideal concept for eliminating hepatitis C Marilyne DEBETTE-GRATIEN Received Received
  1426-FRI Histological improvement of fibrosis in patients with hepatitis C who exhibit for 5 years a sustained virological response to antiviral treatment with direct-acting antivirals Takayuki Iwamoto Received Received
  1427-FRI Sustained virologic response and posttreatment liver function are associated with 5-year survival after direct-acting antiviral treatment in decompensated cirrhotic patients with hepatitis C virus: A long-term follow up study of Japanese clinical trial co Yuki Tahata Received Received
  1428-FRI HCV Ab titer and ALT mark occult hepatitis C virus infection in treatment-naïve HCV Ab-positive and -negative patients, respectively: A 3-year prospective cohort study Ming-Ling Chang Received Received
  1430-FRI Hepatic steatosis in chronic hepatitis C affects the risk of hepatocellular carcinoma mainly in women Shiho Miyase Received Received
  1431-FRI Fatigue in Chronic Hepatitis B (CHB) and C (CHC) is Associated with Impairment of Patient-Reported Outcomes (PROs) and Work Productivity Yusuf Yilmaz Received Received
  1432-FRI Close partnership with NGOs increases attendance and DAA treatment uptake in people who previously injected drugs (ex-PWID) with chronic hepatitis C Grace Lai-Hung Wong Received Received
  1433-FRI Service Evaluation of Children with HCV and neurodevelopment delay; Incidental finding of high rates of learning and behavioural difficulties in UK children living with HCV Carla Lloyd Received Received
  1435-FRI Factors associated with the aggravation of gastroesophageal varix in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy Yuki Tahata Received Received
  1436-FRI Closing The Gap: Implementing Hepatitis C Reflex Testing Within UNM Health System Colleen Chávez Received Received
  1437-FRI Alterations in The Tryptophan Pathway During Hepatitis C Virus Infection Demonstrates a Shift Towards a Pro-inflammatory State Jenna Oringher Received Received
  1438-FRI Incidence of liver disease progression in patients with hepatitis C virus genotype 3 after SVR following DAA therapy Dachuan Cai Received Received
  1440-FRI Changes in Hepatitis C Virus Screening and Treatment Rates in Pregnant Individuals Before and After Implementation of Universal Screening Guidelines Chandler Shapiro Received Received
  1441-FRI Impact of sustained virological response on long-term outcomes after curative resection in patients with of hepatitis-C-virus-related hepatocellular carcinoma in the era of direct-acting antiviral therapy Hayato Abe Received Received
  1442-FRI Telehealth to increase healthcare access; perspectives of people who use drugs Zoi Papalamprakopoulou Received Received
  1443-FRI Stability of capillary whole blood (CWB) in microtainer, and Limit of Detection (LoD) for Hepatitis C Virus (HCV) (genotypes 1-6) in CWB versus Venous WB (VWB) using Cepheid Xpert HCV RUO System. Anuradha Rao Received Received
  1444-FRI Comparing baseline FIB-4 versus post-SVR12 FIB-4 to predict HCC occurrence following direct-acting antiviral attained SVR12 Mustafa Al-Karaghouli Received Received
  1445-FRI Three for Two or One for Three: Evaluating HCV Treatment Regimens, Compliance, and Subpopulations Fadi Abu Baker Received Received
  1446-FRI Sex and Race Disparities in Liver Listings and Transplants for Hepatocellular Carcinoma in the United States Abdellatif Ismail Received Received
  1447-FRI Long-term glycemic control in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection Chen-Hua Liu Received Received
  1448-FRI Sustained Virologic Response (SVR) in HCV-infected Patients with Hepatocellular Carcinoma (HCC): Real-world Outcomes and Predictors of Success David Twitchell Received Received
  1449-FRI Avoiding phlebotomy entirely: Validation of a point-of-care measure of APRI & FIB4 from finger-prick blood David Smookler Received Received
  1450-FRI Sofosbuvir/Velpatasvir Effectiveness in Treating Chronic Hepatitis C Genotype 3: A Real-World Study in Xinjiang, China. WEI SUN Received Received
  1451-FRI Implementation of Glecaprevir-Pibrentasvir treatment for children aged 3-12 years with chronic Hepatitis C: Multicenter real-world data Yaniv Faingelernt Received Received
  1452-FRI Multistep Hepatocarcinogenesis in Preneoplastic Nodules on EOB-MRI after Long-Term Sustained Virologic Response in Patients with Chronic Hepatitis C Tomoko Tanaka Received Received
  1454-FRI Analysis of influence factors on antiviral efficacy in patients with chronic hepatitis C virus infection in Tianjin area Peng Chen Received Received
  1455-FRI The SVR10K study: A Real-World Data with Pangenotypic Direct-Acting Antivirals Across Multiple Diverse Regions Grace Lai-Hung Wong Received Received
  1457-FRI Prevalence and risk factors for hepatocellular carcinoma (HCC) among patients with current and prior hepatitis C virus (HCV) infection in a real-world cohort in the post-DAA era. Mai Sedki Received Received
  1458-FRI Trends in Care Utilization in Two Large Nationally Representative Datasets Reveal Important Disparities in Hepatitis C Access to Screening and Treatment Brian McSteen Received Received
  1459-FRI Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of patients on multiple concomitant medications Shweta Raina Received Received
  1460-FRI Methionine Sulfoxide, Methionine, and Ornithine as Biomarkers for Predicting Development of Hepatocellular Carcinoma after Hepatitis C Virus Elimination Takeshi Chida Received Received
  1461-FRI Directly observed DAA therapy comprising extended dispensation intervals as a unique approach to streamlined HCV microelimination for PWID Caroline Schwarz Received Received
  1462-FRI Including underserved populations in the global efforts against viral hepatitis - an Austrian approach to HCV elimination among homeless people without health insurance Caroline Schwarz Received Received
  1464-FRI Multi-collaboration contributes to HCV DBU Relink in Guangdong,China (First report) Yue Wu Received Received
  1465-FRI A review of phase 1 & 2 of the Joint United Kingdom Health Security Agency (UKHSA) & National Hepatitis C Paediatric Multi-Disciplinary Operational Delivery Network (pMDT ODN) National Hepatitis C Paediatric tracking project Carla Lloyd Received Received
  1466-FRI Bemnifosbuvir does not alter cardiac repolarization in healthy participants: results from a thorough QT study Patrick Scoble Received Received
  1467-FRI Multiscale modeling of lead-in results from a Phase 2 study of an 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection Patrick Scoble Received Received
  1469-FRI Epidemiological Insights into Hepatitis B and C through Blood Samples from the Korea National Health and Nutrition Examination Survey Chang Hun Lee Received Received
  1470-FRI A multicenter real world study of sofosbuvir/velpatasvir for HIV/HCV coinfected patients Jing Chen Received Received
  1471-FRI Examination of factors predicting hepatic decompensation after elimination of HCV in patients with liver cirrhosis Ryo Sasaki Received Received
  1472-FRI Metabolic dysfunction-associated steatotic liver disease is associated with liver fibrosis in hepatitis C Wesal Elgretli Received Received
  1473-FRI The power of the Community Pop-up Clinic: Cascade of Care and HCV Treatment among Vancouver´s inner-city Populations as a path towards elimination Shana Yi Received Received
  1474-FRI A Comparison of Sofosbuvir/Velpatasvir (S/V) and Glecaprevir/Pibrentasvir (G/P) for the Treatment of HCV infection Among HCV-Infected People Who Use Drugs (PWUDs) Shana Yi Received Received
  1477-FRI Transient Elastography in the ED Enhances Triage of Hepatitis C Virus Patients Compared to FIB-4 Morgan Stacey Received Received
  1478-FRI Costs and outcomes of a one-step hepatitis C virus RNA point-of-care diagnostic strategy among people who inject drugs in the U.S. Emily Kahn Received Received
  1479-FRI Trends in HCV Screening, Follow-up Testing, and Treatment in Pregnant People and Infants in a Tertiary Care Center Randeep Kaur Received Received
  1480-FRI Successful Performance of the Xpert HCV test for Point of Care Detection of HCV RNA in a CLIA-Waived Setting Lesley Miller Received Received
  1483-FRI Long Term Outcome Following HCV Treatment With Glecaprevir/Pibrentasvir In People Who Use Drugs Shana Yi Received Received
  1484-FRI Virologic effect and hepatotoxicity of BCR-ABL tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: a prospective study Khalis Mustafayev Received Received
  1485-FRI Attempt to Predict Outcomes in DAA-Treated Patients Using Machine Learning with Hepatitis C Virus and Human Genetic Information Hiroaki Haga Received Received
  1487-FRI Default Hepatitis C Screening and Proactive Linkage To Care Among Hospitalized Adults Lina Yagan Received Received
  1488-FRI Engaging community pharmacies within hepatitis C (HCV) test and treat networks to enhance access to care for key populations living with HCV: experience from Alberta, Canada. Jenny Godley Received Received
  1489-FRI Current Status of Hepatitis C Virus Infection and Treatment in Hemodialysis centers in Sichuan Province, China Xiaoxia Geng Received Received
  1490-FRI A government-leading multi-organization collaborative model for HCV elimination in Chengmai County, Hainan Province Xiaoyang Yang Received Received
  1491-FRI Validation of an artificial intelligence model for prediction of hepatocellular carcinoma risk after oral antiviral therapy in patients with chronic hepatitis C Yu Rim Lee Received Received
  1493-FRI Seizing the moment: Opportunistic screening impact on viral hepatitis prevalence in the Emergency Department over four years Juan Carlos Ruiz Cobo Received Received
  1494-FRI Exploration of influencing factors and predictive models for the decrease of non-invasive liver fibrosis indicators in patients with HCV infection treated with DAA Xiaoxia Geng Received Received
  1496-FRI Tailoring HCC risk stratification in chronic hepatitis C patients following viral eradication: a simple algorithm utilizing alpha-fetoprotein Yen-Chun Liu Received Received
  1497-FRI POSITIVE ANTI-HBC IGG IS AN INDEPENDENT RISK FACTOR FOR HEPATOCELLULAR CARCINOMA IN A COHORT OF CHRONIC HEPATITIS C PATIENTS Mario Pessoa Received Received
  1498-FRI HCV Promotes Aging in HIV-Infected Individuals: Evaluating Immune Senescence using Telomere Length and DNA Methylation Jacob Ciricillo Received Received
  1499-FRI Prevalence of HBV and HIV infection in anti-HCV positive individuals with a history of drug use CHARIKLEIA KRANIDIOTI Received Received
  1501-FRI Bemnifosbuvir Poses High Barrier for Resistance in both Preclinical and Phase 1b Monotherapy Studies Patrick Scoble Received Received
  1503-FRI HCV Reinfection Among People Who Use Drugs (PWUD) Treated For HCV Infection: A Long-Term View Shana Yi Received Received
  1505-FRI Direct acting antiviral therapy is associated with increased one-year overall survival in patients with Hepatitis C related Hepatocellular carcinoma Sarah Huang Received Received
  1508-FRI SEX DISPARITIES IN THE RATE OF DELAYED HEPATITIS C DIAGNOSIS IN PATIENTS WITH A LIVER COMPLICATION-RESULTS OF A POPULATION-BASED ANALYSIS Charles Levesley Received Received
  1509-FRI Automated Screening Outcomes for Hepatitis B and C in the Preanesthesia Unit: A Hospital-Based Study Carlos Alventosa-Mateu Received Received
  1510-FRI The Impact of Homelessness on the Outcomes of Patients with Hepatitis C: An Analysis of a National Database David Lee Received Received
  1512-FRI Access to a primary care provider (PCP) both reduces the risk of untreated viremia and of incomplete diagnosis among patients with hepatitis C virus (HCV) Mai Sedki Received Received
  1513-FRI A descriptive analysis of injection-related infections among people living with hepatitis C for direct acting antiviral (DAA) treatment received and naiive individuals across pre- and post-treatment phases. Ji Hyun Choi Received Received
  1514-FRI The Impact of Pre-Transplant Portal Vein Thrombosis on Post-Transplant Patient Survival Nazli Begum Ozturk Received Received
  1515-FRI Presentation and malformations associated with extrahepatic congenital portosystemic shunts Valerie McLin Received Received
  1517-FRI Ursodeoxycholic acid improves liver enzymes in patients with obliterative portal venopathy - a pilot study Gene Im Received Received
  1518-FRI Porto-sinusoidal vascular disorder and sinusoidal obstructive syndrome in patients treated with thiopurines: a systematic analysis Erica Nicola Lynch Received Received
  1520-FRI Hepatic congestion promotes liver pathogenesis through the activation of Integrin αV-YAP/TAZ-CTGF axis in LSECs Seiya Kato Received Received
  1521-FRI Liver Nodules including Hepatocellular Cancer Rather than Impaired Liver Function are the Primary Clinical Challenge in Management of Patients with Fontan Associated Liver Disease Aliya Gulamhusein Received Received
  1522-FRI Thromboembolic Event Risk Factors in Patients with Liver Abscesses: Development of a Predictive Nomogram Jaejun Lee Received Received
  1523-FRI Porto-sinusoidal vascular disease:A new nomenclature different from Idiopathic non-cirrhotic portal hypertension Jie Liu Received Received
  1524-FRI Machine Learning of CT Images for Noninvasive Discrimination of Porto-sinusoidal Vascular Disease from Cirrhosis in Patients with Portal Hypertension Yanna Liu Received Received
  1528-FRI Safety and outcomes of an on-demand transfusion strategy versus prophylactic transfusion of platelets in patients with liver cirrhosis and severe thrombocytopenia undergoing high-risk invasive procedures Sagnik Biswas Received Received
  1529-FRI The liver and spleen stiffness measure by transient elastograghy a promising tool for the clinical management of patients after Fontan-type surgery circulation Barbara Coco Received Received
  1530-FRI S100A8/9 is Upregulated in Platelets and Platelet-Derived Microparticles in Alcohol-Associated Hepatitis and Can Mediate Endothelial Inflammation Fallyn Kirlin Received Received
  1531-FRI Reliability of splenic stiffness in prediction of variceal bleeding and high-risk varices in non-cirrhotic portal fibrosis (NCPF) Akash Shukla Received Received
  1532-FRI Galectin-3 Binding Protein May Act Via Platelet-Derived Microparticles to Promote Hepatic Stellate Cell-Monocyte Crosstalk Leading to Disease Progression in Alcohol-Associated Cirrhosis Ainsley Baker Received Received
  1533-FRI Preprocedural Thromboelastography Decreases Need For Blood Product Transfusion Prior to Endoscopy for Upper Gastrointestinal Bleeding in Cirrhotics: A Retrospective Review Adam Vinall Received Received
  1534-FRI Portal vein thrombosis in cirrhosis, etiological spectrum, risk profile, and outcome. Babu Lal Meena Received Received
  1536-FRI DNA methylome analysis reveals epigenetic alteration of complement genes in advanced MASLD Won Kim Received Received
  1537-FRI Effects of various genetic polymorphisms in f metabolic dysfunction-associated steatotic liver disease in Japan and their appropriate use in risk assessment of liver-related events yuya seko Received Received
  1538-FRI NAFLD does not affect the effectiveness of tenofovir alafenamide in patients with chronic HBV infection after expanding the antiviral indications: A real-world multicenter, retrospective cohort study from Eastern and Central China Yang Ling Received Received
  1539-FRI Impact of Glucagon-Like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients Idris Yakubu Received Received
  1540-FRI Deep learning model to predict steatotic liver disease diagnosis and staging in pregnant individuals Jeanette Rios Received Received
  1541-FRI Serum Noninvasive Testing Scores and Modeling to Predict Intermediate or High Risk for Advanced Fibrosis due to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Type 2 Diabetes (T2D) Population Cohort. Gretchen Arndt Received Received
  1542-FRI Safety and Efficacy of Endoscopic Sleeve Gastroplasty after Orthotopic Liver Transplantation Benjamin Richter Received Received
  1543-FRI Hepatocellular carcinoma and lifestyle: How do dietary patterns differ in those with metabolic and non-metabolic dysfunction associated steatotic liver disease? Nikil Vootukuru Received Received
  1544-FRI Degree of Metabolic Dysfunction is linked to Steatohepatitis (MASH), Fibrosis, and Higher Cardiovascular Risk in Patients with Metabolic Dysfunction-Associated Steatotic liver disease (MASLD) David Kim Received Received
  1545-FRI Using Panel Management to Identify Adult Patients With High Risk MASLD/MASH Fibrosis in a Primary Care Clinic: A Pilot Study Sarah Householder Received Received
  1547-FRI MASLD is a night-time disease driven by nocturnal hepatic, adipose, and skeletal muscle insulin resistance Thomas Marjot Received Received
  1548-FRI Lean Non-Alcoholic Fatty Liver Disease Is Not A Distinct Pathophysiological Entity Prajna Anirvan Received Received
  1549-FRI Biomarker response in metabolic dysfunction-associated steatohepatitis (MASH) patients with high-risk baseline FAST scores: Observations from the ENLIVEN Phase2b trial with pegozafermin. Cynthia Hartsfield Received Received
  1550-FRI THE INTERPLAY BETWEEN COAGULATION IMBALANCE AND PNPLA3 MUTATION IN MASLD DIABETIC PATIENTS: IMPACT ON HEPATIC AND VASCULAR COMPLICATIONS Rosa Lombardi Received Received
  1551-FRI Analysis Of Cardiovascular Risk Factors During The Treatment Of Metabolic Dysfunction Associated Fatty Liver Disease With A Low Carbohydrate Diet Kwan Kit Cheung Received Received
  1552-FRI Plasma immune profile associated with MASLD in persons with HIV Kara Wegermann Received Received
  1554-FRI Improving Screening of Metabolic-Dysfunction Associated Liver Disease (MASLD) in Patients with Type 2 Diabetes Mellitus: A Quality Improvement Initiative MARAM ALENZI Received Received
  1560-FRI Spatial transcriptomics maps the metabolic zonation of hepatocytes in MASLD I148M-PNPLA3 carriers Erika Paolini Received Received
  1561-FRI Application of artificial intelligence algorithm as a vascular evaluation tool for intra-stage assessment in the cirrhotic patients with metabolic dysfunction-associated steatotic liver disease Zhengxin Li Received Received
  1562-FRI Lower Prevalence of MASLD in Non-Hispanic Black Patients Is Not Explained by Higher Hepatic Fat Oxidation Fernando Bril Received Received
  1563-FRI Pegozafermin reduced progression to cirrhosis: A post-hoc analysis from the Phase 2b ENLIVEN study Cynthia Hartsfield Received Received
  1567-FRI The combination of fatty acids desaturase 2 rs174583 and PNPLA3 rs738409 polymorphisms is a risk factor in advanced fibrosis in metabolic dysfunction-associated steatotic liver disease Shunsuke Ikejima Received Received
  1570-FRI Steatotic liver disease in people living with hepatitis C virus following viral eradication with direct-acting antiviral therapy Mohamed Shengir Received Received
  1571-FRI Lipidomic and eicosanoid profiles in individuals with steatotic liver disease in pregnancy, gestational hypertension, and preeclampsia. Jeanette Rios Received Received
  1572-FRI Exploring an Unlikely Association: Outcomes of MASLD Patients Hospitalized with Upper Gastrointestinal Bleeding Binyamin Abramowitz Received Received
  1573-FRI VLDL lipidomics capture signatures of MASLD-associated genetics and disease progression through a novel acyl chain distribution analysis David GUARDAMINO OJEDA Received Received
  1575-FRI The Prognostic Implications of Dietary Vitamin D Intake Among Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: An Analysis of the NHANES Database David Lee Received Received
  1576-FRI The long-term prognostic effects of caffeine intake in patients with metabolic dysfunction-associated steatotic liver disease: An analysis of the NHANES Database David Lee Received Received
  1577-FRI National Trends in the Costs Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Admissions Stratified by Patient Demographics: An Analysis of US Hospitals David Lee Received Received
  1580-FRI Unveiling the Hidden Connection: Exploring the Interplay Between Pericarditis and Metabolic dysfunction-associated steatohepatitis (MASH) Lisnaldy Ramirez Received Received
  1583-FRI Dissecting liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure Xia Yu Received Received
  1585-FRI Shifting of PBMC Transcriptomic Landscape from Acute Decompensation to Acute-on-Chronic Liver Failure Jiyang Chen Received Received
  1586-FRI Monocyte/macrophages-derived RESISTIN is a potential therapeutic target for acute-on-chronic liver failure Xianbin Xu Received Received
  1587-FRI A new prognostic method for acute-on-chronic liver failure: a machine learning prognostic model based on elastography Jieyang Jin Received Received
  1590-FRI Development and patterns of acute-on-chronic liver failure in cirrhotic patients with acute kidney injury: implications for prognosis and therapeutic approaches Susan Fischer Received Received
  1591-FRI Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression Jun Li Received Received
  1592-FRI SEMA6B accelerates acute-on-chronic liver failure by triggering systemic inflammation and hepatocyte apoptosis Jun Li Received Received
  1593-FRI Comparative analysis of Liver cirrhosis and Acute Coronary Syndrome (STEMI and NSTEMI) and their outcomes: Case Control Study of an In-patient analysis Anwar Uddin Received Received
  1594-FRI HIV patients with Low CD4 counts and the development of Acute Liver Injury and Cirrhosis: An In Patient Analysis Study from 2016-2020 Anwar Uddin Received Received
  1596-FRI Integrating prior decompensation in ACLF definitions for simplified clinical management Jun Li Received Received
  1597-FRI Intravenous administration with the ASK1 inhibitor SRT-015 alleviates liver injury and systemic inflammation in disease models of liver failure Vanessa Legry Received Received
  1599-FRI Natural killer cell-derived extracellular vesicles alleviate CD8+ T cell exhaustion in acute-on-chronic liver failure via TGF-β/Smad pathway Zhouhan Wang Received Received
  1600-FRI A Nation-wide Retrospective Cohort study of the Outcomes, Prevalence and Comparative analysis of Liver Cirrhosis and Pulmonary Hypertension Anwar Uddin Received Received
  1601-FRI Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: An Analysis of a Multicenter Cohort JIHYE LIM Received Received
  1602-FRI The Etiology of Chronic Liver Disease is an Independent Prognostic Factor in Patients with Acutely Decompensated Chronic Liver Disease. Do Seon Song Received Received
  1607-FRI AARC Liver failure score based on registry of 10,994 patients is a better prognostic model for ACLF patients justifying global application and expansion of AARC database Ashok Kumar Choudhury Received Received
  1609-FRI Resource utilization following liver transplantation for acute on chronic liver failure in alcohol associated liver disease. Nehna Abdul Majeed Received Received
  1610-FRI Evolving role and outcome of liver transplantation for acute-on-chronic liver failure: a 20-year single-center experience. William Bernal Received Received
  1612-FRI Designation of Acute-on-Chronic Liver Failure in Patients with Severe Alcoholic Hepatitis Kevin Houston Received Received
  1613-FRI Hepatic irradiated pigs develop radiation induced veno-occlusive liver disease with ferroptosis Zhen Sun Received Received
  1614-FRI Use of continuous renal replacement therapy in critically ill patients with cirrhosis/acute-on-chronic liver failure: the Multicentre CRRTnet substudy Constantine Karvellas Received Received
  1615-FRI Cirrhotic Cardiomyopathy Independently Increases Post-Transplant Mortality in Patients Transplanted For Acute on Chronic Liver Failure: The MODEL Consortium Experience Thuraya Al-Sayegh Received Received
  1616-FRI The Echocardiographic Markers of Cirrhotic Cardiomyopathy Can Independently Predict Circulatory Failure and Posttransplant Death in Patients with Acute on Chronic Liver Failure: 15 Centers Experience Thuraya Al-Sayegh Received Received
  1617-FRI Albumin Reprograms the B cell Transcriptional Landscape and Rescues Neutrophil Dysfunction in Immunocompromised Patients with Advanced Cirrhosis Joan Claria Received Received
  1618-FRI Deep Learning Model for Prediction of Prognosis in Patients with Acute-on-Chronic Liver Failure Seong Hee Kang Received Received
  1621-FRI Pharmacokinetics and Safety of Tenofovir Alafenamide in Chinese Patients with Acute-on-Chronic Liver Failure Taotao Yan Received Received
  1622-FRI Hemoadsorption with continuous renal replacement therapy reduces catecholamine requirements and hypercytokinemia in ACLF patients with septic shock and stage 3 AKI- A prospective cohort study. Rakhi Maiwall Received Received
  1625-FRI Evaluating the Impact of Pre-Liver Transplant Acute-on-Chronic Liver Failure on Post-Liver Transplant Prognosis in Patients with Alcohol-Associated Liver Disease David Lee Received Received
  1626-FRI How Does the Presence of Pre-Transplant Acute-on-Chronic Liver Failure Affect Post-Liver Transplant Outcomes Among Patients with Metabolic Dysfunction-associated Steatotic Liver Disease David Lee Received Received
  1628-FRI The Influence of Geographical Differences and COVID-19 on Hepatic-Failure Related Mortality Rates Qasim Chohdry Received Received
  1629-FRI How Important is Acute-on-Chronic Liver Failure Grade for Post-Liver Transplant Outcomes? A Single-Center Analysis Constance Mobley Received Received
  2001-SAT Risk factors associated with decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study at a health examination center Shinya Yokoyama Received Received
  2002-SAT Enhancing prediction of moderate fibrosis or higher in MASLD patients for Resmetirom treatment via machine learning Winston Dunn Received Received
  2003-SAT Deep Learning Predicts Hepatocellular Carcinoma Development in Steatotic Liver Disease Using Digital Pathology Takuma Nakatsuka Received Received
  2004-SAT A novel steatosis liver disease (SLD) index with easy-to-use clinical parameters in primary care settings for steatotic liver disease Dae Won Jun Received Received
  2005-SAT Allyl nonanoate, a bile metabolite, activated hepatic stellate cells through GPR 119 signaling in metabolic dysfunction associated steatosis disease (MASLD). Dae Won Jun Received Received
  2007-SAT Screening for Advanced Fibrosis among Alaska Native peoples with Metabolic Dysfunction-Associated Steatotic Liver Disease Janet Johnston Received Received
  2008-SAT Quantitative Analysis and Integration of Machine Learning for Biomarker Assessments and their Association with Treatment Response: Insights from the ENLIVEN Phase 2b Trial of Pegozafermin Oliver Mansbach Received Received
  2011-SAT Multiple DP/AI quantification approaches are complimentary in identifying histology features: Cross sectional study in a Japanese cohort. Vandana Gupta1, Ruixue Hou1, Hiroaki Yashiro1, Shuling Zhang1, David Cordover1, Simon Kim1, Mark Chen1, Erin Smith1, Vandana Gupta Received Received
  2012-SAT Comparative evaluation of zonal fibrosis patterns in pediatric and adult metabolic dysfunction-associated steatohepatitis biopsies using Second Harmonic Generation/Two Photon Excitation-based qFibrosis analysis Naim Alkhouri Received Received
  2013-SAT Fibro-Scope: an artificial intelligence/neural network system is useful in predicting liver related events, cardiovascular events, and prognosis in Japanese patients with metabolic-dysfunction associated steatotic liver disease yuya seko Received Received
  2014-SAT Diagnostic Potential of FAST and AGILE3+ Scores for F2/F3 Fibrosis: An Analysis of the Phase 2 ENLIVEN Study Naim Alkhouri Received Received
  2015-SAT Clinical management of discrepancies between FIB-4 and liver stiffness measurement in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) Joseph Rabbat Received Received
  2018-SAT Thrombospondin 2: A Key Player in Fibrogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease Uncovered by Multi-Omics Analysis Takefumi Kimura Received Received
  2019-SAT Machine Learning-Facilitated Predictive Model for Liver-related Events in Type 2 Diabetes Mellitus Sherlot Juan Song Received Received
  2021-SAT The associations between circulating metabolic biomarkers on the risk of hepatocellular carcinoma development in the USA Rikita Hatia Received Received
  2022-SAT Factors associated with obtaining lower IQR-CAP values in the detection of hepatic steatosis by transient elastography Iván López-Méndez Received Received
  2023-SAT Framingham Fibrosis Index for Metabolic Dysfunction Associated Steatotic Liver Disease: Validation in Large Nationwide Cohort Krisyah Clemons Received Received
  2024-SAT Automated digital analysis of Shh-injured area correlates with conventional and digital pathologies in MASLD and MASH patients Amon Asgharpour Received Received
  2025-SAT VALIDATION OF THE DIAGNOSTIC ENRICHMENT UTILITY OF NIS2+ FOR VARYING PHENOTYPES OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE Amon Asgharpour Received Received
  2026-SAT PERFORMANCE METRICS OF SPLEEN STIFFNESS MEASUREMENT (SSM) OBTAINED BY TRANSIENT ELASTOGRAPHY IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) Amon Asgharpour Received Received
  2027-SAT Resmetirom Therapy of MASH-Associated Child Pugh A Cirrhosis Reduces Estimated Risk for Clinical Outcome Based on HepQuant RISK ACE Model Gregory Everson Received Received
  2028-SAT The Oral Cholate Challenge Test Identifies the MASH Patients with >=F3 Fibrosis with Greatest Hepatic Impairment Who Show the Most Benefit from Short-term Rencofilstat Therapy Gregory Everson Received Received
  2030-SAT An automatic tissue folding detection algorithm to aid AI segmentation models. Kezia Hobson Received Received
  2031-SAT An automatic out of focus detection model for enabling the assessment of liver biopsies. Kezia Hobson Received Received
  2032-SAT Histological diagnostic tool for detecting and characterising portal tracts in liver disease using Artificial Intelligence. Dylan Windell Received Received
  2033-SAT The use of AI-assisted digital pathology in determining the inflammatory burden in liver disease. Dylan Windell Received Received
  2035-SAT VALIDATION OF THE AGA AND AASLD CARE PATHWAYS FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN A PROSPECTIVE COHORT OF OVERWEIGHT AND OBESE INDIVIDUALS Veeral Ajmera Received Received
  2036-SAT The Oral Cholate Challenge Test Defines Likelihood of Large Esophageal Varices in an Overweight and Obese US Population Michael McRae Received Received
  2037-SAT Maintenance Therapy with GLP-1 Receptor Agonists Does Not Impact the? Clearance of Orally Administered Isotopes of Unconjugated Cholate Michael McRae Received Received
  2038-SAT Multiple genetic polymorphisms are associated with the risk of metabolic syndrome, fatty liver, and airflow limitation: A Taiwan Biobank Study Ying-Ying Yang Received Received
  2039-SAT Enhancing Traditional Fibrosis Prediction Models with Machine Learning in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) David Kim Received Received
  2040-SAT Prevalence and Characteristics of High-Risk FIB-4 among Primary Care Patients with Pre-Diabetes (PreDM): Potential to Improve the Current State of Disease Under-Recognition Max Goldman Received Received
  2041-SAT Performance of Noninvasive Tests in Identifying Appropriate Patients for Resmetirom Treatment: Real World Data from Four Tertiary Care Centers Eda Kaya Received Received
  2042-SAT The diagnostic ability for hepatic steatosis using attenuation imaging and controlled attenuation parameter; a prospective multicenter study in Japan Takashi Nishimura Received Received
  2043-SAT A Single-center, Observational Study to Evaluate the Utility of Ferritin as a Noninvasive Biomarker in Patients with MASLD Keerthi Thallapureddy Received Received
  2044-SAT Misclassification and Discordance with Magnetic Resonance Elastography using FIB-4-based Stratification for at-risk MASLD Akash Roy Received Received
  2045-SAT Identifying Candidates for Liver Biopsy in Metabolic-Associated Steatotic Liver Disease: Machine Learning-Based Predictive Models Dong Yun Kim Received Received
  2046-SAT Clinical utility and diagnostic accuracy of phosphatidylethanol for detecting and differentiating MetALD from MASLD: A prospective study Federica Tavaglione Received Received
  2047-SAT Evaluation of the consistency and heterogeneity of fibrosis assessment in adjacent virtual liver needle biopsies using AI-based qFibrosis Yayun Ren Received Received
  2049-SAT Characterization of Intracellular Organelle Abnormalities in MAFLD Hidenori Kido Received Received
  2050-SAT Diagnostic performance of FibroScan´s controlled attenuation parameter (CAP) and Continuous CAP in MASLD with PDFF as the reference: a multicenter study. Asako Nogami Received Received
  2052-SAT Validation of FibroTest-T2D as a serum biomarker of early bridging fibrosis according to biopsy length, and sex-specific differences in large populations at risk of MASLD. Thierry Poynard Received Received
  2054-SAT A Real World, Large Scale Application of the AGA MASLD Pathway. Pitfalls, Challenges and Success Story Pratishtha Singh Received Received
  2055-SAT Liver virtual biopsy using CSE-MRI in patients with chronic liver disease: a comparative work with elastography and blood test. Juliette FOUCHER Received Received
  2057-SAT A Machine Learning Approach Identifies Patients at Risk of Metabolic Dysfunction-associated Steatotic Liver Disease-related Complications at the Population-level Jaideep Behari Received Received
  2058-SAT Developing a Brief Evaluation Index to Diagnosis Metabolic Dysfunction-Associated Steatotic Liver Disease Xinyuan He Received Received
  2059-SAT The correlation between measurements obtained by the iLivTouch and FibroScan a multicenter randomized study in the US. Calvin Pan Received Received
  2060-SAT Deep-learning-aided quantification of steatohepatitis-associated pathological findings in liver specimens Reiichiro Kondo Received Received
  2061-SAT Comparison of liver fibrosis between MASLD in PLHIV and Non-PLHIV Krishnadas Devadas Received Received
  2062-SAT NIS2+, an effective monitoring tool for tracking disease evolution in patients with fibrotic MASH Arun Sanyal Received Received
  2063-SAT NIS2+, an effective tool for monitoring MASH resolution and fibrosis improvement in patients with at-risk MASH Arun Sanyal Received Received
  2064-SAT Evaluation of Two Non-invasive Approaches to Assessing at-risk MASH in Clinical Practice: MASEF and FAST scores Naim Alkhouri Received Received
  2065-SAT INDEPENDENT VALIDATION OF SECOND HARMONIC GENERATION/TWO PHOTON EXCITATION IMAGING AND ARTIFICIAL INTELLIGENCE-BASED SNOF INDEX FOR METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS CIRRHOSIS ASSESSMENT Kutbuddin Akbary Received Received
  2066-SAT Identification of new exosomal microRNA markers for metabolic dysfunction-associated steatotic liver disease using artificial intelligence approach Michinori Kohara Received Received
  2067-SAT Detecting MASH resolution and fibrosis improvement with NIS2+ in patients with at-risk MASH Vlad Ratziu Received Received
  2068-SAT Plasma proteome signatures associated with steatohepatitis in morbidly obese patients MELISSA MARIA MILITO Received Received
  2069-SAT Pathological Significance of Intranuclear Lipid Droplets and Glycogenated Nuclei in Liver Biopsy Norihiro Imai Received Received
  2070-SAT T1-mapping in the liver: The need for standardization Irdina Nadziruddin Received Received
  2071-SAT A combined imaging and proteomic approach identifies inflammatory response proteins upregulated in MASH: results from the UK Biobank Alessandro Fichera Received Received
  2072-SAT Anthropometric Factors and Their Association with Fibrosis and MASH in Patients with MASLD in Japan and the United States Ryuki Hashida Received Received
  2074-SAT Evaluation of the Performance of MASEF score in Patients with Metabolic Dysfunction Associated Steatohepatitis (MASH) under a Lipid-Lowering Medication Ibon Martinez-Arranz Received Received
  2075-SAT Improved diagnostic accuracy of Vibration-Controlled Transient Elastography based tests in Identifying Metabolic Dysfunction-Associated Steatohepatitis (MASH) and at-risk MASH in obese and lean individuals with Metabolic Dysfunction-Associated Steatotic L Joo Wei Ethan Quek Received Received
  2076-SAT Corrected T1 Mapping (cT1) outperforms in evaluating clinically significant and advanced fibrosis in non-obese Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Findings from a multi-ethnic Asian cohort with histologically Joo Wei Ethan Quek Received Received
  2079-SAT Simple noninvasive tests have poor diagnostic accuracy for MASLD F2-3 in a real world Canadian cohort Nashla Hamdan Received Received
  2080-SAT Stain-free digital pathology imaging provides microarchitecturally-resolved insights into scar evolution and histological injury allowing direct clinical outcome prediction in metabolic dysfunction-associated steatotic liver disease Timothy Kendall Received Received
  2081-SAT Usefulness of serum microRNAs as biomarkers for pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) Caroline Blakley Received Received
  2082-SAT Machine Learning based Predictive Modeling using Proteomic Signatures in Extracellular Vesicles as Diagnostic Indicators of Metabolic Dysfunction-Associated Steatohepatitis. Ola Leszczynska Received Received
  2083-SAT Development of a Machine Learning Model to Predict Progression of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Jamie Yang Received Received
  2084-SAT DISPARITIES IN NON-INVASIVE TESTING-BASED RISK STRATIFICATION AMONG HISPANIC COMPARED TO NON-HISPANIC INDIVIDUALS AT-RISK FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: ANALYSIS OF A PROSPECTIVE COHORT OF 358 OVERWEIGHT AND OBESE INDIVIDUA Monica Tincopa Received Received
  2085-SAT Explainable Artificial Intelligence on Proteomics for the diagnosis of advanced liver fibrosis on MASLD patients using open data Eleni Myrto Trifylli Received Received
  2086-SAT An Effective, Inexpensive, and Simple Alternative to Current AGA Guidelines for Risk-Stratifying Liver Fibrosis: MASHFIB-10 Machine Learning Model Devon Chang Received Received
  2087-SAT Agile 3+ and Agile 4 Scores Predict Cardiovascular Events in a Large General Population Cohort Madeleine Chang Received Received
  2088-SAT Prevalence of Cardiovascular Events in MASLD, MetALD, and ALD Patients in a Large General Population Cohort Madeleine Chang Received Received
  2089-SAT Noninvasive assessment of steatotic liver disease in individuals with class 2 and class 3 obesity Michael Thornton Received Received
  2090-SAT PLIN2 expression is a reliable biomarker of MASH that is specifically associated with inflammation and ballooning rather than steatosis Giulia Angelini Received Received
  2091-SAT Artificial Intelligence (AI) in Metabolic dysfunction-associated steatotic liver disease (MASLD): a dual approach for innovating genomic analysis and development of risk prediction models Miriam Longo Received Received
  2092-SAT PLIN2 is a specific marker for MASH and is not a marker for cardiovascular disease or diabetes Giulia Angelini Received Received
  2093-SAT Clinical comparison of the HeparDx™ diagnostic blood test with MyLab™ elastography of significant fibrosis in patients with non-cirrhotic MASH Giulia Angelini Received Received
  2094-SAT Exploring the impact of mitochondrial biomarkers on HCC risk according to etiologic drivers: a multicenter study Miriam Longo Received Received
  2095-SAT Single-cell RNA Sequencing Reveals the Heterogeneity of Monocyte-derived Macrophages in Metabolic Dysfunction-associated Steatotic Liver Disease Haozhe Xu Received Received
  2096-SAT Clinically Significant Portal Hypertension by Non-Invasive Tests in Compensated Advanced Chronic Liver Disease due to Metabolic dysfunction-Associated SteatoHepatitis (MASH) with Obesity and Overweight. Denise Vezozzo Received Received
  2099-SAT MetaSight´s Metabolic Dysfunction-Associated Steatohepatitis (MASH)-fibrosis score: A blood test enabling patient monitoring of liver fibrosis Shira Shaham-Niv Received Received
  2100-SAT Comparisons of diagnostic performance according to the scoring systems using magnetic resonance elastography and transient elastography for discriminating patients with metabolic-associated steatohepatitis and significant fibrosis Min Joo Yoon Received Received
  2101-SAT Screening for advanced liver fibrosis due to MASLD with VCTE alongside retina scanning in patients with type 2 diabetes: A cross-sectional study of 1005 patients Andrea Lindfors Received Received
  2102-SAT AGILE3+ encompasses the two-step approach needed to enhance diagnostic accuracy of advanced fibrosis in patients with suspected MASLD Savvoula Savvidou Received Received
  2103-SAT Differentiation of steatotic liver disease from advanced liver fibrosis/cirrhosis by breath volatile organic compound analysis Vaclav Smid Received Received
  2105-SAT The Diagnostic Performance of Agile 3+ Score for Detecting Advanced Fibrosis in Individuals with Chronic Hepatitis B and Concurrent MASLD: A Multicenter Study Fajuan Rui Received Received
  2106-SAT PLIN2 and RAB14 are potentially useful biomarkers for monitoring treatment response post bariatric surgery Giulia Angelini Received Received
  2108-SAT NF-TE Score: A Novel predictor for liver fibrosis in Metabolic dysfunction Associated Steatotic Liver Disease Krishnadas Devadas Received Received
  2114-SAT EVALUATING IMPACT OF WEIGHT CHANGES ON HISTOLOGICAL PATTERNS OF LIVER FIBROSIS IN MASH: IMPLICATIONS FOR SPATIAL INTERROGATION Nicholas Syn Received Received
  2115-SAT Model for Advanced fibrosis in MASLD-Informed by Inflammation (MAM-I): A Novel Model To Predict Adavanced Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) David Kim Received Received
  2116-SAT Differential patterns of liver and spleen stiffness in chronic viral hepatitis and metabolic associated steatotic liver disease Giovanni Petralli Received Received
  2119-SAT Retrospective cross sectional evaluation of the LIVERFASt Test for staging liver fibrosis in MASLD patients in NIDDK studies´ populations using liver biopsy Mona Munteanu Received Received
  2120-SAT Comparison of transient elastography and magnetic resonance elastography for assessment of MASLD/MASH: a retrospective review Anandita Mathur Received Received
  2121-SAT Prognostic significance of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) Antonio Liguori Received Received
  2123-SAT FIB-4 based referral pathways to identify liver fibrosis and incident advanced liver disease have poor clinical utility in two independent General population cohorts Laurens van Kleef Received Received
  2131-SAT Retrospective Analysis of a Cohort of Patients with Various Liver Diseases Followed At An Urban Clinic Who Underwent a Liver Biopsy Over The Past 25 Years. Pattern of Liver Biopsy Utilization and Pitfalls. Magdy Elkhashab Received Received
  2132-SAT Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles Marco Arrese Received Received
  2135-SAT Validation of the 2023 Diagnostic Criteria for Metabolic Dysfunction-associated Steatotic Liver Disease and the Role of PNPLA3 I148M Variant in Latin America Luis Antonio Diaz Received Received
  2136-SAT Rapid identification of resmetirom-eligible patients in a large healthcare system using database programming and natural language processing Marc Sherman Received Received
  2138-SAT Ethnic Differences in ELF scores in a suburban MASH population Kinnari Modi Received Received
  2140-SAT High Mortality at Safety-Net Hospitals for Patients with Cirrhosis Sachin Shah Received Received
  2141-SAT Shifting Burdens: Gender Disparities and Evolving Trends in Liver Cirrhosis Across Low SDI Countries Gautam Maddineni Received Received
  2143-SAT Analysis of the distribution and severity of liver fibrosis stages among the local population within the Rio Grande Valley: identification of risk factors and accuracy of non-invasive diagnostic tools. Dimple Desai Received Received
  2144-SAT Real-world experience with FibroScan in a tribal specialty liver clinic Janet Johnston Received Received
  2145-SAT Significant Racial/Ethnic Disparities in Liver Transplant Waitlist Outcomes Among U.S. Adults with End-Stage Liver Disease Due to Steatotic Liver Disease Shyam Patel Received Received
  2146-SAT A nationwide retrospective study: the association of race with clinical outcomes in hospitalized patients with hepatorenal syndrome Shahana Prakash Received Received
  2147-SAT Racial/Ethnic Disparities in Liver Transplant Outcome Tomoki Sempokuya Received Received
  2148-SAT Racial/Ethnic Disparities in Liver Transplantation: The Unintended Consequence of Disparate Alcohol-Associated Liver Disease Tomoki Sempokuya Received Received
  2149-SAT HEALTH LITERACY AND EDUCATION LEVEL ARE DETERMINANTS OF DISEASE SEVERITY IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE Alana Saddic Received Received
  2150-SAT Evaluating Gaps and Disparities in Hepatitis B Treatment among US Adults: A Real-World Analysis using a Nationwide Electronic Health Records Database Robert Wong Received Received
  2151-SAT Disparities in Primary Biliary Cholangitis: A retrospective study using real-world data from a single hepatology clinic in the greater Los Angeles area Sabrina Alff Received Received
  2155-SAT HOSPITALIZED PATIENTS WITH CIRRHOSIS, ESPECIALLY THOSE NOT IN HIGH INCOMECOUNTRIES CONTINUE TO HAVE WORSE OUTCOMES REGARDLESS OF WHETHEROUTCOMES WERE STUDIED DURING AND AFTER THE COVID PANDEMIC Ashok Kumar Choudhury Received Received
  2156-SAT Racial/Ethnic Disparities in Risks of Cirrhosis Among Veterans with Metabolic Dysfunction Associated Steatotic Liver Disease in the United States Robert Wong Received Received
  2157-SAT Gaps and Disparities in Hepatocellular Carcinoma Surveillance Among a Multi-Center Safety-Net Cohort of Adults with Cirrhosis Robert Wong Received Received
  2158-SAT Disparities and Barriers in Improving Oral Health in Cirrhosis: The ORACLE (Oral Health In Cirrhosis of the Liver) study Mette Munk Lauridsen Received Received
  2159-SAT A Cross-Sectional Analysis of Disparities for Acute Liver Failure-Related Mortality in the United States Nazli Begum Ozturk Received Received
  2160-SAT Social Vulnerability (SV) is Associated with Higher Premature Mortality from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the United States (US) James Paik Received Received
  2161-SAT The Association Between Food Environment and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Socioeconomically Developed (SED) Countries: A Global Study of the United Nations and the Global Burden of Disease (GBD) Data Zobair Younossi Received Received
  2162-SAT Trends in Alcohol-Associated Cirrhosis: Incidence and Mortality Disparities Between Men and Women, and Young and Older Individuals in a Central Canadian Province (2010-2020) Nabiha Faisal Received Received
  2163-SAT Social Drivers of Health Prevalence and Screening Acceptability Among Patients with Chronic Liver Disease Rebecca Kim Received Received
  2164-SAT Disparities and Outcomes of Physical Restraint Use in Hepatic Encephalopathy: A National Inpatient Assessment Yasmin Ali Received Received
  2165-SAT Sex Differences in Disease Severity at Diagnosis of Cirrhosis in a National Cohort Mary White Received Received
  2166-SAT Outcomes in a Multidisciplinary MASLD Clinic Are Affected by Race Malcolm Chapman Received Received
  2170-SAT Palliative Care Consultation Can Improve End of Life Care for Patients with Cirrhosis Removed from the Liver Transplant List Compared to Patients with Pancreatic Adenocarcinoma Katherine Cooper Received Received
  2172-SAT Elevated Rates of Liver and Intrahepatic Duct Cancer in Native American and Alaskan Native Females Versus Males When Compared to Their White Counterparts: A 5-Year Regional Analysis Tulika Saggar Received Received
  2173-SAT The Wall Within: Understanding Racial Disparities in Liver Transplant Outcomes in the US Southwestern Region Centre Anandalakshmi Ponnaluri Received Received
  2175-SAT Racial and ethnic disparities in liver cancer risk by birth cohort: An electronic health record (EHR)-based epidemiologic cohort study Chanda Ho Received Received
  2176-SAT Safety and Efficacy of Contraceptive Agents After Liver Transplantation Grace Zhang Received Received
  2177-SAT Disparities in Alcohol-associated Liver Disease: Trends in Liver Transplantation and Listing to Death Ratio Alexander Zhao Received Received
  2178-SAT The Impact of Housing Insecurity on Hospitalized Patients with Diagnosis of Cirrhosis: A Comparative Analysis Using Data from the National Inpatient Sample (2016-2019) Joseph Akambase Received Received
  2179-SAT The Effect of Socioeconomic Factors on Outcomes of Variceal Hemorrhage Cerise Kleb Received Received
  2181-SAT Navigating behavioral change: The lived experience of Mexican and Central American patients with MASLD Maya Balakrishnan Received Received
  2182-SAT High Prevalence and Low Awareness of Markers of Chronic Liver Disease Among Men Who Have Sex with Men in Los Angeles Grace Yi Received Received
  2183-SAT Community Resilience Estimates (CRE) can predict patient outcomes related to end-stage liver disease and liver transplantation in the United State Kenji Okumura Received Received
  2185-SAT THE BURDEN OF STEATOTIC LIVER DISEASE IN CROATIAN VETERANS THREE DECADES AFTER THE WAR Tatjana Reic Received Received
  2187-SAT Bridging Gaps in Vibration Controlled Transient Elastography (VCTE) Usage for Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH) Patients: Insights on Sociodemographic Influences and Care Connections Taranika Sarkar Das Received Received
  2189-SAT GLOBAL DISPARITIES IN LIVER DISEASES RESEARCH FUNDING: A ROOT CAUSE OF HEALTH DISPARITIES Daniel Huynh Received Received
  2190-SAT Disparities in Waitlist Outcomes for Hepatocellular Carcinoma: Insurance Status and Access to Locoregional Therapies Soobin Lee Received Received
  2191-SAT Equity in Liver Transplant Access for Critically Ill Patients Alaina Miller Received Received
  2193-SAT Liver Transplantation Disparities in Listing to Death Ratio and Mortality from 1999-2021 Alexander Zhao Received Received
  2194-SAT Subgroup disparities in patients with cirrhosis that received palliative/hospice care and discussion: Findings from a large, single-center study Annie Fung Received Received
  2198-SAT Racial Differences in Progression through Living Donor Liver Transplant Donor Candidacy Evaluation Melanie Zheng Received Received
  2199-SAT Health Disparities in Autoimmune Hepatitis Irina Dan Adao Received Received
  2202-SAT Exploring multilevel risk factors for metabolic-dysfunction-associated steatotic liver disease (MASLD) in a racially, ethnically, and socioeconomically diverse cohort Janet Chu Received Received
  2203-SAT Alcohol Relapse After Liver Transplantation Among Patients with Alcohol-Associated Liver Disease in the Mountain West Rebecca Kim Received Received
  2206-SAT Characterizing Non-Medical Referral and Evaluation Drop-offs in Adult Liver Transplantation: A California Liver Network Study Shayana Seneviratne Received Received
  2208-SAT Hepatic osteodystrophy in cirrhosis, etiological spectrum, and outcome. Babu Lal Meena Received Received
  2213-SAT Socioeconomic deprivation is an independent risk factor for liver fibrosis in fatty liver disease: a community-based propensity-score matched case-control study Manya Prasad Received Received
  2214-SAT Evaluation of Pharmaceutical Care Service (PCS) for Liver Cirrhosis Patients in Acute Tertiary Hospital in Singapore Mei-Ling Yee Received Received
  2215-SAT Transplanting Hepatitis C NAT positive solid organs into HCV negative recipients; an Advanced Practice Provider (APP) led clinic, 4-year real world outcomes Ariana Peguero Received Received
  2217-SAT The PNPLA3 I148M variant aggravates inflammation in macrophages through impaired nuclear receptors (LXR alpha, PPAR gamma, and GR alpha) signalling Emmanuel Dixon Received Received
  2219-SAT Monocyte transcriptomic landscape and inter-organ crosstalk between the liver, brain and bone marrow in a model of alcohol misuse in aging Marti Ortega-Ribera Received Received
  2220-SAT CD73 enhances the immunoregulatory functions of hepatic Tregs through enzymatic and nonenzymatic pathways in MAFLD development Xinjie Zhong Received Received
  2221-SAT A Pilot Study of the Combination of Sorafenib plus Nivolumab in Unresectable Hepatocellular Carcinoma (HCC): Safety, Efficacy, and Immune Cell Profiling in Child Pugh A and B Cohorts Bridget Keenan Received Received
  2224-SAT Interplay between CD40 and Integrin α5β1 Enhances Tumor Cell Survival in Poorly Differentiated Hepatocellular Carcinoma Le Thuy Received Received
  2230-SAT The effect of high-salt diet in the immunology and development of hepatocellular carcinoma Amalia Tzoumpa Received Received
  2231-SAT The impact of PD-1+innate-like CD8+ T cells on the HBsAg reduction in active chronic hepatitis B patients receiving nucleos(t)ide analogue therapy Rachel Wen-Juei Jeng Received Received
  2234-SAT NLRP3 activation in monocytes drives murine liver inflammation and fibrogenesis Christian Stoess Received Received
  2239-SAT A large-scale metabolomics screen to define pathways for microbiome-derived small molecules Kazuma Sekiba Received Received
  2243-SAT INTESTINAL COLONIZATION BY A GUT PATHOBIONT ACCELERATES METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: IMPLICATIONS OF THE GUT IMMUNE RESPONSE IN SHAPING THE LIVER CELLULAR LANDSCAPE Erika Prando Munhoz Received Received
  2248-SAT Gut commensal bacteria exert anti-inflammatory and anti-fibrotic effects by regulating macrophage polarization through secondary bile acids Hongyan Xiang Received Received
  2250-SAT Gut Microbe-Produced Indole-3-Propionic Acid Alleviates Hepatitis B-Related Fibrosis by Regulating Th17 Cell Differentiation through Glucose Metabolism Reprogramming Fangyuan Chen Received Received
  2251-SAT Analysis for gut microbial profile changes by Japanese diet identified specific species that reflect MASLD progression Yoshimi Yukawa-Muto Received Received
  2252-SAT Prevalence, risk factors, and outcomes of Clostridioides difficile infection in liver transplant recipients Kelly Thomas Received Received
  2263-SAT Association between the gut microbiota and primary biliary cholangitis: A two-sample Mendelian randomization study Hongqin Xu Received Received
  2264-SAT Salivary Microbiome is Independently Associated with Hospitalizations in a Multi-Center Prospective Cohort of Outpatients with Cirrhosis: NACSELD3 Experience. Jasmohan Bajaj Received Received
  2265-SAT Dietary intervention improves intestinal permeability and reduces colon fibro-inflammation in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH? Susanne Pors Received Received
  2266-SAT Acyl-CoA thioesterase 12-mediated PPARγ activation preserves gut barrier integrity by suppressing intestinal epithelial cell necroptosis: Protective role in metabolic dysfunction-associated steatohepatitis Akiko Sugiyama Received Received
  2267-SAT Reduced Bacteroides Thetaiotaomicron Contributes to the Disordered Metabolism of Bile Acids in MASLD Patients Jian Wu Received Received
  2270-SAT Clostridium spp. cocktail alleviates hepatocellular carcinoma progression by modulating HIF1a-derived lipid profiling. seol hee Song Received Received
  2273-SAT Cryptogenic Pyogenic Liver Abscess: A Sentinel Marker for Colorectal Cancer? Guneet Sidhu Received Received
  2274-SAT Lactulose is associated with increased risk of disseminated infection from intestinal pathogens Aaron Hecht Received Received
  2275-SAT Intra-Tumoral Microbiome Promote Hepatocellular Carcinoma Cell Proliferation and Is Associated with Prognosis Ming-Lun Yeh Received Received
  2278-SAT Acute alcohol binges alter colonic mucosal architecture to cause transient changes in defecation Scott Minchenberg Received Received
  2280-SAT Western diet contributes to MASH by remodeling gut microbiota and metabolite 2-OG Ming Yang Received Received
  2283-SAT ´From Abscess to Tumor: Tracking the Prevalence of Colon Cancer Among Pyogenic Liver Abscess Patients (2016-2020)´ Khalid Home Received Received
  2284-SAT Utilizing FIB-4 and transient elastography to diagnose steatotic liver disease in patients with type 2 diabetes: Quality improvement project at a Veterans Affairs resident clinic Nimmy Thomas Received Received
  2285-SAT Risk of incident extrahepatic cancers among Medicare patients with non-alcoholic steatohepatitis (NASH) Jesse Fishman Received Received
  2286-SAT Risk of all-cause mortality and adverse outcomes from steatotic liver disease and its subgroups in the general population Maurice Michel Received Received
  2287-SAT Racial Differences and Comparative Clinical Outcomes among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Hospitalized for COVID-19: Insights from the National Inpatient Sample Database. Fnu Vikash Received Received
  2288-SAT Prognostic value of the FIB-4 index for all-cause mortality in heart failure with steatotic liver disease: Results from the MyoVasc study Joost Boeckmans Received Received
  2289-SAT Pruritus is Common and Persistent in Patients with MASLD Nasir Hussain Received Received
  2290-SAT Structural equation modelling identifies sex-specific classes to characterize subtypes of metabolic dysfunction-associated steatotic liver disease Carlos Pirola Received Received
  2291-SAT Clinical outcomes of steatotic liver disease in Japan Tomomi Kogiso Received Received
  2292-SAT Gender Disparities in Metabolic Dysfunction Associated Steatotic Liver Disease: Transcriptomic results from the BARIA longitudinal cohort study Mijra Koning Received Received
  2294-SAT Analysis of the distribution and severity of liver fibrosis stages among the local population within the Rio Grande Valley: identification of risk factors and accuracy of non-invasive diagnostic tools. Dimple Desai Received Received
  2295-SAT The Effect of Diet Composition Exposome on the Natural History of Metabolic-Associated Steatotic Liver Disease in the Million Veteran Program Cohort Lauren Callans Received Received
  2296-SAT Metabolic-Associated Steatotic Liver Disease in Relation to Food Behaviors in the Million Veteran Program Cohort: Eat Your Broccoli Lauren Callans Received Received
  2297-SAT Lifestyle habits significantly mitigate MASLD risk: Results from a prospective multi-center study Gediz Dogay Us Received Received
  2298-SAT Risk difference for long-term clinical outcomes in steatotic liver disease (MASLD, MetALD and ALD) Nobuharu Tamaki Received Received
  2299-SAT Evolution of MASLD/MASH Patient Experiences: Insights from ´The State of Steatotic (Fatty) Liver Care in America´ Surveys 2022-2024 Neeraj Mistry Received Received
  2300-SAT Associations between Metabolic Dysfunction-Associated Steatotic Liver Disease and Abdominal Pain: A Single-Center Retrospective Study George Waldenmaier Received Received
  2301-SAT Synergistic Impact of Low Body Mass Index and Metabolic Dysfunction-Associated Steatotic Liver Disease on Incident Alzheimer´s Disease Risk: A Nationwide Cohort Study Tae Seop Lim Received Received
  2303-SAT Neighborhood-level social determinants of health are associated with MASLD burden, complications, and mortality Claire Faulkner Received Received
  2304-SAT Economic Cost of Inaction for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany, Japan, and the United States Zobair Younossi Received Received
  2305-SAT Understanding Metabolic Dysfunction-Associated Steatohepatitis: Differences in Clinical and Demographic Characteristics Across Racial and Ethnic Groups Michelle Jajko Received Received
  2306-SAT Validation and epidemiologic definition of the novel steatotic liver disease nomenclature in a national cohort with cirrhosis Catherine Mezzacappa Received Received
  2307-SAT Thyroid Disorders (hypothyrodism and hyperthyrodism) and their associations with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: A Study on Inpatient Outcomes, Incidence and Prevalence Anwar Uddin Received Received
  2310-SAT Characteristics and clinical outcomes in patients with cirrhosis due to metabolic dysfunction-associated steatotic liver disease (MASLD) in Sweden Ying Shang Received Received
  2311-SAT Clinical features of MetALD: database analysis of 108,446 subjects Hideki Fujii Received Received
  2312-SAT Differences in prevalence of MASLD with clinically significant fibrosis by sex/menopause status in a large prospective US cohort of persons with HIV Kara Wegermann Received Received
  2313-SAT The Cumulative Impact of Concurrent Diabetes Mellitus and Obesity on Long-term Risks of Cirrhosis Among a National Cohort of U.S. Veterans with MASLD or MetALD Robert Wong Received Received
  2314-SAT Longitudinal Risk of Cirrhosis Across the Spectrum of Steatotic Liver Disease Among a National Cohort of Veterans in the United States Robert Wong Received Received
  2315-SAT Sexual Dimorphism in Metabolic Dysfunction-Associated Steatotic Liver Disease Among 1,472 People with HIV Sahar Saeed Received Received
  2316-SAT Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Severe Fibrosis have Worse Executive Function Performance Ali Weinstein Received Received
  2317-SAT Significant sex/gender disparities in the prevalence, cardiometabolic risk profiles and management of MASLD: Results from a cohort of 24,888 Canadians Jessica Burnside Received Received
  2318-SAT Investigation of factors contributing to liver fibrosis in MASLD through serial MR elastography and MRI-PDFF Takashi Kobayashi Received Received
  2319-SAT Metabolic-associated Steatotic Liver Disease and Infections: A Systematic Review and Meta-analysis Spyridon Peppas Received Received
  2320-SAT Prognosis of lean and non-lean MASLD in a large-scale Asian population study Shun-Ichi Wakabayashi Received Received
  2322-SAT Changes in Hemoglobin A1c and Body Weight are Strongly Associated with Changes in Liver Stiffness in Adults with Biopsy-Proven MASLD Matthew Dukewich Received Received
  2324-SAT The Global Profile of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Presentation, Histologic Stage, Non-invasive Tests and Mortality from the Global NAFLD/MASLD Registry Zobair Younossi Received Received
  2326-SAT Real-world experience of a multidisciplinary MASLD clinic Joshua Fricker Received Received
  2328-SAT Epigenetic age acceleration is associated with steatotic liver disease in adolescence and early adulthood: A 10 year cohort study. Phillip Melton Received Received
  2329-SAT Current multi-dimensional view of non-alcoholic steatohepatitis (NASH)/ metabolic dysfunction-associated steatohepatitis (MASH) global epidemiological rates Gauri Saal Received Received
  2330-SAT Liver-related events and mortality in patients with Metabolic Dysfunction Associated Steatotic Liver Disease varies with the type of Cardiometabolic Risk Factor . Shalimar Received Received
  2331-SAT Comparing Rates of Decompensation, Hepatocellular carcinoma, Overall and Liver-related death between MASLD, MetALD and ALD in a National Cohort Binu John Received Received
  2332-SAT Independent risk factors for chronic kidney disease: The impact of SLD and obesity in a large-scale health checkup cohort Michihiro Iwaki Received Received
  2334-SAT A prospective assessment of the impact of decompensation of cirrhosis on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease Ian O´Connor Received Received
  2336-SAT Impact of hemoglobin A1c (HbA1c) trajectory on the risk of liver-related complications in patients with type 2 diabetes mellitus (T2DM): A territory-wide cohort study Terry Cheuk-Fung Yip Received Received
  2337-SAT Predicting hepatic decompensation in patients with metabolic dysfunction-associated steatotic liver disease-related cirrhosis: The ABID-LSM model. Luis Bertot Received Received
  2339-SAT CORONASH study: prospective study of prevalence and severity of metabolic dysfunction - associated steatotic liver disease (MASLD) in patients undergoing coronary angiography Raluca Pais Received Received
  2340-SAT Low Anti-Mullerian Hormone in Reproductive-Aged Women is Associated with MASLD in Midlife: Data from the Longitudinal CARDIA Cohort Katherine Cooper Received Received
  2341-SAT Stability of the NASH-CHECK patient-reported outcome measure over time in patients with metabolic dysfunction-associated steatotic liver disease and stable clinical status Ian O´Connor Received Received
  2342-SAT Steatotic Liver Disease with Metabolic Dysfunction and Modest Alcohol Consumption Cumulatively Impact Survival in the Younger Populations. Jesse Pustjens Received Received
  2343-SAT Increasing liver fibrosis in MASLD is associated with higher risk of hip fractures in males Elena Gibson Received Received
  2344-SAT Incidence of cirrhosis and extrahepatic manifestations among lean and non-lean individuals with Metabolic Dysfunction-associated Steatotic Liver Disease Majd Aboona Received Received
  2348-SAT Obesogenic Medication Use is Associated with Increased Risk of MASLD and Liver Fibrosis Ian Jaffe Received Received
  2349-SAT Predictive Models for Hepatocellular Carcinoma (HCC) development in Cirrhotic and Non-Cirrhotic Metabolic Dysfunction-Associated Steatotic Liver Disease patients Prerana Sruthi Vatsavayi Received Received
  2350-SAT Balancing the Booze: How Light to Moderate Drinking Affects Liver and Cardiovascular outcomes in Steatotic Liver Disease Felice Cinque Received Received
  2351-SAT Association of BMI trajectory with Mortality Among Non-alcoholic fatty liver disease Individuals: a prospective cohort study Junping Shi Received Received
  2352-SAT Association between use of anti-hypertensive drugs and risk of hepatocellular carcinoma (HCC) in metabolic dysfunction-associated steatotic liver disease (MASLD) patients with cirrhosis Ahmed Elhariri Received Received
  2353-SAT Real-world outcomes of patients with metabolic dysfunction-associated steatohepatitis (MASH) compensated cirrhosis at a large academic referral center Shadera Slatter Received Received
  2354-SAT PNPLA3 rs738409 is significantly and independently associated with histological progression and regression in MASLD: A large paired and prospective liver biopsy study. Eduardo Vilar-Gomez Received Received
  2355-SAT Evaluating acute healthcare utilization post implementation of a primary care metabolic-associated steatotic liver disease risk stratification pathway: A large Canadian cohort study Elizabeth Baguley Received Received
  2356-SAT Characteristics of adult MASH patients and factors associated with MASH-relevant clinical endpoints in a real-world US cohort Philip Newsome Received Received
  2357-SAT Time to Disease Progression and All-Cause Mortality in Adult MASH Patients in a Real- World US Cohort Alfred Barritt IV Received Received
  2358-SAT Quantitation of Plasma Cells, Cytotoxic T cells, and Kupffer cells/Macrophages with Hepatic Fibrosis Stage in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Michael Estep Received Received
  2359-SAT Association of Steatotic Liver Disease (SLD) with Adverse Pregnancy Outcomes: Results from the Prospective Fatty Liver in Pregnancy (FLIP) Cohort. Tatyana Kushner Received Received
  2360-SAT Artificial Intelligence for Early MASLD Identification in the Electronic Medical Record Ariana Stuart Received Received
  2361-SAT Clinical characteristics and FIB-4 risk stratification of primary care patients with obesity, diabetes, or both: real-world implications for adopting a FIB-4 referral algorithm to detect metabolic dysfunction-association steatotic liver disease (MASLD) wi Janet Chu Received Received
  2362-SAT Three gradient boosting machine-learning models in Indeterminate FIB-4 Score Are Superior to Noninvasive Tests in Predicting Cirrhosis: A National and VA Analysis Sebastian Niezen Received Received
  2363-SAT Smoking and Progression to Cirrhosis Samantha Wray Received Received
  2364-SAT The Effects of Visceral Adipose Tissue on Survival in MASLD James Lee Received Received
  2365-SAT Disparities in the Association between Metabolic Associated Steatotic Liver Disease and Visceral Adipose Dysfunction Across Sexes, Races, and Diabetes Status: A Cross-Sectional Study of US Adults. Bhargav Vemulapalli Received Received
  2366-SAT Prevalence of Metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with Diabetes Mellitus: A Clinical Investigation of Patients in Puerto Rico West area. Milaris Sanchez-Cordero Received Received
  2367-SAT Sex differences in clinical outcomes of patients with metabolic dysfunction-associated steatotic liver disease -results of a nationwide real-world U.S. cohort Taotao Yan Received Received
  2368-SAT CAUSE-SPECIFIC MORTALITY AMONG AUSTRALIANS WITH CIRRHOSIS DIFFERS BY CIRRHOSIS ETIOLOGY AND DECOMPENSATION STATUS Vikas Bhasker Received Received
  2369-SAT Patterns of Dietary Supplement Use among Patients with Steatotic Liver Disease in the United States: Vitamins, Minerals and Botanicals Gabrielle Jutras Received Received
  2370-SAT Discordance of FIB-4 and SAFE scores for the prediction of advanced fibrosis in primary care patients with obesity, diabetes, or both Janet Chu Received Received
  2371-SAT Differential Prognosis and Impacts of Cardiometabolic Risk Factors and Alcohol Intake in MASLD and MetALD Patients Young Chang Received Received
  2375-SAT Association between metabolic dysfunction-associated steatotic liver disease and mortality: A nationwide cohort study Gi-Ae Kim Received Received
  2377-SAT MASLD and metALD: the amount of liver fat and number of cardiometabolic risk factors in relation to the risk of type 2 diabetes and cardiovascular disease Gabrielle Alblas Received Received
  2378-SAT Minimal or Moderate Alcohol Use before Liver Transplantation for MASLD is not associated with Steatosis Recurrence or Survival Ashish Bibireddy Received Received
  2379-SAT Long-Term Vascular Outcomes and Mortality After Bariatric Surgery Among Patients with Obesity, Type 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease Arunkumar Krishnan Received Received
  2381-SAT Cause-specific mortality in patients with metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study Axel Wester Received Received
  2383-SAT Change in nomenclature and definition from NAFLD to MASLD maintains the disease severity determining association between type 2 DM and MASLD - The results of multi-centre Indian Consortium on MASLD (ICOM-D). Ajay Duseja Received Received
  2385-SAT Cumulative Dose and Duration of Statin use are associated with a reduced risk of liver cancer after adjusting for age, FIB-4 score, and prior cirrhosis diagnosis in MASLD patients; a 10-year cohort study Georgia Sofia Karachaliou Received Received
  2386-SAT Health Goal Coaching is Associated with Higher Health Goal Motivation and Satisfaction in Participants at Risk for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Jillian Price Received Received
  2387-SAT HEALTHCARE PROVIDERS´ PERSPECTIVES ON NEW METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) NOMENCLATURE Somaya Albhaisi Received Received
  2388-SAT Sodium-Glucose Cotransporter-2 Inhibitors and the Risk of Hepatocellular Carcinoma Among Patients with Type 2 Diabetes, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Obesity: A Large Population-Based Cohort Study Arunkumar Krishnan Received Received
  2389-SAT Primary Care Based Implementation of Electronic Clinical Decision Support for Metabolic Dysfunction Associated Steatotic Liver Disease Improves Care Delivery Independent of Patient Demographics and Clinical Factors: A Prospective Implementation Study Ashley Spann Received Received
  2390-SAT All-cause mortality differs between steatotic liver disease subtypes: Results from a prospective cohort of 16,560 Adults in Canada Jessica Burnside Received Received
  2391-SAT Statin Use with Cardiovascular Disease and All-Cause Mortality in Patients with Hypertension, Metabolic Dysfunction-Associated Liver Disease, and Obesity: A Population-Based Cohort Study Arunkumar Krishnan Received Received
  2392-SAT Fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease patients with diabetes in Taiwan- A multi-center cohort study Jee-Fu Huang Received Received
  2393-SAT Hepatic Fibrosis But Not Steatosis is Associated with Early-Stage/Sub-clinical Markers of Heart Failure in Metabolic Dysfunction-Associated Steatotic Liver Disease Rabab Ali Received Received
  2396-SAT Forecasted changes in tumor characteristics and survival of patients with nonviral hepatocellular carcinoma in the United States: a modeling study based on the SEER-Medicare database Joanne Liu Received Received
  2397-SAT Sex differences in long-term overall, liver and nonliver-related mortality of patients with metabolic dysfunction-associated steatotic liver disease: a real-world longitudinal cohort study Taotao Yan Received Received
  2398-SAT Suboptimal diagnosis rate and peri-complication diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) in the U.S.: A population-based study Vy Nguyen Received Received
  2399-SAT Cost utility of bariatric surgery among obese patients with chronic liver disease Shalini Bansal Received Received
  2400-SAT Use of a Computerized Clinical Decision Support (cCDS) Tool in Primary Care Increases Rates of Confirmatory Testing in patients with Metabolic Associated Steatotic Liver Disease (MASLD) at Risk for Advanced Liver Fibrosis: A Pilot Study James Miller Received Received
  2401-SAT Increasing metabolic dysfunction-associated steatotic liver disease-related mortality rates in the United States from 2006 to 2023 and future forecast to 2040 Xinrong Zhang Received Received
  2402-SAT Global epidemiology and characteristics of MASLD in type 1 diabetes: an updated systematic review and meta-analysis Matheus Souza Received Received
  2403-SAT Identifying social determinants of health and environmental factors associated with significant fibrosis in MASH patients enrolled in the Mount Sinai MASH Center of Excellence Registry and Biobank Alejandra Paredes-Marin Received Received
  2404-SAT Clinical, Psychosocial and Social Determinants of Health Factors Associated with Degree of Hepatic Steatosis and Liver Stiffness Among Overweight and Obese Adults at Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease Monica Tincopa Received Received
  2405-SAT Representation of sex, race and ethnicity in MASH trials: a systematic review and meta-analysis Matheus Souza Received Received
  2410-SAT The best cutoff for transient elastography as a predictor of liver outcomes in metabolic-associated steatotic liver dysfunction (MASLD) patients Gil Salles Received Received
  2411-SAT Association of NAFLD with and without Advanced Fibrosis with Fatal, Non-Fatal, and Combined Cardiovascular Events: A Systematic Review and Meta-Analysis Mannat Kaur Bhatia Received Received
  2412-SAT Magnesium depletion score and mortality in individuals with metabolic dysfunction-associated steatotic liver disease over a median follow-up of 14 years Lei Fan Received Received
  2413-SAT Examining the prevalence of hepatic steatosis and advanced fibrosis using multiple non-invasive measures in Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano Received Received
  2417-SAT Investigating the prevalence of MetALD in comparison to MASLD in patients previously diagnosed with NAFLD Yousef Almahanna Received Received
  2419-SAT Relationship between Alcohol Consumption and All-cause Mortality in patients with Steatotic liver disease: Findings from NHANES III Jie Li Received Received
  2420-SAT Assessing the prevalence of cardiometabolic risk factors in patients referred to a Steatotic Liver Disease clinic Yousef Almahanna Received Received
  2421-SAT Diabetic Microvascular Complications are Associated with Mortality in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes Mellitus: A Nationwide Study Yee Hui Yeo Received Received
  2422-SAT Frequent misclassification of MetALD results in underestimation of its prevalence and long-term prognosis Dae Won Jun Received Received
  2423-SAT High adherence to the Mediterranean diet is associated with lower Liver Risk Scores - Analysis of the NHANES 2017-2018 Cohort TSUBASA TSUTSUMI Received Received
  2424-SAT Olanzapine-Induced Liver Injury: A Case Report Karen Young Received Received
  2425-SAT Lipofuscinosis as a novel discriminating feature for drug-induced liver injury vs. autoimmune hepatitis Sabine Weber Received Received
  2427-SAT Unveiling Preventable Liver Damage: Exploring LAAT and Hallas Tools in Hospitalized Patients Assessed with Updated RUCAM Scale Hussam Almasri Received Received
  2428-SAT Single-cell investigation of mercaptopurine-associated liver injury Keito Hoshitsuki Received Received
  2429-SAT Deep learning-based diagnostic model of pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome based on CT: development and validation study Hong Gao Received Received
  2430-SAT ´Shrooms´ and Severe Hepatitis - A Unique Entity Lakshmi Chirumamilla Received Received
  2431-SAT Induction of Cyp2e1 contributes to asparaginase-induced hepatocyte sensitization to lipotoxicity. Yin Zhu Received Received
  2432-SAT The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury Occurring During Clinical Trials: Consensus Recommendations from the IQ DILI Consortium Melissa Palmer Received Received
  2433-SAT Nuclear factor erythroid 2-related factor 2 (NRF2) activation aggravates liver injury by causing mitochondrial dysfunction Alejandro H. Gutierrez Received Received
  2434-SAT KEAP1 deletion rescues cell death associated with GPX4 knockdown in hepatocytes in acute models of liver injurydelta Leticia Colyn Received Received
  2435-SAT Hepatic Sinusoidal Congestion Associated with Inotuzumab in Patients with B-cell Acute Lymphoblastic Leukemia: A Case Series Report Derek Tai Received Received
  2436-SAT Variability in Reference Ranges of Hepatic Biochemical Tests in Pediatric Populations: Implications for Monitoring and Assessment of Drug Induced Liver Injury Arie Regev Received Received
  2437-SAT Early Bile Drainage Saves Beagles from Amanita Subjunquillea-Induced Acute Liver Failure Xiuying Ma Received Received
  2438-SAT Drug-Induced Liver Injury due to Medications for Alcohol Use Disorder: Insights from the DILIN Prospective Study Harish Gopalakrishna Received Received
  2439-SAT Liver Injury in Clinical Trials of Biologic Agents Has a Lower Rate of Attribution to Drug-Induced Liver Injury (DILI) Compared to Non-Biologic Agents Jasmine Amirzadegan Received Received
  2440-SAT Impact of lipophilicity and daily dose on drug-induced liver injury in the Japanese cohort Kota Tsuruya Received Received
  2442-SAT Intrathecal Methotrexate is Associated with Acute Transient Hepatocellular Liver Injury Harish Gopalakrishna Received Received
  2444-SAT Drug induced liver injury: A unusual case of cholestatic hepatitis caused by highly active anti-retroviral therapy (HAART) haniya waseem Received Received
  2445-SAT Evolving Patterns of Potentially Hepatotoxic Botanical use in the United States: Results from NHANES 2003 - 2018 Surveys. Alisa Likhitsup Received Received
  2447-SAT Improving the Diagnostic Accuracy of the RECAM in North American Patients with Suspected Idiosyncratic Drug-Induced Liver Injury Jacob Ciricillo Received Received
  2449-SAT The MetaHeps technology for drug causality assessment in patients diagnosed with idiosyncratic drug-induced liver injury (DILI) Michele Visentin Received Received
  2450-SAT Sequential analysis of serum levels of ten intestinal permeability and inflammation markers in patients with drug-induced liver injury and other forms of acute liver injury Daniel Di Zeo-Sánchez Received Received
  2451-SAT The Ongoing Problem of Mislabeling of Herbal and Dietary Supplements Implicated in Hepatotoxicity Victor Navarro Received Received
  2453-SAT Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα extracellular vesicles for treating acute liver failure Seohyun Kim Received Received
  2454-SAT A Novel Machine Learning Model for Distinguishing Drug-Induced Liver Injury from Autoimmune Hepatitis: Development and Validation Yu Wang Received Received
  2455-SAT Higher pre-treatment ALT level and pre-existing liver disease are associated with increased risks of fluconazole related liver toxicity. Pinghsin Hsieh Received Received
  2456-SAT Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis Yu Su Received Received
  2457-SAT IDENTIFICATION OF RISK PROFILES FOR LIVER INJURY IN ADULTS WITH MULTIPLE SCLEROSIS USING ARTIFICIAL INTELLIGENCE METHOD Dominique Larrey Received Received
  2458-SAT TransDILI: a deep transfer learning based prediction for drug-induced liver injury through leveraging molecular structure images Yue Li Received Received
  2459-SAT Clinical Outcomes of Idiosyncratic DILI are Improving in the United States: Results from the DILIN Prospective Study, 2004 to 2024 Robert Fontana Received Received
  2460-SAT Muscle steatosis significantly increases the risk of death in patients with cirrhosis - a retrospective cohort study Hong Yu Received Received
  2462-SAT Co-administration of Alcohol, Ritonavir and Lopinavir Affects Expression of the SET Cheperone Protein in Hepatocytes and Monocytes and HIV-1 Infectivity In Vitro Liting Chen Received Received
  2463-SAT The pivotal role of ABCB11 on genetic susceptibility to drug-induced liver injury from anabolic steroids Paola Nicoletti Received Received
  2464-SAT Exploring the Impact of Acetaminophen Overdose on Patients with Acute Alcoholic Liver Failure Nisha Sanghani Received Received
  2465-SAT CXXC-type zinc finger protein 5 deficiency in mice ameliorates acetaminophen-induced liver injury via the STAT1 signaling pathway Hyuneui Jeong Received Received
  2466-SAT Exposure to cigarette smoke aggravates hepatic damage in mice induced by ethanol or acetaminophen Hyuneui Jeong Received Received
  2468-SAT Correlation between decreased type 3 innate lymphocyte and deterioration of liver function in cholestatic drug induced liver injury Rongtao Lai Received Received
  2469-SAT Characterization of liver injury induced by CDK 4/6 inhibitors induced liver injury LUCY MEUNIER Received Received
  2470-SAT The burden of anti-cancer drugs in drug-induced liver injury in the French-speaking hepatotoxicity network LUCY MEUNIER Received Received
  2475-SAT Efficacy of UDCA as first-line treatment for cholestatic checkpoint inhibitor-induced liver injury LUCY MEUNIER Received Received
  2476-SAT Trends and Outcomes of Acetaminophen-induced Hepatotoxicity: A 2016 to 2021 Analysis Using the National Inpatient Sample Dataset Chineye (Brenda) Amuchi Received Received
  2477-SAT The role of 2´-5´-oligoadenylate synthase-like protein (OASL1) in cholestatic- and hepatotoxin-mediated liver fibrosis Daram Yang Received Received
  2478-SAT Maternal smoking exacerbates subsequent liver damage in offspring mice Daram Yang Received Received
  2479-SAT Decoding Acetaminophen Risks: A U.S. Inpatient Data Comparison of Acetaminophen toxicity in patients with Alcoholic and without Alcoholic Liver Disease Raj Patel Received Received
  2481-SAT Aging promotes liver injury: Studies on C57Bl/6 mice Sathish kumar Perumal Received Received
  2482-SAT Nilotinib Induced Hepatotoxicity with Decade Long Latency and Newly Discovered Pancreatic Head Mass Jason John Received Received
  2483-SAT Frontal EEG Monitoring Reduces Anesthesia Requirement During Liver Transplantation Gabriel Rice Received Received
  2484-SAT Comprehensive deep learning-based assessment of living liver donor CT angiography: from vascular segmentation to volumetric analysis Jinsoo Rhu Received Received
  2485-SAT The Impact of Arrhythmias: Outcomes of Patients with Liver Transplantation and Atrial Fibrillation Jason John Received Received
  2486-SAT The classification of portal vein thrombosis and a tactical algorithm based on it Boris Yaremin Received Received
  2487-SAT Risk Factors and Survival in Patients with De Novo Malignancies Following Liver Transplantation Alone or Simultaneous Liver-Kidney Transplantation Nazli Begum Ozturk Received Received
  2488-SAT Outcomes of Simultaneous Liver-Kidney Transplantation vs Liver Transplantation Alone in Patients with Cirrhosis Requiring Renal Replacement Therapy Nazli Begum Ozturk Received Received
  2489-SAT Cystatin C vs. Creatinine: Who Wins in Cirrhosis? Alexandra Fiedler Received Received
  2490-SAT Streamlining Nutritional Support for Inpatient Cirrhosis Management Alexandra Fiedler Received Received
  2491-SAT Reprogramming of bile acid metabolism attenuates liver inflammation during ischemia/reperfusion injury Kunpeng Huang Received Received
  2492-SAT Frailty is associated with multiple negative clinical outcomes in patients referred for liver transplantation. Heidi Johnston Received Received
  2493-SAT Comparative Outcomes of Trans-arterial Chemoembolization and Radioembolization as Bridging Therapy for Hepatocellular Carcinoma in Liver Transplant Candidates. Butros Fakhoury Received Received
  2495-SAT Characterization and Post-Transplant Outcomes of Machine Perfusion Organs for Liver Re-Transplantation Roy Wang Received Received
  2496-SAT Operational Time and Severe Postoperative Complications: Their Impact on Long-term Survival in Liver Transplant Patients Ayato Obana Received Received
  2498-SAT Center-level Variability in Utilizing Normothermic Machine Perfusion and the Association with Recipient Insurance Chawin Lopimpisuth Received Received
  2499-SAT Tracking Long-Term Outcomes in ALPPS Procedure: A Follow-Up Study Analyzing Extended Survival Mohammad AbuAssi Received Received
  2500-SAT Clinical outcomes of TACE in patients listed for liver transplantation at a single center from 2018-2022 Elizaveta Makarova Received Received
  2502-SAT Etiology-specific trends of delisting for liver disease improvement and re-compensation among candidates on liver transplant list in the US Mohamed Elfeki Received Received
  2505-SAT The impact of tacrolimus level and its intrapatient variability on the development of chronic kidney disease following liver transplantation Soon Kyu Lee Received Received
  2506-SAT Enhanced recovery of warm ischemic damaged rat liver graft using normothermic machine perfusion (NMP) by supplementing perfusate with bone morphogenetic protein-7 (BMP-7) mimetic TBD 184 Anil Kharga Received Received
  2507-SAT Application of Hemopure based oxygenated solution during pig to baboon liver xenotransplantation to minimize duration of ischemia during back benching: Bioenergetic metabolites analysis Anil Kharga Received Received
  2509-SAT Analysis of the impact of female sex and sarcopenia on serum creatinine and waitlist priority for liver transplantation Shivangi Gupta Received Received
  2513-SAT Sleep Disturbance is Associated with Frailty, Impaired Physical Function, Fatigue, Anxiety, and Depression in Liver Transplant Recipients: Results from the LivCog Cohort Study Minjee Kim Received Received
  2514-SAT Stress-Induced Cardiomyopathy in Liver Transplant Recipients: A Systematic Review Mohammad AbuAssi Received Received
  2515-SAT High-Throughput Proteomics Analysis Identifies Changes in Circulating Proteome Signatures Across Different Stages of Liver Transplantation Surgery Xing Li Received Received
  2516-SAT Evaluating effects of two oxygenated solutions for flushing by simulating liver transplantation on pump: Hemopure combined with William´s E culture media or University of Wisconsin (UW) solution Anil Kharga Received Received
  2517-SAT Establishment and observation of a long-term viable allogenic murine liver transplantation model Keiko Iwaisako Received Received
  2520-SAT Serum and Urinary Metabolomics are Associated with the Development of De Novo Metabolic Syndrome after Liver Transplant: A Multi-center Longitudinal study. Jasmohan Bajaj Received Received
  2521-SAT ASSESSING LIVER TRANSPLANT REJECTION USING PAIRED BLOOD AND BIOPSY SAMPLES Katelynn Madill-Thomsen Received Received
  2524-SAT Incidence and outcome of rejection in hyperimmunized liver transplant recipients receiving an induction therapy Faouzi Saliba Received Received
  2525-SAT VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY AS A NON-INVASIVE TOOL TO EXCLUDE HEPATIC STEATOSIS IN LIVING LIVER DONOR EVALUATION Sarita Ratana-Amornpin Received Received
  2526-SAT The Impact of Recipient Body Mass Index and Cold Ischemic Time on Post-Liver Transplant Biliary Strictures Ebehiwele Ebhohon Received Received
  2528-SAT Calibrating Exception Points for Continuous Distribution: Why Matching HCC to Non-HCC Waitlist Dropout Falls Short Joshua Norman Received Received
  2529-SAT Atrial Fibrillation Pre-Liver Transplant Associated with Increased All-Cause and Cardiovascular Mortality Post-Transplant John Barnes Received Received
  2530-SAT Living Donor Liver Transplantation: The Role of Transplant Kinship on rejection rates and allograft survival, using genetic related vs unrelated live donors. Maisa Elbadawi Received Received
  2533-SAT Liver Transplantation for MASH Cirrhosis Has Better Post-Transplant Outcomes Than Non-MASH Cirrhosis Waqas Rasheed Received Received
  2534-SAT Exercise stress echocardiography is a feasible alternative to pharmacologic stress echocardiography for cardiac risk evaluation in patients with cirrhosis prior to liver transplantation Madeleine Gill Received Received
  2535-SAT National Trends of Bridging Locoregional Therapy in Liver Transplant Candidates with Hepatocellular Carcinoma. Butros Fakhoury Received Received
  2536-SAT Sex and Race Disparities in Liver Listings and Transplants for Non-Hepatocellular Carcinoma Indications in the United States Abdellatif Ismail Received Received
  2538-SAT Anxiety and depression are significantly associated with worse health-related quality of life in liver transplant survivors Alexander Scherer Received Received
  2539-SAT Early Extubation: A Promising Strategy to Mitigate Post-Liver Transplant Complications and Enhance Recovery Justin Lin Received Received
  2540-SAT Recognizing the Need for Statin Use in Liver Transplant Recipients: How Effective are Providers at Adhering to Primary and Secondary Prevention Guidelines? Jacob Ciricillo Received Received
  2541-SAT Favorable outcome in Patients Over 65 Years with Hepatocellular Carcinoma Undergoing Liver Transplantation Saad Alghamdi Received Received
  2543-SAT CHOLESTEROL CONTENT AND EXPRESSION OF SREBF-2 AND HMGCR PREDICT EARLY ALLOGRAFT DYSFUNCTION AND THE OUTCOME OF HUMAN LIVER TRANSPLANTATION Sandra Torres Received Received
  2544-SAT Risk Factors and Outcomes of Rejection in Liver Transplant Recipients with Autoimmune Liver Diseases: A Comprehensive Analysis Ahmad Yanis Received Received
  2546-SAT Worse tumor biology, and not tumor size, is associated with lower post-liver transplant survival in recipients with hepatocellular carcinoma Behnam Saberi Received Received
  2547-SAT Relapse of alcohol use in liver transplant recipients before and during the COVID-19 pandemic. Abla Alj Received Received
  2548-SAT The Difference in Liver Transplant Outcomes between Normothermic and Hypothermic Machine Perfused Livers Ahmad Anouti Received Received
  2549-SAT Predicting Liver Graft Discard Criteria: A Machine Learning Approach to Key Donor Characteristics Ahmad Anouti Received Received
  2551-SAT The Impact of Machine Perfusion on Transplanted Liver Grafts with Macro-Steatosis Ahmad Anouti Received Received
  2552-SAT The Role of Smoking in Post-Transplant Cancer Development: Insights from a Two-Decade Cohort Study Carmen Alonso Martín Received Received
  2553-SAT The Risks Associated with Thymoglobulin Use in Patients with Liver Transplant Rejection: A National Database Analysis Jordan Carty Received Received
  2554-SAT A SYSTEMATIC REVIEW OF TREATMENT AND OUTCOMES FOR LATE CELLULAR REJECTION, CHRONIC DUCTOPENIC REJECTION, AND ANTIBODY MEDIATED REJECTION AFTER LIVER TRANSPLANTATION Yianni Protopapadakis Received Received
  2557-SAT Impact of Post-Transplant Body Mass Index Trajectory on Liver Transplant Outcomes Roy Wang Received Received
  2558-SAT Comparative Analysis of Liver Biopsy Complications across the United States: A Propensity Matched Study of Patients with Normal and Reduced Platelet Counts Using Inpatient Data Raj Patel Received Received
  2559-SAT Hepatocellular carcinoma recurrence after liver transplant: an Australian single-centre study Matthew Garas Received Received
  2560-SAT MRI-serum based score accurately identifies liver transplant patients without rejection avoiding need for liver biopsy: a multisite European study Jelte Schaapman Received Received
  2561-SAT Acupuncture in the pre and post liver transplantation setting is safe, well accepted and improves quality of life. Giada Pietrosi Received Received
  2562-SAT Research Trends in Liver Transplantation for Hepatocellular Carcinoma and Related Tumors: A Comprehensive Bibliometric Review (2000-2022) Mohammad AbuAssi Received Received
  2563-SAT Tenofovir Alafenamide Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation Ying-hong Shi Received Received
  2564-SAT Coronary Artery Disease Liver Transplantation (CAD-LT) score can accurately identify patients requiring invasive Coronary Angiography Nandhakumar Rajadurai Received Received
  2566-SAT Social Determinants of Health Measured by SDI and ADI do not Impact Liver Transplant Outcomes Hiba Khan Received Received
  2567-SAT Human versus artificial intelligence: Head-to-head comparison of predictive performance of MELD 3.0 and latest machine learning models Vivek Charu Received Received
  2568-SAT LONG-TERM OUTCOMES OF PATIENTS TRASPLANTED FOR ACUTE LIVER FAILURE IN THE UNITED STATES: AN ANALYSIS OF THE UNOS DATABASE Ana Marenco-Flores Received Received
  2569-SAT Outcome of utilizing MELD 3.0 from a Canadian perspective: a retrospective study in a single tertiary-care transplant centre Crystal Liu Received Received
  2570-SAT Liver transplant immunosuppression education in the US: a survey of transplant hepatology fellowship program directors Jinxuan Hao Received Received
  2571-SAT Albumin Infusions can Lead to Clinically Significant Changes in MELD 3.0 scores for Patients Waitlisted for Liver Transplantation Priyata Dutta Received Received
  2572-SAT The Patient And Kidney Graft Outcomes of Safety Net Kidney Transplants Are Similar to Kidney Transplant Recipients Without A Previous Liver Transplant: A Retrospective UNOS database Analysis Mohanad Awadalla Received Received
  2573-SAT Post-liver transplantation renal dysfunction primarily driven by older age and MELD at listing rather than liver disease etiology type Niki Wadhwa Received Received
  2574-SAT Post-Transplant Predictors and Outcomes of Persistent Cholestasis after Liver Transplantation Aaroh Patel Received Received
  2575-SAT Liver Transplantation for Short Telomere Syndrome: outcomes, and detailed histopathologic evaluation of explants. Ashwin Akki Received Received
  2577-SAT Psychological Burden of the Liver Transplant Process Christina Tsai Received Received
  2578-SAT Human Immune Organoids to Model Liver Transplant Rejection Elsa Solà Received Received
  2579-SAT Palliative Medicine Utilization for Older Adults with End-Stage Liver Disease Referred for Liver Transplantation Gavisha Waidyaratne Received Received
  2580-SAT Improved Self-Efficacy in Post-Liver Transplant Patients in Management of Post-Transplant Metabolic Syndrome Through Behavioral Resources and Intervention Through Digital Group Education (BRIDGE): A Share Medical Appointment Program Asal Bastani Received Received
  2581-SAT Post liver transplant resource utilization in early versus standard liver transplant in alcohol associated liver disease. Nehna Abdul Majeed Received Received
  2582-SAT Survival Outcomes for Living versus Deceased Donor Liver Transplantation for PSC: A 2 decade multicenter experience Omar Mousa Received Received
  2583-SAT Liver Transplantation for Wilson disease: A Spectrum from Acute Liver Failure to Neuro-Wilson Saad Alghamdi Received Received
  2584-SAT Metabolic Dysfunction-Associated Steatohepatitis Emerges as the Leading Cause for Adult Liver Transplantation in Saudi Arabia: A single-center study Saleh Alqahtani Received Received
  2585-SAT Features of a very long-term survival after liver transplantation in Italy: a preliminary single center experience Maria Donato Received Received
  2586-SAT Neurocognitive impairment in liver transplant (LT) recipients: comprehensive cognitive evaluation Kacey Berry Received Received
  2587-SAT Impact of Early mTOR Inhibitor Immunosuppressive Therapy following Liver Transplantation: Enhancement of Glomerular Filtration Rate Sidart Pradeep Received Received
  2589-SAT EXTENDED CRITERIA DONORS IN DONATION AFTER CIRCULATORY DEATH: CAN ABDOMINAL NORMOTHERMIC REGIONAL PERFUSION SAFELY EXPAND THE DECEASED DONOR POOL? Philippe Paci Received Received
  2591-SAT Geographic distribution of US donor recovery facilities in relationship to liver transplant centers: Should we rethink the origin of donor allocation? Anji Wall Received Received
  2593-SAT AH and MetALD have higher overall survival after liver transplantation for SLD compared to ALD and MASLD Smruti Rath Received Received
  2594-SAT Pre-Transplant Oral Midodrine Exposure Does Not Affect Mortality Among Liver Transplant Recipients Sudharshan Achalu Received Received
  2597-SAT The safety and tolerability of QEL-001, an autologous Chimeric Antigen Receptor (CAR) T regulatory (Treg) cell therapy, in liver transplantation - A safety cohort in the LIBERATE study Alberto Sanchez-Fueyo, Received Received
  2601-SAT Is Pre-Liver Transplant Cannabis Use Actually Risky? Association with Survival, Rejection, and Fungal Infections Sudha Kodali Received Received
  2602-SAT One-third of liver donors for recipients of severe alcoholic hepatitis experience psychological distress. Chinmay Hegde Received Received
  2606-SAT Pediatric liver transplant trends and outcomes in 2011-2023: A single-center study Saleh Alqahtani Received Received
  2607-SAT Longer Cold Ischemia Time Predicts Increased Transfusion Requirements During Liver Transplantation Maham Ghani Received Received
  2608-SAT Worse Metabolic Outcomes in Black Females Who Receive a Liver Transplantation Hiba Khan Received Received
  2609-SAT Impact of Sarcopenia, Frailty, and Muscle Fat Infiltration on Mortality in Patients Undergoing Liver Transplant Evaluation Maham Ghani Received Received
  2610-SAT The Impact of Acute Pancreatitis in Patients with Liver Failure in a Single Tertiary ICU Terra Pearson Received Received
  2611-SAT Lipoprotein-Insulin Resistance (LP-IR) Score Predict Future Risk of Atherogenic Events in Liver Transplant Recipients: A Prospective Study Madison Nguyen Received Received
  2612-SAT Assessing the Prognostic Impact of Acute-on-Chronic Liver Failure Severity on Post-Liver Transplant Outcomes David Lee Received Received
  2613-SAT The Prognostic Relationship Between Varying Degrees of Acute-on-Chronic Liver Failure on the Post-Transplant Prognosis of Patients with Autoimmune Liver Diseases Undergoing Liver Transplantation David Lee Received Received
  2614-SAT Mental Health Needs Of Patients Seeking Support Through Transplant Receipients´ International Organization (TRIO) Lorrinda Gray-Davis Received Received
  2615-SAT The Prognostic Correlation Between Pre-Liver Transplant Acute-on-Chronic Liver Failure and Post-Transplant Outcomes Among Patients with Hepatitis C David Lee Received Received
  2616-SAT SURVIVAL OUTCOMES OF PATIENTS WITH AUTOIMMUNE LIVER DISEASE AND ACUTE-ON-CHRONIC LIVER FAILURE AWAITING LIVER TRANSPLANT: A 20-YEAR PERSPECTIVE Romelia Barba Received Received
  2617-SAT Racial and Ethnic Disparities in Post-Liver Transplant Outcomes for Patients with Acute-on-Chronic Liver Failure: An Analysis of the UNOS Database David Lee Received Received
  2618-SAT The Effects of Recipient Body Mass Index on the Prognostic Outcomes of Patients with Acute-on-Chronic Liver Failure Undergoing Liver Transplantation David Lee Received Received
  2619-SAT Association of Cirrhotic Cardiomyopathy and its Echocardiographic Markers with Intraoperative and Perioperative Cardiac Outcomes in Two Large Liver Transplant Centers Alex Liu Received Received
  2620-SAT Value of Educational Components of a Peer-to-Peer Mentoring Program: A Transplant Recipients´ International Organization (TRIO) Study Lorrinda Gray-Davis Received Received
  2621-SAT The Impact of Functional Status on the Post-Transplant Outcomes of Patients with Acute-On-Chronic Liver Failure Undergoing Liver Transplantation David Lee Received Received
  2622-SAT Determinants of Caregiving Burden; Interim Results from the Multi-Center LivCog Cohort Study Marina Serper Received Received
  2627-SAT Neoadjuvant Immunotherapy in Patients Undergoing Liver Transplantation for Primary Liver Cancer at a Single Center Sudha Kodali Received Received
  2628-SAT Effects of a structured, modified Mediterranean dietary intervention after liver transplantation (MEDDIET): Interim analysis of a randomized, controlled trial Mohammad Qasim Khan Received Received
  2630-SAT Pre-Transplant Phosphatidylethanol Levels are Predictive of Post-Transplant Relapse Risk in Short-Term Abstainers: A Single-Center Study Ethan Berman Received Received
  2631-SAT A Path to Better Patient Selection: A Risk Score to Predict Post-Transplant Survival Among Patients with Hepatocellular Carcinoma Kali Zhou Received Received
  2632-SAT Evaluating the prognostic value of Right Ventricular dilation in Liver Transplantation Chathur Acharya Received Received
  2636-SAT Frailty and Sarcopenia predict peri-operative outcomes in patients undergoing liver transplantation: Analysis of National Inpatient Sample 2016-2020. Aalam Sohal Received Received
  2637-SAT Advancing Diagnosis, Management, Treatment, and Transplantation of Liver Disease in Telomere Biology Disorders: Publication and Dissemination of Guidelines Heidi Carson Received Received
  3001-SUN Evolving Trends and Outcomes for Alcohol-Associated Hepatitis Patients with severely High MELD Scores on the US Liver Transplant Waitlist Tomohiro Tanaka Received Received
  3002-SUN In-hospital Outcomes for Acute Alcohol Associated Cirrhosis and Major Cardiac Arrhythmias Anwar Uddin Received Received
  3003-SUN Mortality From Alcohol-associated Liver Disease and Alcohol Use Disorder is Decreasing Globally yet Increasing in the United States Pojsakorn Danpanichkul Received Received
  3004-SUN Vitamin D deficiency exacerbates alcohol-associated liver disease via gut barrier dysfunction and hepatic overload of endotoxin in mice KOSUKE KAJI Received Received
  3006-SUN Administration of polyethylene glycol ameliorates inflammation of liver and gut, and hangovers against acute alcohol consumption Tom Ryu Received Received
  3007-SUN Cognitive Interviewing of Experts and Patients to Develop an Alcohol Insight Scale for Patients with Alcohol-Associated Liver Disease Victoria Gill Received Received
  3008-SUN ATP-Binding Pocket Inhibitor for Mixed Lineage Kinase Domain-like Protein (MLKL) Attenuated Alcoholic Liver Disease via Necroptosis-independent Pathway Dae Won Jun Received Received
  3009-SUN Comprehensive profiling of infiltrated circulating immune cell types and their subset responsible for alcoholic steatohepatitis by scRNAseq analysis Dae Won Jun Received Received
  3011-SUN Trends in Hospitalizations for Alcohol Related Hepatitis in the Pre-COVID, COVID, and Post-COVID Era: A National Database Study Regis Lee Received Received
  3012-SUN Impacts of smoking on alcoholic liver disease: A nationwide cohort study Jeong-Ju Yoo Received Received
  3013-SUN Prevalence and impact of cardiometabolic risk factors in alcohol-related liver disease and MetALD Wesley Dixon Received Received
  3015-SUN Targeted Breath Biopsy profiling of induced biomarkers unveils a metabolic adaptation in cirrhosis toward alcohol production Giuseppe Ferrandino Received Received
  3016-SUN The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: early outcomes from a multidisciplinary clinic. Shreya Sengupta Received Received
  3017-SUN Autophagy deficiency induces the expression of interferon-stimulated genes in mouse livers Shengmin Yan Received Received
  3018-SUN Sympathetic nervous system-beta 3 adrenergic receptor-mediated lipolysis in binge drinking-induced fatty liver disease Lin Jia Received Received
  3019-SUN Beer Consumption is Associated with Low Dietary Quality Among Alcohol Users Madeline Novack Received Received
  3020-SUN Cardiolipin Treatment in hepatocyte specific Ptpmt1-/- mice is Hepatoprotective in an Animal Model of Alcohol-associated Hepatitis Josiah Hardesty Received Received
  3021-SUN Patients Receiving Liver Transplantation for Acute on Chronic Liver Failure and Known Alcohol Related Liver Disease have Equivalent Relapse Risk Compared to those Transplanted for First Presentation of Severe Alcohol Related Hepatitis Stephanie Zanowski Received Received
  3022-SUN Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation Sung-Eun Kim Received Received
  3023-SUN Body mass index influences liver-related mortality after the first decompensation event in patients with alcohol-related liver disease Noriyo Yamashiki Received Received
  3024-SUN POTENTIAL USE OF iPSC-DERIVED HEPATOCYTE-LIKE CELLS TO DEVELOP PRECISION MEDICINE FOR ASH Samantha Hoey Received Received
  3025-SUN The role of C/EBPβ-SAA1/2 axis in alcohol-associated liver disease resolution. Irina Tikhanovich Received Received
  3026-SUN Prevalence of Infection in Alcohol-Associated Hepatitis and Impact on Mortality Regis Lee Received Received
  3027-SUN Clinical impact of harm reduction in patients with chronic liver disease and alcohol use disorder by brief intervention in a hepatology outpatient unit Nagisa Hara Received Received
  3028-SUN Cardiometabolic Comorbidities are Associated with Lower Rates of Recompensation and Transplant Free Survival in Patients with Acute Alcohol Associated Liver Disease Kelly Torosian Received Received
  3029-SUN Early pharmacologic treatment of alcohol use disorder and psychiatry consultation are associated with improved overall survival in severe alcohol-associated hepatitis Claire Durkin Received Received
  3030-SUN TREATMENT OF ALCOHOL USE DISORDER WITH MEDICATIONS AND WITH INTEGRATED CARE MODEL BENEFIT PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE Prabha Bhandari Received Received
  3031-SUN Survival benefit from corticosteroids in severe alcohol-associated hepatitis attributed to clinical and treatment differences in a large multicenter cohort Claire Durkin Received Received
  3032-SUN Prognostic significance of skeletal muscle mass in patients with alcoholic cirrhosis Tadashi Namisaki Received Received
  3033-SUN Screening of compensated alcohol-related liver disease: efficacy of a holistic approach (hepatology visit, brief intervention, and non-invasive test) on alcohol abstinence and relapses Ares Villagrasa Received Received
  3034-SUN Obesity and acute alcohol-associated hepatitis: adding insult to injury Yun-Cheng Hsieh Received Received
  3036-SUN Influence of the COVID-19 pandemic and alcohol on hospitalizations for decompensated liver disease Erika Dorff Received Received
  3038-SUN Incidence and Predictors of Long-Term Risks of Cirrhosis Among Veterans with Alcohol-Associated Liver Disease Robert Wong Received Received
  3040-SUN A Balancing Act: The Life-Saving Potential and Dilemma of Liver Transplantation as an Endpoint in Alcohol-Associated Hepatitis Trials Aparna Goel Received Received
  3041-SUN Combination of high-fat diet with chronic ethanol consumption in mice results in early-stage alcohol-associated liver disease. Marta Szydlowska Received Received
  3042-SUN A NOVEL ROLE OF STARD10 IN ERBB2-MEDIATED LIPOGENESIS IN ALCOHOL-ASSOCIATED LIVER DISEASE Manisha Dagar Received Received
  3043-SUN A NOVEL ROLE OF PHOSPHORYLATED UBIQUITIN CONJUGATING ENZYME 9 ON LIPOGENESIS IN ALCOHOL-ASSOCIATED LIVER DISEASE Swati Chandla Received Received
  3045-SUN Trends in Alcohol-Associated Hepatitis Among U.S. Veterans: Exploring Alternative Definitions Beyond Solely Using ICD-9/10 Codes to Improve Accurate Estimates of Disease Burden Zeyuan Yang Received Received
  3046-SUN UBC9 PHOSPHORYLATION REGULATES CYTOKINE SECRETORY SIGNALING IN ALCOHOLIC ASSOCIATED LIVER DISEASE Youngyi Lim Received Received
  3047-SUN Engagement with addiction medicine post-liver transplant increases treatment for alcohol use disorder Mounica Konjeti Received Received
  3048-SUN The Histologic Features of Severe Alcohol-Associated Hepatitis Undergoing Liver Transplantation: An Explant Study Chad Spencer Received Received
  3052-SUN Naltrexone Use in Patients with Combined Metabolic and Alcohol-associated Liver Disease (MetALD), Propensity Score Matched Study Amir Hossein Gougol Received Received
  3053-SUN Predictors of survival and hepatic recompensation in patients with ALD referred for early liver transplantation Nicholas Lim Received Received
  3054-SUN Brewing Bias: Alcohol biomarker testing trends for patients on the liver transplantation waitlist Hamza Sadhra Received Received
  3055-SUN Using a human liver-on-a-chip model to study alcohol-associated liver disease by targeting LSECs and ALDH2 Takashi Tsuchiya Received Received
  3056-SUN Population Based Screening For Alcohol Associated Liver Disease Using the Electronic Health Record Kristina Folta Received Received
  3057-SUN Cirrhosis is Associated With Worse Outcomes in Hospitalizations for Alcohol Withdrawal Yasmin Ali Received Received
  3058-SUN SUBCUTANEOUS INJECTION OF GALANIN ATTENUATES ALCOHOLIC HEPATITIS AND ABDOMINAL ADIPOSE TISSUE INFLAMMATION INDUCED BY ETHANOL BINGE IN OB/OB MICE Yuanwen Chen Received Received
  3059-SUN Statin therapy may protect against variceal bleeding in patients with alcohol-associated liver disease Nariman Hossein-Javaheri Received Received
  3060-SUN Real-world Evidence of Emerging Health Disparities in Severe Alcoholic Hepatitis Incidence in the Post-COVID Era Jiangqiong Li Received Received
  3061-SUN What is the correlation between AUDIT score and phosphatidylethanol level both taken on admission to a tertiary liver unit? A cirrhosis registry studySkladany L1,2, Ciefova J1, Adamcova Selcanova S1, Zilincanova D1, Havaj D1, Sulejová KK1, Gazda J2 Lubomir Skladaný Received Received
  3062-SUN Short-term Costs of Alcohol-associated Hepatitis Care in Different Clinical Settings Chi Mai Nguyen Received Received
  3063-SUN Impact of Steroids and Infection on Mortality in Alcohol-related Hepatitis Joseph Alukal Received Received
  3066-SUN Gene isoform transcript usage is associated with higher alcohol-associated hepatitis susceptibility in females than males Alastair Kilpatrick Received Received
  3067-SUN Prognostic Utility of Systemic Inflammatory Response Syndrome Criteria in Acute Alcoholic Hepatitis Joseph Spengler Received Received
  3071-SUN Cholesterol toxicity and PON-1 levels in alcohol-associated hepatitis correlate with severity and survival Praveena Narayanan Received Received
  3073-SUN Longitudinal Outcomes And Recovery In Patients With Decompensated Alcohol Associated Liver Disease Weiyu Wu Received Received
  3074-SUN Biased agonism of FPR1 signaling in neutrophils mitigates alcohol-associated liver disease Yong He Received Received
  3075-SUN Alcohol binge drinking impairs lipid metabolism in healthy hamsters and aggravates liver lesions in diet-induced obese MASH hamsters Francois Briand Received Received
  3076-SUN Deciphering the impact of myeloid cell-derived osteopontin in alcohol-associated liver disease Nithyananthan Subramaniyam Received Received
  3079-SUN The Impact of Type 2 Diabetes (T2D) on the Outcomes of Liver Transplantation (LT) Among Patients with Alcohol-associated Liver Disease (ALD) In the United States Maria Stepanova Received Received
  3080-SUN Prior Diagnosis of Decompensated Alcohol-Associated Liver Disease Does Not Increase Risk of Alcohol Relapse During Transplant Evaluation and May Increase Risk of Post-Transplant Alcohol Relaps Sasha Deutsch-Link Received Received
  3085-SUN Non-enzymatic Targeting of Metabolic-Alcohol-Associated Liver Disease and Cancer associated with ALDH2 deficiency and altered TGF-beta Signaling Xiaochun Yang Received Received
  3086-SUN Formoterol promotes mitochondrial biogenesis and decreases liver injury after chronic-binge ethanol (CBE) treatment in mice Devadoss Samuvel Received Received
  3087-SUN Post-liver transplant PETH monitoring: Potential as an early Biomarker for Rejection and Graft Failure Muhammad Ali Butt Received Received
  3091-SUN Plasma cell-free mtDNA is released in alcohol-related liver disease and correlates with liver injury MARAM ALENZI Received Received
  3092-SUN Sex differences in characteristics and outcomes of Veterans with alcohol-associated hepatitis Anahita Rabiee Received Received
  3094-SUN Identification of Alcohol-associated Hepatitis Using Electronic Medical Records Rachel Thompson Received Received
  3095-SUN GLP-1 RECEPTOR AGONISM REDUCES INJURY, HEPATIC CYP2E1 ACTIVITY AND INCREASES ANTIOXIDANT ACTIVITY IN A MOUSE MODEL OF ALCOHOL-INDUCED ACUTE HEPATITIS frhaan zahrawi Received Received
  3096-SUN Prevalence, Risk Factors, and Outcomes of Fungal Infections in Patients with Severe Alcohol-Associated Hepatitis Filippa Trikantzopoulou Received Received
  3098-SUN Impact of Social Determinants of Health on Transplant Candidacy for Alcohol-Associated Liver Disease Avni Malik Received Received
  3100-SUN Alcohol Use Disorder Treatment During Evaluation in Patients with ALD Referred for Early Liver Transplant Kevin Wang Received Received
  3101-SUN Demographic Disparities in The Outcomes of Patients Admitted with Alcohol-Associated Hepatitis: A Cross-Sectional Study Nehna Abdul Majeed Received Received
  3102-SUN Development of Alcohol-associated Liver Disease in Young Indian Adults: An Observational Study of Clinical and Socio-Demographic Correlates and opportunities for early intervention Mohit Varshney Received Received
  3103-SUN Impact of COVID-19 on Alcoholic-Related Hepatitis Admissions at a Midwest Tertiary Care Hospital Padmavathi Mali Received Received
  3104-SUN Cardiometabolic Comorbidities Influence Early Mortality in Patients with Alcohol-associated Hepatitis (AH) Christina Tran Received Received
  3105-SUN Initiation of naltrexone is associated with lower rates of SBP and mortality than acamprosate in patients with decompensated alcohol-associated cirrhosis Vinay Jahagirdar Received Received
  3106-SUN Performance of urine rapid Ethyl glucuronide testing to characterize recent and unhealthy alcohol use at HIV clinics in Zambia Michael Vinikoor Received Received
  3107-SUN Therapeutic inhibition of Bruton´s tyrosine kinase (BTK) acts on both immune cells and hepatocytes to attenuate immune cell activation and steatosis in a mouse model of alcohol-associated hepatitis Prashanth Thevkar Nagesh Received Received
  3109-SUN Single-cell RNA sequencing analysis reveals specific cell subpopulations in alcohol-associated hepatitis characterized by inflammatory, angiogenic and fibrogenic profile Elisa Pose Received Received
  3113-SUN Liver-related Complications are Associated with Worse Outcomes in Patients with Severe Alcohol-Associated Hepatitis Filippa Trikantzopoulou Received Received
  3116-SUN Impact of area-level income and residence on in-hospital mortality and intensive care unit admissions among patients with cirrhosis and alcohol-related hepatitis hospitalizations: A population-based study. Liam Swain Received Received
  3117-SUN The effect of area-level material and social deprivation on cirrhosis and alcohol-related hepatitis hospitalization rates during the COVID-19 pandemic: A population-based study. Liam Swain Received Received
  3118-SUN Engineered Human Liver Co-cultures to Model Hepatic Dysfunctions in MetALD Owen Lally Received Received
  3119-SUN Impact of Pre-Transplant Steroid Therapy on Early Post-Transplant Infections in Alcohol-Associated Hepatitis Patients Undergoing Liver Transplantation Alex Chang Received Received
  3120-SUN Rising Trends of Concurrent Mood Disorders in Hospitalized Patients with Alcohol-Associated Liver Disease Between 2014 and 2023: A Nationwide Study of Insured and Uninsured Populations Emily Shu-Yen Chan Received Received
  3121-SUN Post-Transplantation Outcomes in Alcohol-Related Liver Disease: Higher Relapse Rates Associated with Alcohol-Associated Hepatitis Alex Chang Received Received
  3123-SUN Risk Reduction is Possible in Patients with High-Risk SIPAT Scores Undergoing Liver Transplantation for Alcohol-Related Liver Disease Alex Chang Received Received
  3124-SUN Trends in Post-Discharge Pharmacological Alcohol Cessation Therapy and Psychiatric Referrals for Hospitalized Patients with Alcohol-Associated Liver Disease (ALD) Between 2014 to 2023: A Nationwide Study Emily Shu-Yen Chan Received Received
  3130-SUN Acute-on-Chronic Liver Failure (ACLF) criteria in Alcohol-associated Hepatitis: Implications for Liver Transplantation Luis Antonio Diaz Received Received
  3132-SUN Inflammation during alcohol associated hepatitis is mediated by liver sinusoidal endothelial cell production of Galectin-9 and PD-L1 Benjamin Swartzwelter Received Received
  3133-SUN Thirty-Day Readmissions Among Patients with Alcoholic Hepatitis, Risk factors, Impact on Mortality and Healthcare Resource Utilization: A Nationwide Analysis Shahryar Khan Received Received
  3134-SUN Prevalence and outcome of Concomitant Hepatitis B or C infection in Alcohol associated Liver Disease Akash Shukla Received Received
  3137-SUN Hepatic Methyltransferase Proteins Mediate PNPLA3-I148M-Driven Lipid Droplet Dynamics in Fatty Liver Xinshou Ouyang Received Received
  3138-SUN Medications for AUD in Patients with Alcohol-associated Cirrhosis or Hepatitis: No hepatotoxicity, but side-effect risks and decompensation Gene Im Received Received
  3140-SUN Drinking Behavior in the AHFIRM trial as measured by Phosphatidyl Ethanol Steven Flamm Received Received
  3145-SUN The Development, Feasibility, and Usability of an Artificial Intelligence-Enabled Conversational Agent in Virtual Reality for Patients with Alcohol-Associated Cirrhosis Yee Hui Yeo Received Received
  3146-SUN Sociodemographic disparities in access to liver transplantation waitlist in patients with Alcohol associated liver diseases: A single center study. Islam Mohamed Received Received
  3148-SUN Abstinence triggers site-specific metabolomic changes in the resolution of Alcohol-related Liver Disease NUPUR SHARMA Received Received
  3149-SUN The Clinical Significance of Homelessness on the Hospital Outcomes of Patients Admitted with Alcohol-associated Liver Disease David Lee Received Received
  3150-SUN National Trends in the Costs of Patients Admitted with Alcohol-associated Liver Disease Stratified by Patient Demographics: Analysis of National Hospital Database David Lee Received Received
  3151-SUN National trends in the Costs of Patients admitted with Alcohol Associated Liver Disease Stratified by Psychiatric Comorbidities and Substance Use: Analysis of National Hospital Database David Lee Received Received
  3152-SUN Identifying Risk Factors for Return to Alcohol Use in Post-Liver Transplant: The Role of Sobriety Duration and Age Natalia Rodriguez-Payan Received Received
  3153-SUN Integrated hepatology and addiction care for hospitalized patients with alcohol use disorder improves medical alcohol therapy engagament at discharge Jay Luther Received Received
  3155-SUN Hepatocyte-specific deletion of betaine homocysteine methyltransferase promotes age-dependent progression of liver disease Poonam Sagar Received Received
  3156-SUN Exploring the interplay of graded alcohol use and excess weight on atherogenic lipid profiles among Latinos with underlying chronic liver disease Shyam Patel Received Received
  3157-SUN Differences in Alcohol Use Disorder Treatment and Return to Drinking According to Severity of Alcohol-Associated Hepatitis Kamalpreet Hara Received Received
  3161-SUN Hepatocyte-specific deletion of betaine homocysteine methyltransferase promotes alcohol-induced liver injury Ramachandran Rajamanickam Received Received
  3162-SUN Psychiatric Comorbidities and Risk of Return to Drinking Amongst Liver Transplant Recipients Sienna Li Received Received
  3165-SUN LIVER TRANSPLANTATION IN ALCOHOLIC HEPATITIS AND ACLF: REDEFINING SELECTION AND SOBRIETY CRITERIA Parvez Mantry Received Received
  3166-SUN Alcohol intervention after acute variceal bleeding: reduces alcohol consumption, but remains underutilized in real-world setting YU JUN WONG Received Received
  3167-SUN SGLT2 Inhibitors Suppressed the Onset of Esophageal Varices and Extrahepatic Cancer Compared to DPP4 Inhibitors in Type 2 Diabetic Patients with MASLD: A Nationwide Medical Claims Database Study in Japan Takumi Kawaguchi Received Received
  3168-SUN Identification of Candidates for MASLD Treatment with Indeterminate Vibration-Controlled Transient Elastography David Marti-Aguado Received Received
  3169-SUN Effects of Luseogliflozin on MASLD in Patients with Type 2 Diabetes Mellitus: A Pooled Meta-analysis of Phase III Clinical Trials Takumi Kawaguchi Received Received
  3170-SUN Changing Prescription Pattern of Anti-diabetic Medications and Improvement in Glycemic Control in Patients with T2DM, with and without Cirrhosis: a territory-wide cohort study in Hong Kong from 2000-2023 Mary Yue Wang Received Received
  3171-SUN Evaluation of MASH drug efficacy using liver organoids based on drug target pathways Yeonjoo An Received Received
  3172-SUN Long-term outcomes of GLP-1 analogues treatment in MASLD patients with type 2 diabetes Takamasa Ohki Received Received
  3174-SUN The association between levothyroxine and its potential preventative effect on liver conditions, particularly in MASLD and MASH Joel Joy Received Received
  3175-SUN Effects of Saroglitazar in Compensated MASLD Cirrhosis: A Magnetic Resonance Elastography-Based (MRE) Based Single Arm Prospective Study Akash Roy Received Received
  3176-SUN Real-world Assessment of Glucagon-like Peptide 1 Receptor Agonist (GLP-1RA) in the Management of Patients with MASLD with Different Stages of Liver Fibrosis Dalton Caviness Received Received
  3177-SUN A real-world evidence, phase 4, multicenter, open-label, single-arm study to evaluate the safety and efficacy of saroglitazar 4 mg in patients with non-alcoholic fatty liver disease with obesity, type 2 diabetes mellitus, dyslipidemia, or metabolic syndro Deven Parmar Received Received
  3178-SUN The 5-Year Mortality Rate in MASLD Patients Undergoing Pharmacologic versus Bariatric Interventions Leith Ghani Received Received
  3179-SUN A Phase I trial to determine lowest effective dose of betaine for improvement of ALT in metabolic dysfunction-associated steatotic liver disease Andrew Lim Received Received
  3180-SUN Patterns of Practice for Screening and Management of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Report of a Global Survey. Aysha Aslam Received Received
  3181-SUN Comparing Major Adverse Cardiovascular Event (MACE) incidence in MASLD patients undergoing pharmacologic versus bariatric interventions Qumber Ali Received Received
  3184-SUN Validating pre-identified morphological baseline features for predicting fibrosis progression in MAESTRO-NASH Jörn Schattenberg Received Received
  3185-SUN Resmetirom protects against diet-induced MASLD and reduces atherosclerosis development in obese Ldlr-/-.Leiden mice Eveline Gart Received Received
  3186-SUN Accurate prediction of liver fat reductions across range of weight loss by quantitative systems pharmacology modeling Scott Siler Received Received
  3189-SUN Pemafibrate improves liver function with alteration of bile acid composition in patients with steatotic liver disease Kota Tsuruya Received Received
  3191-SUN Differential class effects of oral anti-diabetic drugs on cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease Heejoon Jang Received Received
  3192-SUN Comparison of Bariatric Surgery vs. GLP-1 Receptor Agonists on Cardiovascular Outcomes and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease, Diabetes, and Obesity: A Large Population-Based Cohort Study Arunkumar Krishnan Received Received
  3193-SUN Saroglitazar is more effective than simvastatin in reducing steatosis in patients with Met-ALD. Anand Kulkarni Received Received
  3198-SUN Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis EN YING TAN Received Received
  3200-SUN CVI-2742, a novel THR-beta selective agonist, exhibits enhanced liver-targeting properties in non-human primates and potent anti-NASH activity in mouse NASH model Jingwen Liu Received Received
  3201-SUN SkQ1, a mitochondria-targeted ferroptosis inhibitor, demonstrates efficacy against steatosis, ballooning and fibrosis in preclinical models of MASH Anton Petrov Received Received
  3203-SUN DUAL SILENCING OF YAP1/WWTR1 AS A NOVEL THERAPEUTICAL APPROACH FOR LIVER FIBROSIS Masayuki Sugimoto Received Received
  3204-SUN EFFICACY AND ADVERSE EVENTS OF RESMETIROM 80 MG IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): A SYSTEMATIC REVIEW AND META-ANALYSIS Ankita Nekkanti Received Received
  3207-SUN Oral mannose supplementation dampens liver fibrosis in murine MASH model by reducing activated hepatic stellate cells John Hong Received Received
  3210-SUN A small molecule inhibitor of fibroblast activation protein (FAP) blocks enzymatic activity and improves liver histopathology in cynomolgus monkeys with MASH and F1/F2 fibrosis Xiao-Rong Peng Received Received
  3211-SUN TGF-β Signaling Targeting Peptide BTI615 Attenuated Liver Fibrosis by Modulating Fibrotic Niche in CCl4-induced Mouse-model Qiu Jiang Received Received
  3218-SUN Evaluation of Efficacy of Berberine Ursodeoxycholate (HTD1801) Compared to Ongoing Use of GLP-1 Receptor Agonists in Patients with MASH and T2DM Kjersti Swearingen Received Received
  3219-SUN Time Course of Onset, Incidence and Prevalence of Gastrointestinal Adverse Events with HTD1801 (Berberine Ursodeoxycholate) in Patients with MASH and T2DM Kjersti Swearingen Received Received
  3221-SUN A Systematic Review on Resmetirom: Arresting MASH/MASLD Progression Charmy Parikh Received Received
  3222-SUN Efficacy and Safety of Pegbelfermin in MASH Cirrhosis- A Meta-Analysis and Systematic Review of Randomized Controlled Trials Muhammad Shahzil Received Received
  3225-SUN Sigma1 regulation of hepatic lipid metabolism in response to diet-induced obesity Luis Martinez Received Received
  3229-SUN Real World Data Assessing the Impact of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease Reeti Gulati Received Received
  3233-SUN MASH 2B TRIALS- A SYSTEMATIC REVIEW Bipneet Singh Received Received
  3234-SUN Surge in incidence and prevalence of autoimmune hepatitis since the COVID-19 pandemic Yuting Huang Received Received
  3235-SUN Quality Improvement for Vibration Controlled Transient Elastography Using a Novel Analysis Algorithm Jeffrey Schwartz Received Received
  3236-SUN Timely post-discharge follow-up after a first diagnosis of cirrhosis is associated with reduced mortality and rehospitalization in a large national cohort Max Schechter Received Received
  3237-SUN Patient Perceptions of Undergoing Routine Viral Hepatitis Screening and Receiving a Hepatitis C (HCV) Diagnosis While Incarcerated: A Qualitative Study Harit Agroia Received Received
  3238-SUN Hope for the Best, Prepare for the Worst: Integrating Palliative Care with Liver Transplant Candidate Evaluation and Management Jesslyn McMahon Received Received
  3239-SUN Rising Proportion of Hispanics and Women with Steatotic Liver Disease-related End-Stage Liver Disease and Hepatocellular Carcinoma Awaiting Liver Transplantation in the United States Shyam Patel Received Received
  3240-SUN Poor Access to Anti-Obesity Medications in Metabolic Dysfunction-Associated Steatotic Liver Disease Jane Giang Received Received
  3241-SUN Assessing transitions of care amongst inpatients with cirrhosis discharged from a diverse, urban liver transplant center: the importance of hepatology involvement and discharge destination Max Schechter Received Received
  3242-SUN Early palliative care (PC) in end-stage liver disease (ESLD) patients significantly improves health-related quality of life (HRQoL) Shirley Bong Received Received
  3244-SUN Activity Metrics Measured by Wearable Technology Correlates with Patient-Reported Wellbeing in Cirrhosis Brian McSteen Received Received
  3245-SUN Psychometric Properties of a Novel Tool to Measure Goal Concordant Care (GCC) From Patients with End Stage Liver Disease, and their Caregivers. Manisha Verma Received Received
  3246-SUN State-Level Variability and Disparities in Location of Death of Patients with End-Stage Liver Disease: A Retrospective Cross-Sectional Analysis Julia Meguro Received Received
  3247-SUN Healthcare Contact Days Pre- and Post-Liver Transplant in Patients with Cirrhosis: A National Cohort Study Gurmehr Brar Received Received
  3248-SUN A QUALITATIVE INQUIRY INTO THE EXPERIENCES OF PARTICIPANTS AND NURSES IN THE AUSTRALIAN LIVER FAILURE TRIAL Jeyamani Ramachandran Received Received
  3249-SUN The perceived psychological benefits and harms of undergoing HCC screening among Cherokee Nation patients - a patient perspective Nicole Kim Received Received
  3250-SUN Hepatology Clinician Perspectives on Addiction Stigma in the Care of Patients with Liver Disease and Addiction Lamia Haque Received Received
  3251-SUN Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) have Similar Clinical, Non-invasive Tests (NITs) and Patient-Reported Outcomes (PROs) Profile Zobair Younossi Received Received
  3252-SUN The long-term follow-up status of 3,643 patients achieving SVR after DAAs, managed by Specialists in hepatology; Nationwide survey Masatsugu Ohara Received Received
  3253-SUN The Quality of Care Provided to Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease in the Department of Veterans Affairs Kaitlyn Carlson Received Received
  3254-SUN Racial Differences in Perception of Healthcare Experiences Among Patients with Alcohol-Associated Liver Diseases: A Cross-Section Analysis of the All of Us Database Nicole Ng Received Received
  3255-SUN Socioeconomic Factors Impact the Perception of Care in Patients with Cirrhosis: Findings from the All of Us Database Nicole Ng Received Received
  3256-SUN Effectiveness of polyene phosphatidylcholinein improving liver function for patients with non-hepatitis B chronic liver disease: a real-world study Ning Lin Received Received
  3257-SUN Impact of distance from liver transplant centre on outcomes following liver transplantation - an Australian single centre study Ken Liu Received Received
  3258-SUN Mortality improvement in cirrhotic and hepatocellular carcinoma patients with major discrepancies according to etiology: a 10-year nationwide study Claire DELACOTE Received Received
  3260-SUN Exploring the Impact of Weekend Admission and Rurality on Outcomes and Practices in Hospitalized Patients with Decompensated Cirrhosis: A Nationwide Cross-Sectional Study Ahamed Khalyfa Received Received
  3261-SUN Compensated Advanced Chronic Liver Disease Management in Primary Care: Good Quality With the Right Model Alvin Lee Received Received
  3262-SUN The Effect of Implementation Intervention (Gilead FOCUS program) on Linkage to Hepatitis C Care Time at a Community Health Center in Deep South Adelero Adebajo Received Received
  3263-SUN Bisphosphonate effectiveness in patients with cirrhosis: an emulated clinical trial Beanna Martinez Received Received
  3265-SUN Annual Out-of-Pocket Medical Costs and Financial Burden Among Transplant Recipients in the United States Gabrielle Jutras Received Received
  3266-SUN Treatment persistence and discontinuation among chronic hepatitis B patients initiating antiviral treatment Sarah Hague Received Received
  3267-SUN Early detection of liver fibrosis in patients with alcohol use disorder improves long-term abstinence Amelia Orgill Received Received
  3268-SUN Liver Cancer Risk in Individuals Under 35 and PM2.5 Exposure: A Global Analysis of 179 Countries from 1990 to 2019, with Projections to 2035 Wang Zixing Received Received
  3269-SUN Caregivers of Liver Transplantation Recipients Experience Significant Anxiety Pre-Transplant and Decreased Informational Support Post-Transplant Meena Tadros Received Received
  3270-SUN Trends in Prescriber Characteristics of Oral Hepatitis B Medications in the United States Xiaohan Ying Received Received
  3271-SUN Immunogenicity of SARS-CoV-2 Vaccine in Patients with Chronic Liver Disease Asif Hitawala Received Received
  3272-SUN Creation of a New VA Transplant Center Increased Access and Reduced Wait Times for Liver Transplant Jessica Davis Received Received
  3273-SUN The Supportive Needs Assessment tool in Cirrhosis is a feasible tool for Identifying Unmet Needs in a US academic cohort Cristal Brown Received Received
  3274-SUN DIAGNOSIS OF HEPATITIS C IN BABY BOOMERS THROUGH AN AUTOMATIC NOTIFICATION IN THE GREEK PRESCRIPTION SYSTEM Anthie Chatziioannou Received Received
  3275-SUN Technology Utilization and Health Literacy Assessment in Patients with Chronic Liver Disease (TULAP-CLD) Zoe Post Received Received
  3278-SUN The Cost of DILI: Exploring How Drug Induced Liver Injury Burdens the U.S. Healthcare System Danielle Zolotnitsky Received Received
  3279-SUN Symptom burden and management in patients with end stage liver disease versus pancreatic cancer: a comparative analysis. Mary Bassaly Received Received
  3280-SUN Gender disparities in listing and transplantation in patients with ALD referred for early liver transplantation Katherine Cooper Received Received
  3282-SUN Advanced care planning in advanced liver disease remains dismally low in Singapore: lessons learned from examining referrals amongst a cohort of hospitalized patients with cirrhosis. Chanda Ho Received Received
  3283-SUN Liver transplantation (LT) is not commonly broached amongst a cohort of patients with decompensated liver disease in Singapore. Chanda Ho Received Received
  3285-SUN Patient Voice in MASH Initiative: Foundational Principles for the Conduct of Patient-Centric MASH Research Michael Betel Received Received
  3286-SUN Cost-effectiveness of expanding eligibility for antiviral prophylaxis to all HBsAg-positive pregnant women inaccessible to HBV DNA or HBeAg testing in China Xueru Yin Received Received
  3288-SUN New diagnosis of cirrhosis is common in the Emergency Department and associated with higher healthcare utilization. Swetha Parvataneni Received Received
  3289-SUN Medicare Part D Coverage Restrictions for Drugs Commonly Prescribed for Hepatitis B Treatment, 2019-2023 Misha Gautam Received Received
  3290-SUN Medicare Part D Coverage Restrictions for Drugs Commonly Prescribed for Hepatitis C Treatment, 2019-2024 Misha Gautam Received Received
  3291-SUN Increasing Readiness and Self-efficacy for Serious Illness Communication Engagement in Patients with ESLD Cristal Brown Received Received
  3292-SUN The Indian Metabolic and Liver Disease (IMELD) study: Utilizing Epidemiology and Implementation Sciences to Stratify Population Risk for NAFLD Kanica Kaushal Received Received
  3293-SUN The patient experience of a new ´referral´ pathway for liver disease in the Somerset Liver Improvement Project Christina Owen Received Received
  3294-SUN Assessing Economic Burden Among Unique Patient Segments in an HDV-infected Population Prajakta Bhounsule Received Received
  3295-SUN Utilizing Technology to Risk Stratify Patients with MASLD and Increase Rates of Identification of Clinically Significant Liver Fibrosis Rachel Orbuch Received Received
  3296-SUN Comparative Analysis of Two Methods of FIB-4 Calculation in Primary Care to Identify Advanced Fibrosis in Patients with Diabetes: Implications for Adherence to the AASLD MASH Care Pathway Anna Mageras Received Received
  3297-SUN Development of a sexual function assessment tool in men and women with liver disease and liver transplantation Yooyun Chung Received Received
  3298-SUN Recommendations for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Disease Management: A Modified Delphi Panel Anna Watzker Received Received
  3299-SUN Achievements and Challenges of HCV mass screening granted by the Italian Ministry of Health dedicated funds Loreta Kondili Received Received
  3301-SUN A Hepatitis C (HCV) Surveillance Systems Evaluation to Improve Understanding of Local HCV Disease Burden and Its Effects on Impacted Communities in Santa Clara County, California Amelia Salmanson Received Received
  3302-SUN Caregiver Involvement and Characteristics are Associated with Patient Quality of Life: Baseline Analyses from the PAL LIVER Trial Eric Orman Received Received
  3304-SUN Contraception counseling and pregnancy after liver transplantation: A single center experience Juan Gonzalez Received Received
  3305-SUN The Self-Rating Scale Item Is a Valid Measure of Lactulose Adherence in Patients With Hepatic Encephalopathy Stacey Tam Received Received
  3306-SUN The Hospital Frailty Risk Score Predicts Outcomes in Patients with Hepatic Fibrosis or Cirrhosis Imran Qureshi Received Received
  3307-SUN Terlipressin Is Associated with Decreased Healthcare Resource Utilization Compared with Midodrine/Octreotide Among Patients with Hepatorenal Syndrome Alexandra DeSousa Received Received
  3308-SUN Association Between Cirrhosis and Liver Injury and Toxic Metals Exposures Nikia Smith Received Received
  3309-SUN The Otago Exercise Program Improves Liver Frailty in Pre-Transplant Candidates Neil Shah Received Received
  3311-SUN Estimating local transmission dynamics of Hepatitis A virus increased incidence among men who have sex with men in New York City and California, 2016-2019 Oluwatosin Jegede Received Received
  3312-SUN To achieve functional cure for chronic hepatitis B infection- new therapy vs expanding the existing therapy George Lau Received Received
  3313-SUN Data Driven Clinical Trial Recruitment - From the Common to the Rare Robert Miller Received Received
  3314-SUN Advance Care Planning Completion Rates and Perceptions Among Adults with End-Stage Liver Disease in a Population-Based Cohort Arpan Patel Received Received
  3315-SUN Etiological transitions in patients with liver cirrhosis and hepatocellular carcinoma: a single-center study from an institution located in a district with a high prevalence of viral hepatitis Hirayuki Enomoto Received Received
  3317-SUN Hepatic encephalopathy and acute kidney injury largely drive transfer of patients to higher centers of care: A National Analysis Chathur Acharya Received Received
  3318-SUN A nationwide cross-sectional survey in viral hepatitis screening for Japanese workers and consultation behavior of positive patients for HCV antibody -13.7 million general checkup applicants Masaaki Korenaga Received Received
  3319-SUN Exploring Campaign Preference Styles and Trusted Information Sources regarding Hepatitis B and Hepatocellular carcinoma among Adults in the Midwest: A Cross-Sectional Survey with Visual Aids Erin Mann Received Received
  3320-SUN Premature Mortality for the Spectrum of Steatotic Liver Disease (SLD) in the US populations James Paik Received Received
  3321-SUN Improvement in time to hepatitis C virus treatment in New Mexico state prisons, 2020-2023 Juan Ceniceros Received Received
  3322-SUN Impact of Hospice Utilization in Acute Hospital Care of Patients Admitted with Decompensated Cirrhosis and Hepatocellular Carcinoma - A Systematic Review and Meta-Analysis. Shahryar Khan Received Received
  3323-SUN National Hepatitis Profiles: A Global HBV Report Jana Manning Received Received
  3324-SUN Evaluating the Role of Palliative Care in Hepatocellular Carcinoma Using the National Inpatient Sample: Cost Savings, Reduced Interventions, and Racial Disparities Amir Sultan Seid Received Received
  3326-SUN PRISMA (Patient Resonance Intelligence Supporting Medical Analysis): An AI Algorithm in de-ciphering lifestyle factors effects on liver disease Fatma Barakat Received Received
  3327-SUN Opioid Use after Adult Liver Transplantation: Predicting Incidence, High-Risk Use, and Opioid-Related Complications in a National Cohort Olgert Bardhi Received Received
  3328-SUN Inadequate viral hepatitis immunization and testing amongst vulnerable patients in the ambulatory setting Chip Bowman Received Received
  3331-SUN Prevalence of compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights from NHANES 2017-2020 Ritik Mahaveer Goyal Received Received
  3332-SUN Assessing Liver Biopsy Methods: Comparing Adequacy and Safety. A Real-World Single-Center Experience Divya Devabhaktuni Received Received
  3333-SUN Hepatitis Delta Testing and Positivity Rates are Increased in More Highly Resourced Communities in a Large, Urban Cohort: An Analysis of the INSIGHT PCORnet Database in New York City Lauren Alpert Received Received
  3336-SUN National Hepatitis Profiles: A Global HCV Report Jana Manning Received Received
  3337-SUN Missed Diagnosis of Ambulatory Community Acute Kidney Injury Is Common and Associated with Major Adverse Kidney Events in Patients With Cirrhosis Kavish Patidar Received Received
  3338-SUN Advanced Liver Disease Coordinator Improves Hepatocellular and Variceal Surveillance Across a Diverse Veterans Affairs Healthcare Network Melissa Kaltenbach Received Received
  3339-SUN Comparing Health Related-Quality of Life of Patients Between Compensated and Decompensated Cirrhosis - A Systematic Review and Meta-Analysis Shahryar Khan Received Received
  3340-SUN Breaking Down Barriers: Investigating Trans Arterial Chemo Embolism (TACE) as a Palliative Measure for Unresectable HCC Along the US-Mexico Border Swati Mahapatra Received Received
  3341-SUN Cost-Effectiveness of the HepQuant DuO Test for the Management of Patients at Risk for Large Esophageal Varices Gregory Everson Received Received
  3342-SUN Expanding Access to Liver Transplantation: Effectiveness of a Single-Center Targeted Outreach Program Sudha Kodali Received Received
  3345-SUN Liver Frailty Index, Not Six-Minute Walk Distance, is Associated with Liver Transplant Waitlist Dropout Tania Larsen Received Received
  3346-SUN Unveiling Changes in Racial, Ethnic, and Socioeconomic Disparities in Access to Critical Interventions for Hospitalized Patients with Cirrhosis And Portal Hypertension Complications in the U.S. in 2021 Miriam Sanchez Received Received
  3347-SUN Refining Medication Reconciliation in Liver Clinics: Evidence from a GI Continuity Clinic Hammad Ashraf Received Received
  3348-SUN Use of GLP1RA in a MASLD Clinic Is Influenced by Type of Insurance Coverage Meagan Gray Received Received
  3350-SUN Higher risk of proteinuria in atezolizumab plus bevacizumab than lenvatinib as a first-line systemic treatment in unresectable hepatocellular carcinoma Jiwon Yang Received Received
  3351-SUN Locoregional treatments for bridging patients with hepatocellular carcinoma to liver transplantation Grace Lee Received Received
  3352-SUN Analysis of factors predicting the real-world efficacy of atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma CHANG WON HA Received Received
  3354-SUN Stereotactic Ablative Body Radiotherapy versus Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma Darragh Egan Received Received
  3355-SUN The ASAP score demonstrates high sensitivity for hepatocellular carcinoma (HCC) and is feasible for use in HCC surveillance - a prospective study Chee-Kiat Tan Received Received
  3356-SUN UCSF criteria and liver dysfunction predict hepatocellular carcinoma (HCC) recurrence after surgery for HCC: A large multicentre study Conner Blackmore Received Received
  3357-SUN Multi-omics analyses identify a novel HCC subtype with worse prognosis and better response to immune checkpoint inhibitor based therapies Junjie Xu Received Received
  3360-SUN Resveratrol and tanshinone IIA synergize to suppress hepatocellular carcinoma by modulating stromal cells to remodel tumor microenvironment Jia Shi Received Received
  3361-SUN Risk of bleeding in hepatocellular carcinoma patients treated with atezolizumab/bevacizumab: A systematic review and meta-analysis Jeong-Ju Yoo Received Received
  3362-SUN Evaluation of Prophylactic Esophagogastroduodenoscopy versus Beta Blockade in Hepatocellular Carcinoma Patients Undergoing Anti-Angiogenic Cancer Treatments Panayiotis Kontoyiannis Received Received
  3363-SUN Cholangiocytes´ Primary Cilia Regulates DNA Damage Response and Repair Estanislao Peixoto Received Received
  3365-SUN Digitalized Precise Screening and Risk Stratified Management Improve Early Diagnosis of Hepatocellular Carcinoma (HCC) in China: a Multi-center Real-world Study Tianle Li Received Received
  3366-SUN The Histone Lysine Acetyltransferase KAT2B Inhibits Cholangiocarcinoma Growth: Evidence for Interaction with SP1 to Regulate NF2-Yap Signaling Wenbo Ma Received Received
  3367-SUN RBM39 Enhances Cholangiocarcinoma Growth through Ezh2-Mediated Wnt7b/Β-Catenin Pathway Nianli Liu Received Received
  3368-SUN Non-viral Hepatocellular Carcinoma Has Similar Prognosis after Radical Treatment as Viral HCC: Analysis of a Nationwide Registry for Advanced Liver Diseases (REAL) Kazuya Okushin Received Received
  3369-SUN TGF-β Signaling Molecules in Circulating Tumor Cells as Prognostic Biomarker in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab Yosuke Murata Received Received
  3370-SUN Diagnostic Accuracy of Blood Plasma Spectroscopy for Early Liver Cancer Diagnostics in Obese Patients Petr Hríbek Received Received
  3371-SUN Outcomes by baseline liver function in EMERALD-1: a Phase 3, randomized, placebo-controlled study of transarterial chemoembolization with durvalumab with/without bevacizumab in participants with embolization-eligible unresectable hepatocellular carcinoma Helen Sherratt Received Received
  3372-SUN Intraindividual Comparison of Prognostic Imaging Features of Hepatocellular Carcinomas Between MRIs with Extracellular and Hepatobiliary Contrast Agents: Focus on Microvascular Invasion and Early Recurrence Sunyoung Lee Received Received
  3373-SUN Mechanism of hepatocarcinogenesis due to hepatitis B virus genome integration into host KMT2B locus Jun Tsuchiya Received Received
  3374-SUN METTL3-mediated m6A modification regulates the polycomb repressive complex 1 (PRC1) components BMI1 and RNF2 in hepatocellular carcinoma cells Weina Chen Received Received
  3375-SUN Comparison of liver function injury in intermediate and advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy versus transcatheter arterial chemoembolization combined with immune checkpoint inhibitors and tyrosine Mengya Zang Received Received
  3376-SUN The Hippo Pathway Effector TAZ Is Required for Notch-Driven Cholangiocarcinogenesis via METTL3-mediated m6A modification Wenbo Ma Received Received
  3377-SUN Performance of a Multi-Cancer Early Detection (MCED) Test for Detection of Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis Darine Daher Received Received
  3378-SUN Prospective study on the improvement of prognosis and suppression of cancer development after administration of zinc preparation in patients with liver cirrhosis Atsushi Hosui Received Received
  3379-SUN Fever after the administration of atezolizumab and bevacizumab predicts liver injury in patients with unresectable hepatocellular carcinoma: a prospective observational analysis using a multiplex bead-based immunoassay Takanori Ito Received Received
  3380-SUN Analysis of Varix bleeding complication after Atezolizumab plus Bevacizumab for advanced Hepatocellular carcinoma patients Hee Kim Received Received
  3382-SUN Multi-omics analysis of patients with hepatocellular carcinoma treated with anti-PD-L1 plus anti-CTLA-4 and locoregional therapy: Correlative study of Phase2 trial Yuta Myojin Received Received
  3384-SUN Liver transplantation is the major determinant in achieving over 10-year survival for patients with early-stage hepatocellular carcinoma Joseph Ahn Received Received
  3385-SUN Interaction of solute carrier family 39 member 1 and dynamin related protein 1 to facilitate development of hepatocellular carcinoma by impairing mitochondrial quality control Li Rui Received Received
  3386-SUN Maintenance of good liver function is important for good post-progression survival with atezolizumab/bevacizumab in advanced hepatocellular carcinoma Teiji Kuzuya Received Received
  3387-SUN A comparative validation of clinical prediction scores for hepatocellular carcinoma in steatotic liver disease without cirrhosis Catherine Mezzacappa Received Received
  3389-SUN UBE2D3 negatively regulates hepatocarcinogenesis via suppression of STAT3 signaling Hideharu Nagasawa Received Received
  3390-SUN RNA-Binding Protein Trx regulates alternative splicing and promotes metastasis of HCC via interacting with LINC00152 xiangnan teng Received Received
  3391-SUN A Clinicopathological and Artificial Intelligence-Derived Screening Model as a Tool for Distinguishing Patients with Non-Hodgkin Lymphomas from Inflammatory Hepatic Diseases: A Multicentric Learning Approach Mina Farag Received Received
  3392-SUN Outcomes by comorbidities with tremelimumab and durvalumab in the Phase 3 HIMALAYA study in unresectable hepatocellular carcinoma Helen Sherratt Received Received
  3393-SUN Trends in HCC deaths and contributing chronic liver disease etiologies - a contemporary analysis of national death certificate data Andrew Moon Received Received
  3394-SUN Validation of a risk-stratified approach to screening for hepatocellular carcinoma following liver transplantation Wesley Dixon Received Received
  3396-SUN T cell receptor and immune gene expression pharmacodynamics for durvalumab monotherapy and in combination with tremelimumab or bevacizumab in unresectable hepatocellular carcinoma (uHCC) Robin Kate Kelley Received Received
  3397-SUN EMERALD-Y90: a Phase 2 study to evaluate transarterial radioembolization (TARE) followed by durvalumab (D) and bevacizumab (B) for the treatment of participants (pts) with unresectable hepatocellular carcinoma (uHCC) eligible for embolization Helen Sherratt Received Received
  3398-SUN Non-viral etiology subgroup of the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Helen Sherratt Received Received
  3399-SUN Statin Use Reduces Tumor Recurrence in Hepatocellular Carcinoma After Curative Radiofrequency Ablation: A Propensity-Matched Analysis Mazen Almasry Received Received
  3400-SUN Development of an ultra-sensitive TERT promoter mutant DNA detection method and its application in liquid biopsy Masaru Muraoka Received Received
  3402-SUN The chemoprotective effects of genistein in a rat model of cirrhosis and hepatocellular carcinoma Maneerat Chayanupatkul Received Received
  3403-SUN Nucleos(t)ide analogues in the treatment of long-term prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical surgery: Interim analysis of the phase 3 multi-center prospective trial Zhongguo Zhou Received Received
  3404-SUN The role of HBV pregenomic RNA in influencing the development of hepatocellular carcinoma Yifan Han Received Received
  3405-SUN Identification of PRMT5 as a therapeutic target in cholangiocarcinoma Jasmin Elurbide Received Received
  3406-SUN PIVKA-II as a prognostic factor for patients with hepatocellular carcinoma and with normal serum alpha-fetoprotein levels Chun-Ting Ho Received Received
  3407-SUN Machine learning-based decision-tree model demonstrating the prognostic value of PIVKA-II and AFP in patients with hepatocellular carcinoma Chun-Ting Ho Received Received
  3412-SUN Serum soluble DR5 as a Novel biomarker predicts early recurrence of hepatocellular carcinoma in TACE-treated patients with chronic hepatitis B xuanwei zeng Received Received
  3413-SUN Five-year overall survival and overall survival by tumor response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Lorenza Rimassa Received Received
  3415-SUN Role of myeloid-cell derived osteopontin in hepatocellular carcinoma Chao Wang Received Received
  3416-SUN Circulating tumour DNA markers for prediction of sustained response following the cessation of targeted therapy and immunotherapy in hepatocellular carcinoma (HCC) Jinzhang Chen Received Received
  3417-SUN The Albumin-Bilirubin Score as an Indicator of Effective Immunotherapy in Elderly Patients with Unresectable Hepatocellular Carcinoma Shun Kaneko Received Received
  3418-SUN Longitudinal trends in frailty among patients with hepatocellular carcinoma Madeleine Hu Received Received
  3420-SUN Stem Cell Growth Factor-β as a Predictive Biomarker of Response to Chemotherapy and Prognosis in Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Study Masamichi Kimura Received Received
  3421-SUN Investigation for a role of non-apoptotic cell death in the development of Hepatocellular carcinoma Yoshinobu Saito Received Received
  3422-SUN Prognostic value of combination of neutrophil to lymphocyte ratio and albumin- bilirubin grade in patients with hepatocellular carcinoma undergoing transarterial chemoembolization Young Mi Hong Received Received
  3423-SUN Real-World Study of Adjuvant Therapy After Complete Resection of Early-Stage Hepatocellular Carcinoma Yue Huang Received Received
  3425-SUN Impact of low level viremia on the efficacy of immune checkpoint inhibitors therapy in patients with unresectable hepatocellular carcinoma Jinzhang Chen Received Received
  3426-SUN UTILITY OF THE GAAD ALGORITHM IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG A HIGH-RISK COHORT Emily Larrea Received Received
  3428-SUN Identification of ITGB2 as a Novel MHC-II Neoantigen using Hepatocellular Carcinoma Organoids Deyuan Zhong Received Received
  3433-SUN Systemic Immune Profiling Identifies Predictive Biomarkers for Response to Combination Immunotherapy in Hepatocellular Carcinoma Akira Nishio Received Received
  3434-SUN Phase I clinical trial of adjuvant therapy utilizing six tumor-associated antigen-derived peptides and autologous dendritic cells for hepatocellular carcinoma Hidetoshi Nakagawa Received Received
  3435-SUN Disruption of FGL2 induced TFEB-dependent lysosomal degradation of PD-L1 and Enhanced the efficacy of Anti-PD-1 therapy in Hepatocellular Carcinoma Meiwen Han Received Received
  3436-SUN Soluble FGL2-FcγR?B axis drived memory CD8+ T cells dysfunction in Hepatocellular Carcinoma Qianting Guan Received Received
  3437-SUN Investigation for diagnostic value of circulating tumor DNA for the early HBV-derived HCC by profiling fragmentation Tom Ryu Received Received
  3438-SUN Multi-Omic Risk Prediction for Cholangiocarcinoma Felix Van Haag Received Received
  3439-SUN Analysis of atezolizumab antidrug antibody in HCC patients treated with Atezolizumab and Bevacizumab Ouchi Keishi Received Received
  3442-SUN Spatial Omics Analysis of the Proximity of PD-L1(+) Tumor-Associated Macrophage and CD8T cell Interaction Promoting Hepatocellular Carcinoma Progression Takuto Nosaka Received Received
  3443-SUN Critical Outcomes in Patients with Hepatobiliary Neoplasia during COVID-19: United States Nationwide Analysis Thanathip Suenghataiphorn Received Received
  3444-SUN Misclassification analysis of a multimodal image-based deep-learning model for predicting post-operative HCC recurrence: Implications for model improvement Rex Wan-Hin Hui Received Received
  3445-SUN Phase II study of atezolizumab plus bevacizumab combination therapy in patients with unresectable hepatocellular carcinoma and Child-Pugh B: CHALLENGE trial Takeshi Terashima Received Received
  3446-SUN Hepatocellular Carcinoma Risk in Hispanics with Chronic Hepatitis B Ariel Lee Received Received
  3447-SUN Impact of Prior Locoregional Therapy (LRT) on Outcome of Patients treated with Single-Dose Tremelimumab Induction Regular Durvalumab (STRIDE) Therapy for Unresectable Hepatocellular Carcinoma (uHCC) in a Real-World Cohort Shalini Bansal Received Received
  3448-SUN Viral versus Non-Viral Etiology Does Not Impact Outcomes of Unresectable Hepatocellular Carcinoma (uHCC) Patients Treated with Single Tremelimumab Regular Interval Durvalumab (STRIDE) in a Real-World Setting Shalini Bansal Received Received
  3449-SUN Unraveling immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma MyungJi Goh Received Received
  3450-SUN Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-MS/MS and network pharmacology Yang Cheng Received Received
  3451-SUN DNA demethylation in promoter region restores CYGB expression and attenuates hepatocellular carcinoma progression Hoang Hai Received Received
  3452-SUN Re-classification of combined hepatocellular-cholangiocarcinoma and small duct type intrahepatic cholangiocarcinoma by genetic alterations Motoko Sasaki Received Received
  3453-SUN MARIJUANA USE IS NOT INDEPENDENTLY ASSOCIATED WITH THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS Tae Hoon Lee Received Received
  3455-SUN Outcomes of Combined Heart and Liver Transplants in Patients with Congestive Hepatopathy and HCC: Analysis of US National Database Fadl Zeineddine Received Received
  3456-SUN Causal association and prognostic value of tertiary lymphoid structure-related gene signatures in HCC Lei Pu Received Received
  3458-SUN Prevalence of Chronic Liver Disease in Cholangiocarcinoma: a Meta-Analysis Ethan Kai Jun Tham Received Received
  3459-SUN Hepatoma-derived growth factor (HDGF) is an oncogene on chromosome 1q in liver cancer Tsung-Hui Hu Received Received
  3461-SUN Real-world clinical characteristics and treatment patterns among patients with unresectable hepatocellular carcinoma (uHCC) amenable to locoregional therapy (LRT) in the United States (US) Neehar Parikh Received Received
  3463-SUN Manzamine A Inhibits Proliferation of Human Hepatocellular Carcinoma Cells by Suppression of Mitochondrial and Glycolytic Metabolism Kenji Takemoto Received Received
  3464-SUN MAFLD etiology and multidisciplinary treatment could achieve a good survival in advanced HCC with cirrhosis - a large retrospective data from India. Ashok Kumar Choudhury Received Received
  3466-SUN Safety analysis by treatment periods from EMERALD-1: a Phase 3, randomized, placebo-controlled study of transarterial chemoembolization with durvalumab with/without bevacizumab in participants with embolization-eligible unresectable hepatocellular carcino Helen Sherratt Received Received
  3467-SUN Risks of variceal bleeding in patients with hepatocellular carcinoma receiving immune checkpoint inhibitors and/or tyrosine kinase inhibitors (TIKs) Jing Liang Received Received
  3468-SUN A patient-derived hepatocellular carcinoma spheroid system harnessing patient serum to model the tumor microenvironment and treatment response Emilie Crouchet Received Received
  3469-SUN PFAS exposure as a risk factor for hepatocellular carcinoma: are all PFAS the same? Ana Maretti-Mira Received Received
  3470-SUN Risk factors for post-transarterial chemoembolization hepatic failure in patients with hepatocellular carcinoma: A Systematic Review and Meta-Analysis Vitchapong Prasitsumrit Received Received
  3474-SUN Multistep accumulation of mismatch repair deficiency-associated mutational signature during the hepatocarcinogenesis revealed by whole-genome sequencing analysis Haruhiko Takeda Received Received
  3475-SUN High Proximity of Treg-CD8T/CD4T Cell Interactions in Spatial Omics Analysis Regulating Cancer Progression in Patients with Hepatocellular Carcinoma Junki Yamashita Received Received
  3476-SUN Impact of CRAFITY score on Efficacy and Safety of First-line Atezolizumab plus Bevacizumab Therapy: Multi-center Retrospective Study Masayuki Ueno Received Received
  3477-SUN Statin Use and Hepatocellular Carcinoma in Participants with Hepatic Fibrosis in the All of Us Research Program Erik Almazan Received Received
  3478-SUN Exploring the Influence of Aspirin on Hepatocellular Carcinoma : A Nationwide Inpatient Analysis Manasa Ginjupalli Received Received
  3480-SUN Exosomal miRNA as a Valuable Indicator for Predicting the Response of Atezolizumab and Bevacizumab Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Eunho Choi Received Received
  3481-SUN The Composition of Circulating Immune Cells Following Treatment with Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma Eunho Choi Received Received
  3482-SUN In vivo experiments and omics analysis to explore the effect and mechanism of AnLuoHuaXian pills in alleviating the process of hepatitis to hepatocellular carcinoma Xiaobin Zao Received Received
  3483-SUN Impact of COVID-19 on primary liver cancer-related mortality in the United States Young Eun Chon Received Received
  3485-SUN Differentiating Hemangiomas from Hepatocellular Carcinomas Using Sonazoid-Enhanced Ultrasonography: A Proposed Two-Step Diagnostic Algorithm Jeong Ah Hwang Received Received
  3486-SUN Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma Gwang Hyeon Choi Received Received
  3489-SUN Epigenetic Regulation of ACSM5 Expression in Hepatocellular Carcinoma Lei Yang Received Received
  3490-SUN Dendritic cell exosomes decorated with hepatocellular carcinoma-specific antigenic peptides combined with anti PD-L1 boost cancer immunotherapy Weihua Li Received Received
  3491-SUN Atezolizumab combined with Bevacizumab versus Sorafenib and Lenvatinib for patients with unresectable hepatocellular carcinoma: A systemic review and meta-analysis for randomized controlled trials Sakditad Saowapa Received Received
  3492-SUN A machine learning model to predict the treatment response of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma Moon Haeng Hur Received Received
  3494-SUN DPP4 inhibition augments the anti-tumor effect of combined anti-PD-1 antibody/regorafenib in hepatocellular carcinoma Heejoon Jang Received Received
  3495-SUN Predicting end-stage hepatocellular carcinoma with the ECHO score: refining the definition of Barcelona Clinic Liver Cancer stage D disease in patients treated with immune checkpoint inhibitors Michael Li Received Received
  3496-SUN Circulating exoPD-L1 predicts the outcome of patients with HCC who received atezolizumab-bevacizumab Yu Rim Lee Received Received
  3497-SUN Burden of Liver Cancer and Other Major Gastrointestinal Cancers in The Eastern Mediterranean Region Saleh Alqahtani Received Received
  3498-SUN Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis or bile duct invasion. Hyun Young Woo Received Received
  3499-SUN Machine learning can accurately stratify risk of hepatocellular carcinoma in real-world data Jan Clusmann Received Received
  3500-SUN Targeting UBE2I-mediated protein hyper-SUMOylation halts cholangiocarcinoma progression and rewires the tumor-stroma crosstalk Paula Olaizola Rebe Received Received
  3501-SUN The involvement of microRNA-1297 in lenvatinib resistance in hepatocellular carcinoma cells Takayuki Kogure Received Received
  3503-SUN Transposon-based oncogenes integration in Abcb4 (Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis Pinzhu Huang Received Received
  3507-SUN Initial trans-arterial chemo-embolization (TACE) is associated with similar survival outcomes as compared to upfront percutaneous ablation in those with single hepatocellular carcinoma (HCC) <= 3cm: results of a real-world propensity-matched multi-centre Jonathan Abdelmalak Received Received
  3508-SUN Efficacy and safety of Stereotactic body radiation therapy in elderly patients with cirrhosis and large advanced hepatocellular carcinoma Deepti Sharma Received Received
  3509-SUN The role of adjuvant therapy in HCC treated with curative intent ablation: a step too far? Natalie Commins Received Received
  3510-SUN Relationship between Immune Cell Infiltration and Outcomes in Cholangiocarcinoma Keiko Iwaisako Received Received
  3511-SUN NRF2-mediated immune cold tumor microenvironment contributes to resistance to atezolizumab and bevacizumab in advanced hepatocellular carcinoma Shuhei Yamamoto Received Received
  3512-SUN Lipophilic Statin Increases Sensitivity for Lenvatinib by Suppressing YAP/TAZ in Hepatocellular Carcinoma Cell Lines and Patient-Derived Organoids Jae Seung Lee Received Received
  3513-SUN Trimethylamine N-oxide (TMAO) as a novel predictive biomarker in gallstone disease and gallbladder cancer: Insights from human and mice study Vipin Yadav Received Received
  3517-SUN Sarcopenia impacts treatment tolerance and survival of patients with Hepatocellular carcinoma in cirrhosis Krishnadas Devadas Received Received
  3518-SUN The Relationship between Fatty Acid Composition and Prognosis in Patients with Hepatocellular Carcinoma: Establishment of a New Nutritional Prognostic Score Akitoshi Sano Received Received
  3519-SUN The Steatosis- Associated Fibrosis Estimator (SAFE) Score Predicts Hepatocellular Carcinoma in a Cohort of Chronic Liver DIsease of Mixed Etiology Mai Sedki Received Received
  3520-SUN A comprehensive study employing computational analysis and Mendelian randomization has revealed the impact of key genes on liver cancer Size Li Received Received
  3521-SUN Genomic profiling and pathological differences in MASLD-related hepatocellular carcinoma with and without cirrhosis. Ajay Duseja Received Received
  3522-SUN Role of ALBI score in patients with hepatocellular carcinoma undergoing transarterial chemoembolization in Child-Pugh class A and low MELD score Won Sohn Received Received
  3523-SUN Impact of the SARS-CoV-2 Pandemic on the Diagnosis and Follow-up of Patients with Hepatocellular Carcinoma at Río Hortega University Hospital Natalia Marcos-Carrasco Received Received
  3525-SUN Survival after Removal from Liver Transplant Waitlist for Hepatocellular Carcinoma Progression: Effects of Immunotherapy and Therapy Type David Victor Received Received
  3527-SUN AGAP-APRI as a proposed alternative to GALAD or Liver US with AFP for HCC screening in Filipinos Edhel Tripon Received Received
  3529-SUN Comparative Analysis of Imaging Modalities for Hepatocellular Carcinoma Surveillance Ahmed El sabagh Received Received
  3530-SUN Transarterial Chemoembolization Offers Survival Advantage Over Radioembolization in Early-stage Unresectable Hepatocellular Carcinoma Faisal Sanai Received Received
  3531-SUN Altered Cellular Energetics and Dysregulation of NK Cells in Hepatocellular Carcinoma Pushpa Yadav Received Received
  3532-SUN Baseline liver histological characteristics in patients with chronic hepatitis B who developed into HCC 3- 5 years later Haina Fan Received Received
  3534-SUN Chemical inhibition of phosphoglycerate mutase 5 attenuates hepatocellular carcinoma viability Andrea Johnston Received Received
  3536-SUN Characterization of the immune microenvironment in hepatocellular carcinoma before selective internal radiation therapy and its prognostic role in treatment efficacy Maria Stella Franzè Received Received
  3539-SUN Optimal Treatment Strategies for Hepatocellular Carcinoma: A Meta-Analysis Comparing Transarterial Chemoembolization (TACE) Plus Microwave Ablation (MWA) Versus Microwave Ablation Alone Muhammad Shahzil Received Received
  3543-SUN Prediction of Immune Checkpoint Inhibitor Treatment Response in Hepatocellular Carcinoma Using CT Radiomics Ji Hye Min Received Received
  3544-SUN Tumor-derived circulating carbonic anhydrase 9 as a predictor of resistance to atezolizumab and bevacizumab in advanced hepatocellular carcinoma Yu Sato Received Received